
<html lang="en"     class="pb-page"  data-request-id="a74bfac2-15ba-46a3-8c07-e0c03e7d99f4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100075z;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors" /></meta><meta name="dc.Creator" content="Erik L.  Meredith" /></meta><meta name="dc.Creator" content="Ophelia  Ardayfio" /></meta><meta name="dc.Creator" content="Kimberly  Beattie" /></meta><meta name="dc.Creator" content="Markus R.  Dobler" /></meta><meta name="dc.Creator" content="Istvan  Enyedy" /></meta><meta name="dc.Creator" content="Christoph  Gaul" /></meta><meta name="dc.Creator" content="Vinayak  Hosagrahara" /></meta><meta name="dc.Creator" content="Charles  Jewell" /></meta><meta name="dc.Creator" content="Keith  Koch" /></meta><meta name="dc.Creator" content="Wendy  Lee" /></meta><meta name="dc.Creator" content="HansJoerg  Lehmann" /></meta><meta name="dc.Creator" content="Timothy A.  McKinsey" /></meta><meta name="dc.Creator" content="Karl  Miranda" /></meta><meta name="dc.Creator" content="Nikos  Pagratis" /></meta><meta name="dc.Creator" content="Margaret  Pancost" /></meta><meta name="dc.Creator" content="Anup  Patnaik" /></meta><meta name="dc.Creator" content="Dillon  Phan" /></meta><meta name="dc.Creator" content="Craig  Plato" /></meta><meta name="dc.Creator" content="Ming  Qian" /></meta><meta name="dc.Creator" content="Vasumathy  Rajaraman" /></meta><meta name="dc.Creator" content="Chang  Rao" /></meta><meta name="dc.Creator" content="Olga  Rozhitskaya" /></meta><meta name="dc.Creator" content="Thomas  Ruppen" /></meta><meta name="dc.Creator" content="Jie  Shi" /></meta><meta name="dc.Creator" content="Sarah J.  Siska" /></meta><meta name="dc.Creator" content="Clayton  Springer" /></meta><meta name="dc.Creator" content="Maurice  van Eis" /></meta><meta name="dc.Creator" content="Richard B.  Vega" /></meta><meta name="dc.Creator" content="Anette  von Matt" /></meta><meta name="dc.Creator" content="Lihua  Yang" /></meta><meta name="dc.Creator" content="Taeyoung  Yoon" /></meta><meta name="dc.Creator" content="Ji-Hu  Zhang" /></meta><meta name="dc.Creator" content="Na  Zhu" /></meta><meta name="dc.Creator" content="Lauren G.  Monovich" /></meta><meta name="dc.Description" content="A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic m..." /></meta><meta name="Description" content="A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic m..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 14, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100075z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100075z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100075z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100075z" /></link>
        
    
    

<title>Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100075z" /></meta><meta property="og:title" content="Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0011.jpeg" /></meta><meta property="og:description" content="A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic mechanism with application as a heart failure therapy. As PKC was previously identified as the immediate upstream activator of PKD, PKD vs PKC selectivity was essential to understand the effect of PKD inhibition in models of cardiac hypertrophy and heart failure. The present study describes the modification of the HTS hit to a series of prototype pan-PKD inhibitors with routine 1000-fold PKD vs PKC selectivity. Example compounds inhibited PKD activity in vitro, in cells, and in vivo following oral administration. Their effects on heart morphology and function are discussed herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100075z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100075z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100075z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100075z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100075z&amp;href=/doi/10.1021/jm100075z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 5400-5421</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1000776" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100076w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erik+L.++Meredith">Erik L. Meredith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ophelia++Ardayfio">Ophelia Ardayfio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Beattie">Kimberly Beattie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus+R.++Dobler">Markus R. Dobler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Istvan++Enyedy">Istvan Enyedy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph++Gaul">Christoph Gaul</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinayak++Hosagrahara">Vinayak Hosagrahara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Jewell">Charles Jewell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Koch">Keith Koch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Lee">Wendy Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=HansJoerg++Lehmann">HansJoerg Lehmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+A.++McKinsey">Timothy A. McKinsey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl++Miranda">Karl Miranda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikos++Pagratis">Nikos Pagratis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret++Pancost">Margaret Pancost</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anup++Patnaik">Anup Patnaik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dillon++Phan">Dillon Phan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig++Plato">Craig Plato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Qian">Ming Qian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vasumathy++Rajaraman">Vasumathy Rajaraman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chang++Rao">Chang Rao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Rozhitskaya">Olga Rozhitskaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Ruppen">Thomas Ruppen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Shi">Jie Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+J.++Siska">Sarah J. Siska</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clayton++Springer">Clayton Springer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurice++van+Eis">Maurice van Eis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+B.++Vega">Richard B. Vega</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anette++von+Matt">Anette von Matt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lihua++Yang">Lihua Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taeyoung++Yoon">Taeyoung Yoon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ji-Hu++Zhang">Ji-Hu Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Na++Zhu">Na Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+G.++Monovich">Lauren G. Monovich</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 617-871-7606. Fax: 617-871-7045. E-mail: <a href="/cdn-cgi/l/email-protection#610d001413040f4f0c0e0f0e17080209210f0e1700131508124f020e0c"><span class="__cf_email__" data-cfemail="5539342027303b7b383a3b3a233c363d153b3a233427213c267b363a38">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100075z&amp;href=/doi/10.1021%2Fjm100075z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 5400–5421</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 14, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 January 2010</li><li><span class="item_label"><b>Published</b> online</span>14 July 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 August 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100075z" title="DOI URL">https://doi.org/10.1021/jm100075z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5400%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DErik%2BL.%2BMeredith%252C%2BOphelia%2BArdayfio%252C%2BKimberly%2BBeattie%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D15%26contentID%3Djm100075z%26title%3DIdentification%2Bof%2BOrally%2BAvailable%2BNaphthyridine%2BProtein%2BKinase%2BD%2BInhibitors%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5421%26publicationDate%3DAugust%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100075z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2956</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100075z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;L. Meredith&quot;},{&quot;first_name&quot;:&quot;Ophelia&quot;,&quot;last_name&quot;:&quot;Ardayfio&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Beattie&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;R. Dobler&quot;},{&quot;first_name&quot;:&quot;Istvan&quot;,&quot;last_name&quot;:&quot;Enyedy&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;Gaul&quot;},{&quot;first_name&quot;:&quot;Vinayak&quot;,&quot;last_name&quot;:&quot;Hosagrahara&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Jewell&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Koch&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;HansJoerg&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;A. McKinsey&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;Miranda&quot;},{&quot;first_name&quot;:&quot;Nikos&quot;,&quot;last_name&quot;:&quot;Pagratis&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;Pancost&quot;},{&quot;first_name&quot;:&quot;Anup&quot;,&quot;last_name&quot;:&quot;Patnaik&quot;},{&quot;first_name&quot;:&quot;Dillon&quot;,&quot;last_name&quot;:&quot;Phan&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Plato&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Vasumathy&quot;,&quot;last_name&quot;:&quot;Rajaraman&quot;},{&quot;first_name&quot;:&quot;Chang&quot;,&quot;last_name&quot;:&quot;Rao&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Rozhitskaya&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Ruppen&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;J. Siska&quot;},{&quot;first_name&quot;:&quot;Clayton&quot;,&quot;last_name&quot;:&quot;Springer&quot;},{&quot;first_name&quot;:&quot;Maurice&quot;,&quot;last_name&quot;:&quot;van Eis&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;B. Vega&quot;},{&quot;first_name&quot;:&quot;Anette&quot;,&quot;last_name&quot;:&quot;von Matt&quot;},{&quot;first_name&quot;:&quot;Lihua&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Taeyoung&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Ji-Hu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Na&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;G. Monovich&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;5400-5421&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100075z&quot;},&quot;abstract&quot;:&quot;A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic mechanism with application as a heart failure therapy. As PKC was previously identified as the immediate upstream activator of PKD, PKD vs PKC selectivity was essential to understand the effect of PKD inhibition in models of cardiac hypertrophy and heart failure. The present study describes the modification of the HTS hit to a series of prototype pan-PKD inhibitors with routine 1000-fold PKD vs PKC selectivity. Example compounds inhibited PKD activity in vitro, in cells, and in vivo following oral administration. Their effects on heart morphology and function are discussed herein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100075z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100075z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100075z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100075z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100075z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100075z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100075z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100075z&amp;href=/doi/10.1021/jm100075z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100075z" /></input><a href="/doi/pdf/10.1021/jm100075z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100075z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100075z%26sid%3Dliteratum%253Aachs%26pmid%3D20684591%26genre%3Darticle%26aulast%3DMeredith%26date%3D2010%26atitle%3DIdentification%2Bof%2BOrally%2BAvailable%2BNaphthyridine%2BProtein%2BKinase%2BD%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D15%26spage%3D5400%26epage%3D5421%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jmcmar.2010.53.issue-15/production/jmcmar.2010.53.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic mechanism with application as a heart failure therapy. As PKC was previously identified as the immediate upstream activator of PKD, PKD vs PKC selectivity was essential to understand the effect of PKD inhibition in models of cardiac hypertrophy and heart failure. The present study describes the modification of the HTS hit to a series of prototype pan-PKD inhibitors with routine 1000-fold PKD vs PKC selectivity. Example compounds inhibited PKD activity in vitro, in cells, and in vivo following oral administration. Their effects on heart morphology and function are discussed herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heart failure,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> a leading cause of death in industrialized nations, is characterized by increased cardiac size and loss of cardiovascular function. In patients with cardiac dysfunction, it is unknown whether increased cardiac size or cardiac hypertrophy is causative or compensatory for cardiac dysfunction,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> but the enlarged heart, specifically hypertrophy of the left ventricle, is an independent risk factor for adverse cardiac events.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Further, reduction of existing cardiac hypertrophy decreases mortality.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Cardiac hypertrophy does not reflect hyperplasia of the cardiac muscle cells, or cardiac myocytes, but rather hypertrophy of the individual myocytes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, aberrant hypertrophic signaling pathways in the cardiac myocyte present attractive targets to intercept pathological cardiac hypertrophy and to explore the effect on cardiac function.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Within the normal adult cardiac myocyte, the transcription factor myocyte enhancer factor 2 (MEF2<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: PKD, protein kinase D; PKC, protein kinase C; TAB, thoracic aortic banded; DSS, Dahl salt-sensitive; HDAC, histone deacetylase; MEF2, myocyte enhancer factor 2; GFP, green fluorescence proteint; LV, left ventricle; TL, tibia length; IVRT, isovolumic relaxation time; MAP, mean arterial pressure; PMA, phorbol 12-myristate 13-acetate; PE, phenylephrine; PGF2α, prostaglandin F2α; ET-1, endothelin-1; LPA, lipopolysaccharide A; PMBCs, peripheral blood mononuclear cells; HTS, high throughput screen.</p></div> dependent gene expression is repressed by association with class IIa histone deacetylases (HDACs 4, 5, 7, and 9).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In failing hearts, derepression of MEF2 is believed to be a key player in adverse cardiac remodeling, including hypertrophy. In accordance with this hypothesis, MEF2D<sup>−/−</sup> mice are resistant to cardiac hypertrophy induced by stresses such as chronic β-adrenergic stimulation and pressure overload.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Conversely, targeted disruption of the MEF2 repressor HDACs, including HDAC5, sensitizes mice to pathological cardiac growth.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Cellular localization of class IIa HDACs is controlled by phosphorylation state; phosphorylation of its nuclear localization sequence (NLS) targets HDAC5 for nuclear export to the cytosol, thereby relieving repression of the transcription factor MEF2.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In support of this hypothesis, cardiac myocytes expressing phosphorylation-resistant (e.g., Ser → Ala mutant) HDAC5 resist stress-induced hypertrophy.</div><div class="NLM_p">The subsequent search for the HDAC5 kinase identified the serine/threonine kinase, protein kinase D1 (PKD1),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> one of three PKD isoforms (including PKDs 2 and 3) from the calmodulin kinase family. The role of PKD1 in pathologic signaling is supported by both gain and loss of function studies in isolated cardiac myoctes and in vivo. For example, in isolated cardiac myocytes, knockdown of PKD1 prevents agonist-induced hypertrophy. In vivo, loss of PKD1 protects mice from pressure overload-induced hypertrophy resulting from surgical banding of the thoracic aorta (TAB). Conversely, transgenic mice overexpressing constitutively active PKD1 develop cardiac dysfunction. By preventing phosphorylation and nuclear export of the MEF2 repressor HDAC5, PKD1 inhibitors are anticipated to control activity of the transcription factor MEF2 and the consequent pathological cardiac hypertrophy and dysfunction.</div><div class="NLM_p">At the inception of the present study, pan PKC inhibitors, such as Gö-6976 <b>1</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), had been described as a dual PKC/PKD inhibitors. Subsequently, additional PKD inhibitors<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and an allosteric series exemplified by CID755673<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> have been disclosed. PKC isoforms are described as immediate upstream activator kinases of PKD,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> so PKD vs PKC selectivity, unknown at the inception of the present study, served as an important determinant for a proof of concept PKD inhibitor. Encouragingly, the PKC family, which belongs to the AGC group of kinases, is not closely related to the PKDs, which belong to the calmodulin (CaMK) group of kinases.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Conversely, an ATP-competetive inhibitor must distinguish between close sequence homology near the hing-binding regions of the PKCs and PKDs, as in the sequences V<u class="uu">M</u>EFLNG and V<u class="uu">M</u>EKLHG for PKCδ and PKD1, respectively. The methionine (<u class="uu">M</u>) gatekeeper residue is the most common among both the AGC and CaMK kinase groups.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Similar to the dual PKC and PKDs inhibitors described in the literature, an HTS from the Novartis archive identified novel 2,6-naphthyridine <b>2</b> as a dual inhibitor of PKC and PKD (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), with 10-fold higher potency vs novel PKC isoforms, such as PKCδ, than PKD (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Herein, we describe the optimization of <b>2</b> to prototype PKD inhibitors with oral availability and 1000-fold selectivity vs PKC isoforms.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PKD inhibitor structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PKD, PKC, and HDAC Nuclear Export Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0005.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of <b>2</b> and analogues began with pyridine oxide <b>3</b>, which underwent methylation followed by attack of cyanide to afford compound <b>4</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Nitrile <b>4</b> was efficiently converted to the <i>tert</i>-butylamide <b>5</b> by treatment with <i>t</i>-BuOH in concentrated H<sub>2</sub>SO<sub>4</sub>. Alternatively, compound <b>5</b> was accessed from isonicotinic acid <b>6</b> by formation of the <i>tert</i>-butylamide followed by amide-directed lithiation and trapping with MeI. Deprotonation of compound <b>5</b> with <i>n</i>-BuLi and treatment with ester <b>7a</b> or ester <b>7b</b> afforded ketone <b>8a</b> or ketone <b>8b</b>, respectively. Ring closure with loss of <i>tert</i>-butylamine and dehydration to the pyranone occurred with heating in DMF, followed by heating in AcOH. Treatment of the pyrido-pyranones with 25% NH<sub>3</sub> in EtOH afforded the 2,6-naphthyridones, which were successfully halogenated by treatment with POBr<sub>3</sub> to give 1-bromo-2,6-naphthyridine <b>9a</b> or with POCl<sub>3</sub> to give the 1-chloro-2,6-naphthyridines <b>9b</b> and <b>9c</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0024.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the 2,6-Naphthyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (MeO)<sub>2</sub>SO<sub>2</sub>, EtOH, H<sub>2</sub>O, 60 °C, 18 h; (ii) KCN, EtOH, H<sub>2</sub>O, 18 h; (iii) <i>t</i>-BuOH, conc H<sub>2</sub>SO<sub>4</sub>, 70 °C, 3 h; (iv) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, then <i>t</i>-BuNH<sub>2</sub>; (v) <i>n</i>-BuLi, then MeI; (vi) <i>n</i>-BuLi, THF, −70 °C; (vii) DMF, reflux; (viii) AcOH, 100 °C; (ix) 25% NH<sub>3</sub>, EtOH; (x) POBr<sub>3</sub> or POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (xi) HNRR<sup>1</sup>, Et<sub>3</sub>N, EtOH, reflux; (xii) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (xiii) H<sub>2</sub>NR<sup>2</sup>, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (xiv) isobutyraldehyde, NaBH(OAc)<sub>3</sub>, Cl(CH<sub>2</sub>)<sub>2</sub>Cl.</p></p></figure><div class="NLM_p">Displacement of the halogen of <b>9a</b> or <b>9b</b> with nitrogen nucleophiles, such as BOC-protected ethylenediamine, aminopropanol, or BOC-piperazine, afforded 1-amino-2,6-naphthyridines <b>10a</b>−<b>c</b>. Acidic deprotection of the BOC amines <b>10a</b> and <b>10c</b> afforded PKD inhibitors <b>2</b> and <b>11</b>, respectively. Likewise, chloride <b>9c</b> was treated with nitrogen nucleophiles to afford <b>12a</b>−<b>c</b>. Buchwald amination of 2-chloropyridines <b>12a</b>−<b>c</b> with methylamine, cyclohexylamine, or 4-aminotetrahydropyran gave inhibitors <b>13</b>. Compounds <b>13</b> were further elaborated as indicated, for example, by acidic deprotection of <b>13b</b> or <b>13e</b> to give <b>13c</b> and <b>13f</b>, respectively. Borch reduction of secondary amines <b>13c</b> and <b>13f</b> gave tertiary amines <b>13d</b> and <b>13g</b>, respectively.</div><div class="NLM_p">A similar reaction sequence was used to vary the placement of nitrogen within the core naphthyridine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). <i>N</i>-<i>tert</i>-Butyl-2-methylbenzamide <b>14a</b> or aza analogues <b>14b</b>−<b>d</b> (where A, B, or E equals nitrogen) were lithiated and trapped with 2-chloroisonicotinic acid methyl ester <b>7b</b> as above. The crude ketones <b>15a</b>−<b>d</b> were directly treated with hot AcOH to effect cyclocondensation to yield pyrido-pyranones, which were then converted to naphthyridones <b>16a</b>−<b>d</b> by treatment with ammonia in MeOH. To synthesize the quinazoline-containing analogue, treatment of nitrile <b>17</b> with HCl in methanol gave imidate <b>18</b>, which was condensed with anthranilic acid <b>19</b> to afford the quinazolinone <b>20</b>. Compounds <b>16a</b>−<b>d</b> and <b>20</b> were chlorinated with POCl<sub>3</sub> and treated with BOC-piperazine to afford <b>21a</b>−<b>e</b>. As above, elaboration of chloropyridines <b>21a</b>−<b>e</b> was accomplished by Buchwald amination with cyclohexlyamine. Removal of the BOC-protecting group gave inhibitors <b>22a</b>−<b>e</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0001.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alternative Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>n</i>-BuLi, <b>7b</b>, THF, −70 °C; (ii) AcOH, 100 °C; (iii) 25% NH<sub>3</sub>, EtOH; (iv) HCl, MeOH, dioxane; (v) Na, MeOH; (vi) POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (vii) BOC piperazine, Et<sub>3</sub>N, EtOH, reflux; (viii) cyclohexylamine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (ix) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">Exploration of additional diversity at the 1-position of the naphthyridine was enabled as described in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Selective displacement of the 1-chloronaphthyridine <b>9c</b> with methoxide afforded <b>23</b>, which was reacted with cyclohexylamine utilizing palladium catalysis, demethylated with wet <i>t</i>-BuOK, and chlorinated with POCl<sub>3</sub> to afford <b>24</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Nucleophilic substitution of chloride <b>24</b> with a series of cyclic amines afforded inhibitors <b>13h</b>−<b>j</b>. By analogy to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, direct treatment of dichloride <b>9c</b> with amines gave intermediates <b>12d</b>−<b>i</b>, which were converted to targets <b>13k</b>−<b>q</b> by methods described above. In addition, peptide coupling of piperazine <b>13f</b> to BOC-glycine and subsequent BOC removal afforded target <b>13r</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0002.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Installation of Groups on the 1-Naphthyridine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaOMe, MeOH; (ii) cyclohexylamine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (iii) <i>t</i>-BuOK, <i>t</i>-BuOH, THF; (iv) POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (v) amine, Et<sub>3</sub>N, EtOH, reflux; (vi) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (vii) <i>N</i>-BOC-glycine, HBTU, Et<sub>3</sub>N; (viii) formic acid.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0003.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 1-Naphthyridines with Pendent Amides and Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) amine, Et<sub>3</sub>N, EtOH, reflux; (ii) amine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (iii) amine, Me<sub>3</sub>Al; (iv) LiOH, THF, water; (v) amine, PyBop, HOBt; (vi) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (vii) MsCl.</p></p></figure><div class="NLM_p last">Reaction of <b>9c</b> with piperidine-4-carboxylic acid derivatives yielded intermediates <b>12j</b>−<b>l</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Amides <b>12j</b> and <b>12k</b> were subjected to Pd-catalyzed coupling to cyclohexylamine or 4-aminotetrahydropyran to give compounds <b>13s</b>-<b>u</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Alternatively, ester <b>12l</b> was converted to a series of target amides <b>13v</b>−<b>ae</b>. The ester was either saponifed and coupled to the amine using PyBOP or converted directly by treatment of the amine in the presence of Me<sub>3</sub>Al. Compounds <b>13ac</b> and <b>13ae</b> were generated by acidic deprotection of <b>13ab</b> and <b>13ad</b>, respectively.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Compound Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In vitro, compounds were evaluated for their ability to inhibit the target PKD1, PKD isoforms 2 and 3, and representative PKC isoforms PKCα and PKCδ. All compounds in the present study were found to competitively inhibit the entire PKD family<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (isoforms 1, 2, and 3) with similar potency, consistent with the high sequence identity among PKDs 1, 2, and 3. The sequences of the PKD2 and PKD3 kinase domains are 91% and 94% identical, respectively, to that of PKD1.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Only the PKD1 activity is reported for clarity, but reference throughout the text to PKD inhibition will represent pan-PKD inhibition. The HDAC nuclear export assay, a cellular readout of PKD activity, monitored the ability of the inhibitors to prevent PGF2α-stimulated nuclear export of GFP-HDAC5 in the cardiac myocyte.</div><div class="NLM_p last">In vivo, selected compounds were evaluated for their ability to block cardiac hypertrophy with daily administration for 14 days in a rat model of disease. The two rat models utilized in the present study were the TAB rat, a surgical model of pressure-overload-induced cardiac hypertrophy, recalling that PKD1 knockout was shown to blunt cardiac hypertrophy in the TAB mouse. A second model, the Dahl salt-sensitive (DSS) rat, is a genetic model of high salt-induced hypertension and cardiac hypertrophy. In all rat studies, the effect of compound treatment on blood pressure was monitored to control for the anticipated benefit of antihypertensives on cardiac hypertrophy in both models.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The reported reference PKC/PKD dual inhibitor <b>1</b> showed activity vs PKD (IC<sub>50</sub> = 27 nM) and PKC isoforms (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), as well as the cellular readout of HDAC nuclear export (IC<sub>50</sub> = 62 nM). Screening hit, compound <b>2</b>, showed more modest inhibition of PKD (IC<sub>50</sub> = 321 nM) and HDAC nuclear export (IC<sub>50</sub> = 5420 nM). Like <b>1</b>, compound <b>2</b> did not achieve the desired selectivity vs a subset of the PKC isoforms. Rather, <b>2</b> exhibited 10-fold inverted selectivity vs PKCδ (IC<sub>50</sub> = 20 nM). Further, owing to the role of PKC in PKD activation, the cellular activities of <b>1</b> and <b>2</b> cannot be firmly attributed to PKD inhibition. That is, HDAC nuclear export activity of <b>1</b> and <b>2</b> cannot rule out the contribution of direct and exclusive PKC inhibition.</div><div class="NLM_p">Compound <b>10b</b> highlights the sensitivity of the 1-naphthyridine substituent for PKD, PKCα, and PKCδ activity. Compound <b>13a</b> hinted that introduction of a 2-pyridine substituent benefited PKD activity without enhancing PKC inhibition. The piperazine <b>11</b> gained 5-fold PKD activity vs the parent ethylenediamine <b>2</b>. Combining the piperazine with the 2-pyridine substituent, as with <b>12c</b> (IC<sub>50</sub> = 50 nM) or <b>13c</b> (IC<sub>50</sub> = 0.6 nM), afforded potent PKD inhibitors with useful (20- to 1400-fold) selectivity vs PKCs. Similarly weak PKC activity was observed for all subsequent compounds bearing 2-pyridyl substituents described throughout the present study. Encouragingly, the cellular activity of <b>13c</b> (IC<sub>50</sub> = 32 nM) was more potent than could be expected for micromolar inhibition across PKC isoforms. With simple substitution changes, naphthyridine <b>13c</b> reflects a ∼500-fold increase in target activity and a ∼15,000-fold increase in PKD vs PKCδ selectivity relative to the hit compound <b>2</b>.</div><div class="NLM_p">In Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, a possible binding mode for <b>13c</b> in the ATP-binding site of PKD1 is shown, wherein the alkylaminopyridine forms two hydrogen-bonding contacts with the Leu662 hinge residue, the naphthyridine 6-nitrogen contacts the catalytic Lys612, and the piperazine nitrogen participates in a salt bridge with a pendent Glu710 of the sugar pocket. However, the pseudosymmetry of the series renders the 6-naphthyridine nitrogen of <b>13c</b> a viable alternative for the hinge contact and the pyridine a viable alternative contact for the catalytic Lys. If indeed the binding mode depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> is accurate and a similar orientation is realized for PKC, the intolerance of PKCs for the 2-pyridyl substituent may come from steric clash with the residues adjacent to the hinge, which are uniformly larger (Phe or Tyr) for the PKCs, where the PKDs contain the more flexible Lys. In the absence of X-ray crystallographic data for a representative naphthyridine inhibitor in PKD and PKC, a specific structural basis for the observed selectivity impact with substitution of the pyridine is unknown.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed key contacts for PKD inhibitor <b>13c</b> in PKD1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To better understand the contribution of the core 2,6-naphthyridine to the PKD activity, the team explored modification of the 6-naphthyridine nitrogen, while keeping the “2”-naphthyridine nitrogen constant (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, only the isoquinoline <b>22a</b>, 2,5-naphthyridine <b>22d</b>, and quinazoline <b>22e</b> achieved IC<sub>50</sub>s less than 50 nM. In no case where the 6-nitrogen was deleted or relocated did the PKD activity match that of the parent <b>13c</b>. These results are consistent with the function of the 6-nitrogen as a hydrogen-bond acceptor to the enzyme.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Naphthyridine Core Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0006.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A</th><th class="colsep0 rowsep0" align="center">B</th><th class="colsep0 rowsep0" align="center">D</th><th class="colsep0 rowsep0" align="center">E</th><th class="colsep0 rowsep0" align="center">G</th><th class="colsep0 rowsep0" align="center" char=".">PKD1</th><th class="colsep0 rowsep0" align="center" char=".">HDAC exptl</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">356</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">695</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22c</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">191</td><td class="colsep0 rowsep0" align="char" char=".">1558</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22d</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">262</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22e</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">1521</td></tr></tbody></table></div></div><div class="NLM_p">In certain cases, modulating the bulkiness, basicity, and/or polarity of amine-containing compounds can improve druglike qualities. The compounds indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were prepared to explore the effects of amine branching and basicity on PKD potency. This series highlights the flat SAR with respect to PKD and HDAC export, with only the weakest base <b>13l</b> falling 10-fold outside the IC<sub>50</sub> of the parent <b>13c</b>. Replacing the cyclohexyl with an alternative but neutral branched aliphatic group with greater polarity (e.g., THP) gave compounds <b>13f</b> and <b>13g</b>. The calculated log <i>P</i> values for <b>13c</b> and <b>13f</b> are significantly different (4.12 for <b>13c</b> and 1.72 for <b>13f</b>), yet compounds <b>13f</b> and <b>13g</b> showed equal potency relative to their cyclohexyl comparators <b>13c</b> and <b>13d</b>. Although the piperazine likely contributes to the high aqueous solubility at pH 6.8 of both <b>13c</b> (734 μM) and <b>13f</b> (887 μM), the flexibility to introduce pyridine 2-substituents with greater polarity, like the aminoTHP, can provide a potentially useful mechanism to modify the physical properties (e.g., aqueous solubility) or the off-target profile of naphthyridine analogues.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 1-Naphthyridine Modifications: Piperazines and Aminopiperidine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0007.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0008.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div></div><div class="NLM_p">A second study of the 1-naphthyridine substituent carried either the cyclohexylamino or 4-tetrahydropyranamino findings of the above (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). As with the entries of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, untethered alcohols, such as <b>13n</b>, offered modest PKD inhibition, while introdution of a ring enhanced activity (<b>13j</b>, IC<sub>50</sub> = 15 nM). Building from the piperazine, the first amides <b>13o</b> and <b>13m</b> were disappointing, especially with respect to cellular activity. Reinserting a basic nitrogen, as with <b>13r</b>, enhanced the PKD and cellular activity relative to <b>13m</b>. Thereafter, the team was pleased to identify the piperidine carboxamide series, including <b>13s</b> and <b>13t</b>, which offered good PKD inhibition and cellular activity in the absence of a basic nitrogen. Bulkier analogues, such as <b>13y</b> and <b>13z</b>, exhibited low nanomolar IC<sub>50</sub>s vs PKD but 10-fold weaker HDAC export activity compared to the most potent examples. Again, in cases such as <b>13ae</b> and <b>13v</b>, where a pendent base was (re)installed, the cellular activity (IC<sub>50</sub> values of 44 and 25 nM, respectively) matched that of piperazine <b>13c</b> (IC<sub>50</sub> = 32 nM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. 1-Naphthyridine Modifications: Alcohols and Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0009.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0010.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Further comparison of prototype PKD inhibitors amine <b>13c</b> and amide <b>13y</b> in vitro, in cells, and in vivo follows. In vitro (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), compounds <b>13c</b> and <b>13y</b> dose-dependently inhibited autophosphorylation of recombinant human PKD1 (Ser916) and PKD2 (Ser867). At concentrations as low as 10 nM, <b>13c</b> partially blunted PKD1 autophosphorylation and nearly completely blunted PKD2 autophosphorylation in the absence of the HDAC peptide, a 25-mer substrate peptide designed to model one of the HDAC serine residues (Ser498) that is phosphorylated by PKD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PKD inhibitors <b>13c</b> and <b>13y</b> block in vitro autophosphorylation of PKD1 (Ser916) and PKD2 (Ser867) in the absence or presence of an HDAC5 peptide. The concentrations at which PKD autophosphorylation is inhibited are consistent with the IC<sub>50</sub> values in the PKD biochemical assays: (a) (−) 0 μM, (∗) 0.01 μM, (∗∗) 0.1 μM, (∗∗∗) 1 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For compound <b>13y</b>, partial control of PKD1 autophosphorylation was observed at 10 nM, with near complete inhibition at 100 nM. However, 100 nM of <b>13y</b> was needed to block PKD2 autophosphorylation. These experiments compared well with the relative and absolute biochemical assay results for <b>13c</b> and <b>13y</b> (PKD1 data from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, PKD2 IC<sub>50</sub> values of 2 and 16 nM, respectively) and confirmed the pan-PKD inhibitory activity of the 2,6-naphthyridine series with an alternative substrate. Lastly, inhibition of both PKDs by <b>13c</b> and <b>13y</b> occurred in the presence of an HDAC5 peptide, which served as a surrogate for the native, full length HDAC5 present in cells.</div><div class="NLM_p">GPCR agonists, such as prostaglandin F2α (PGF2α) utilized in the HDAC export assay or phenylephrine (PE) and endothelin-1 (ET-1) utilized for Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> below, initiate cell surface-signaling to PKC and consequent activation of PKD to drive GFP-HDAC5 export to the cytosol of rat cardiac myocytes (top row, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In addition, direct stimulation of PKC with the phorbol ester PMA causes nuclear export of GFP-HDAC5. With all stimuli shown to cause export of GFP-HDAC5, pretreatment of the cells with 1 μM <b>13c</b> controlled GFP-HDAC5 nuclear export, consistent with the hypothesis that PKD integrates multiple signals originating at the cell surface.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In neonatal rat ventricular myocytes (NRVMs), 1 μM <b>13c</b> blocks GFP-HDAC5 nuclear export in response to a variety of stimuli, including 10 μM phenylephrine (PE), endothelin-1 (ET-1), prostaglandin F2α (PGF2α), lysophosphatidic acid (LPA), or phorbol 12-myristate 13-acetate (PMA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In PE-stimulated rat cardiac myocytes (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), <b>13c</b> and <b>13y</b> dose-dependently block PKD activity. PKD activity, which is gauged by both autophosphorylation (Ser916) and phosphorylation of the substrate HDAC5 (Ser498), occurred without loss of PKD activation (PKC-mediated phosphorylation at Ser744/748 not shown). Consistent with the HDAC export assay that tracks PGF2α-driven nuclear export of superphysiologic GFP-HDAC, both <b>13c</b> and <b>13y</b> blocked phosphorylation of GFP-HDAC5 (Ser498) at 1000 nM. Additionally, the relative potency between <b>13c</b> (IC<sub>50</sub> = 32 nM) and <b>13y</b> (IC<sub>50</sub> = 391 nM) in the HDAC export assay is reflected in the ability of 100 nM <b>13c</b>, but not <b>13y</b>, to normalize pHDAC to baseline. As well, both compounds dose-dependently inhibited native PKD autophosphorylation, albeit at concentrations higher than those required to block pHDAC. For example, at a dose 10-fold greater than that which successfully controlled pHDAC, residual pPKD was detected in the presence of 1000 nM <b>13c</b> by comparison to pPKD in unstimulated cells. This phenomenon was matched throughout the present study. That is, we routinely observed inhibition of pHDAC in isolated cardiac myocytes at lower concentrations than those required to blunt autophosphorylation of native PKD.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In NRVMs, compound <b>13c</b> and <b>13y</b> block PE-stimulated PKD activity. In accordance with their relative and absolute potencies in the HDAC export assay, compounds <b>13c</b> (at 0.1 and 1 μM) and <b>13y</b> (at 1 μM) block phosphorylation of the PKD substrate HDAC (pSer498). At 1 μM, <b>13c</b> effectively blocks PKD autophosphorylation (pSer916) while <b>13y</b> produces partial reduction: (a) (−) 0 μM, (∗) 0.1 μM, (∗∗) 1 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further profiling of <b>13c</b> and <b>13y</b> supported their use as prototype PKD inhibitors for in vivo study. In male Sprague−Dawley rats, the pharmacokinetic parameters of <b>13c</b> and <b>13y</b> were evaluated following administration as solutions (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). To accommodate the low aqueous solubility of <b>13y</b> for iv administration, an NMP and Cremophor EL containing vehicle was used for the determination of PK properties. For consistency, the vehicle used for <b>13c</b> to determine PK parameters was matched to that used for <b>13y</b>. For the subsequent high dose exposure and efficacy studies in rats, both <b>13c</b> and <b>13y</b> were administered orally as suspensions in methylcellulose or subcutaneously in acidified captisol. Following an iv dose, <b>13c</b> was cleared rapidly from the plasma and showed a large volume of distribution (12 L/kg) that was significantly greater than the total body water in rats. When administered as a solution via oral gavage, <b>13c</b> was rapidly absorbed with a low absolute oral bioavailability of 4%. A subset of the amides, including <b>13y</b>, showed measurable plasma exposure following oral administration, with <i>C</i><sub>max</sub>, AUC<sub>0-8h</sub>, and bioavailability exceeding those of the piperazine <b>13c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). A 50 mg/kg po dose of compounds <b>13c</b> and <b>13y</b> as suspensions to the DSS rat produced higher plasma exposures and similar plasma curve shapes relative to the low-dose po studies above (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Compound <b>13c</b> for its potency and consistent plasma exposure and high cardiac exposure (not shown) and the amide <b>13y</b> for its different plasma PK profile, improved kinase selectivity, and spotless receptor binding profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) were investigated in the in vivo hypertrophy models.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0017.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. DSS rat plasma exposure following 50 mg/kg oral administration of <b>13c</b> and <b>13y</b> as a suspension in 0.5% methylcellulose and 0.5% Tween-80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of <b>13c</b> and <b>13y</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameter</th><th class="colsep0 rowsep0" align="center"><b>13c</b></th><th class="colsep0 rowsep0" align="center"><b>13y</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose iv/po (mg/kg)</td><td class="colsep0 rowsep0" align="left">2/5</td><td class="colsep0 rowsep0" align="left">2/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po <i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">128 ± 29</td><td class="colsep0 rowsep0" align="left">466 ± 535</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po <i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po AUC<sub>0−8h</sub> (nM·h)</td><td class="colsep0 rowsep0" align="left">193 ± 175</td><td class="colsep0 rowsep0" align="left">633 ± 647</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv AUC<sub>0−8h</sub> (nM·h)</td><td class="colsep0 rowsep0" align="left">1923 ± 460</td><td class="colsep0 rowsep0" align="left">1107 ± 313</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL ((mL/min)/kg)</td><td class="colsep0 rowsep0" align="left">32 ± 12</td><td class="colsep0 rowsep0" align="left">61 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">12 ± 1</td><td class="colsep0 rowsep0" align="left">7.0 ± 7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>half</sub> (h)</td><td class="colsep0 rowsep0" align="left">5.2 ± 1.9</td><td class="colsep0 rowsep0" align="left">5.4 ± 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability (%)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">AUC<sub>0−8h</sub> reported here, not AUC<sub>∞</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Percent Activity Remaining in the Presence of 1 μM <b>13c</b> or <b>13y</b> vs Set of PKD Family Member Kinases and IC<sub>50</sub> Values versus Adrenergic Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">activity (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase </th><th class="colsep0 rowsep0" align="center" char="."><b>13c</b></th><th class="colsep0 rowsep0" align="center" char="."><b>13y</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKD1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKD2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3β</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CaMKIδ</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CaMKIIβ</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CaMKIIγ</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CaMKIIδ</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CaMKIV</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MARK1</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SIK1</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GRK5</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKCδ</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKCε</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr></tbody></table><table class="table "><colgroup><col width="33.33333333333333%" align="left" /></col><col width="33.33333333333333%" align="char" char="." /></col><col width="33.33333333333333%" align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" colspan="2" align="center" valign="top" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">receptor</th><th class="colsep0 rowsep0" align="center" valign="top" char="."><b>13c</b></th><th class="colsep0 rowsep0" align="center" valign="top" char="."><b>13y</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α1AR</td><td class="colsep0 rowsep0" align="char" char=".">7202</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β1AR</td><td class="colsep0 rowsep0" align="char" char=".">2351</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>13c</b> or <b>13y</b> were adminstered at 50 (mg/kg)/day po for 14 days to DSS rats concomitantly with a switch to a high-salt (8%) diet. Control animals remaining on normal-salt diet (0.5%) or on high-salt (8%) diet were administered vehicle daily. As anticipated, vehicle-treated animals on high-salt diet exhibited hypertension, or elevated mean arterial pressure (MAP), and hypertension-driven cardiac hypertrophy relative to the vehicle-treated rats on normal-salt diet (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The mass of the left ventricle (LV) normalized to the animal size by the tibia length (TL) gives the index of cardiac hypertrophy. After 14 days, rats given a high-salt diet exhibited a consistently elevated mean blood pressure (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a) and a corresponding ∼20% increase in the LV/TL relative to the normal-salt rats (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). While neither compound <b>13c</b> nor <b>13y</b> blocked high-salt induced hypertension (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a), the compounds were differentiated with respect to cardiac hypertrophy. Compound <b>13c</b>, but not <b>13y</b>, gave a statistically significant reduction in the LV/TL (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). In the absence of changes to MAP, the antihypertrophic behavior of <b>13c</b> at 50 (mg/kg)/day po cannot be attributed to simple relief of hypertension.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0018.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>13c</b> and <b>13y</b> given 50 (mg/kg)/day po as a suspension in methylcellulose for 14 days in the DSS rat on (a) mean blood pressure and (b) cardiac hypertrophy (left ventricular mass/tibia length) on day 14. Neither compound attenuated the increase in mean blood pressure observed with high (8%) salt diet. Compound <b>13c</b>, but not <b>13y</b>, blunted high-salt-induced cardiac hypertrophy (LV/TL): (∗) <i>p</i> < 0.05 vs 0.05% NaCl plus vehicle; (†) <i>p</i> < 0.05 vs 8% NaCl plus vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To circumvent technical difficulties with monitoring phosphorylation state changes to the modestly abundant HDAC5 in intact rat hearts, the team devised an ex vivo assay to monitor PKD inhibition in a surrogate cell type, the peripheral blood mononuclear cells (PBMCs). As with the cardiac myocytes of Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, PKD was activated in PBMCs by treatment with phorbol ester (PMA). In PMA-stimulated PBMCs taken from the DSS study above (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), both compounds <b>13c</b> and <b>13y</b> reduced the substrate HDAC phosphorylation, but only the efficacious <b>13c</b> also reduced PKD autophosphorylation. A dose−response study conducted with <b>13c</b> given 50, 15, or 5 (mg/kg)/day in the DSS rat (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) confirmed the antihypertrophic response at the 50 (mg/kg)/day dose as above (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). However, while the lower doses of 15 and 5 (mg/kg)/day achieved 6700 and 1000 nM cardiac exposures, respectively, neither compound attenuated high salt-induced cardiac hypertrophy. From the PKD activity biomarkers observed in PBMCs (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), all three doses of <b>13c</b> blunt pHDAC, but only the highest 50 mg/kg dose achieves a statistically significant reduction of PKD autophosphorylation.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0019.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Biomarker readout in the DSS rat in a surrogate cell type on day 14. In peripheral blood mononuclear cells (PBMCs), PMA-stimulated, (a) autophosphorylation of PKD at Ser916 is blunted by compound <b>13c</b> and (b) phosphorylation of the PKD substrate HDAC at Ser498 is blunted by both <b>13c</b> and <b>13y</b> relative to the vehicle control: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0020.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of compound <b>13c</b> given 5, 10, and 50 (mg/kg)/day po as a suspension in methylcellulose on day 14 of 14 days in the DSS rat on cardiac hypertrophy (left ventricular mass/tibia length). Only the 50 mg/kg po dose attenuates high-salt-diet-induced cardiac hypertrophy (LV/TL): (∗) <i>p</i> < 0.05 vs 0.05% NaCl plus vehicle; (†) <i>p</i> < 0.05 vs 8% NaCl plus vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0021.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Biomarker readout in the DSS rat in a surrogate cell type on day 14. In peripheral blood mononuclear cells (PBMCs), PMA-stimulated, (a) autophosphorylation of PKD at Ser916 is blunted by the highest dose of compound <b>13c</b> and (b) phosphorylation of the PKD substrate HDAC at Ser498 is reduced by all compound doses: (∗) <i>p</i> < 0.05 vs vehicle; (#) <i>p</i> < 0.05 vs vehicle plus PMA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To follow up on the observation that PKD1<sup>−/−</sup> limits the pressure-overload-induced cardiac hypertrophy observed in the TAB rat, compound <b>13c</b> was evaluated in a rat TAB model. In this case, surgical banding of the thoracic aorta was completed prior to compound administration. Compound was administered parenterally (15 (mg/kg)/day sc) 1 day postsurgery to limit the postsurgical stress observed with oral gavage. On day 14, 2 h after administration of the final oral dose, plasma and cardiac exposures (∼60000 nM) closely matched those observed at the same time in the DSS rat study (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Unfortunately, compound <b>13c</b> in the TAB rat had no effect on cardiac hypertrophy (LV/TL) in the TAB rat (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>), in direct contrast to the efficacy observed in the DSS rat and the reported results with PKD1 knockout in the mouse TAB model. Neither did <b>13c</b> affect cardiac function, as gauged by the accepted marker of diastolic dysfunction, isovolumic relaxation time (IVRT). In this case, the biomarker readout in the PBMCs indicated significant blunting of pHDAC without statistically significant control of PKD autophosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).</div><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0022.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effect of compound <b>13c</b> given 15 (mg/kg)/day sc in acidified captisol in the thoracic aortic banded (TAB) rat on (a) cardiac hypertrophy (left ventricular mass/tibia length) and (b) a marker of diastolic function isovolumic relaxation time (IVRT) on day 14. Neither parameter is affected by compound treatment: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0023.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Biomarker readout in the TAB rat in a surrogate cell type on day 14. In PBMCs, PMA-stimulated, (a) autophosphorylation of PKD at Ser916 with compound <b>13c</b> treatment is not significantly different from vehicle control and (b) phosphorylation of the PKD substrate HDAC at Ser498 is normalized to baseline levels: (∗) <i>p</i> <0.05 vs vehicle; (#) <i>p</i> < 0.05 vs vehicle plus PMA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. <b>13c</b> and <b>13y</b> Exposures in DSS Rat Plasma and Left Ventricle 2 h after Final Dose on Day 14</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">rat model</th><th class="colsep0 rowsep0" align="center">dose ((mg/kg)/day)</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">in plasma (nM)</th><th class="colsep0 rowsep0" align="center">in left ventricle (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">DSS</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">541 ± 99</td><td class="colsep0 rowsep0" align="left">59681 ± 16330</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DSS</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">305 ± 155</td><td class="colsep0 rowsep0" align="left">6687 ± 3084</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DSS</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">87 ± 42</td><td class="colsep0 rowsep0" align="left">1001 ± 521</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">TAB</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">sc</td><td class="colsep0 rowsep0" align="left">288 ± 111</td><td class="colsep0 rowsep0" align="left">60992 ± 14860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13y</b></td><td class="colsep0 rowsep0" align="left">DSS</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">1653 ± 1046</td><td class="colsep0 rowsep0" align="left">2021 ± 1139</td></tr></tbody></table></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from a dual PKC/PKD inhibitor identified by HTS, potent prototype pan-PKD inhibitors were identified with useful selectivity vs representative upstream PKD-activating PKC isoforms (>1000-fold). Further, compounds <b>13c</b> and <b>13y</b> were well-tolerated by daily po or sc administration up to 2 weeks in rat models of heart failure with micromolar cardiac tissue exposures above the cellular IC<sub>50</sub>.</div><div class="NLM_p">In vivo, the most potent but overall less selective (vs a broad kinome and receptor panel) inhibitor <b>13c</b> (PKD1 IC<sub>50</sub> = 0.6 nM, HDAC export IC<sub>50</sub> = 32 nM) demonstrated efficacy at the 50 mg/kg po dose in the DSS rat model but not at the 15 mg/kg sc dose in the TAB rat model. Although the doses and routes of administration were different (necessitated for technical reasons), the plasma (288−541 nM) and cardiac (∼60000 nM) exposures of <b>13c</b> were matched between the two studies. In both animal models, inhibitor <b>13c</b> blunted PMA-stimulated phosphorylation of the PKD substrate HDAC in a surrogate cell type (PBMCs). Therefore, the same exposure of <b>13c</b> and consequent control of pHDAC produced model-dependent effects on cardiac hypertrophy. Further, the TAB rat, which was anticipated to be the best model of PKD inhibition based on the PKD1 knockout studies in the TAB mouse, provided a second disconnect with the expected in vivo cardiac profile of a PKD inhibitor. The lack of efficacy in the TAB rat with <b>13c</b> represents a point of difference with the observed protection afforded by PKD1 knockout in the TAB mouse.</div><div class="NLM_p">Because of the high cardiac exposure together with the off-target profile, the efficacy of <b>13c</b> in the DSS rat at 50 mg/kg cannot be firmly ascribed to PKD inhibition. Inhibition of an alternative kinase or antagonism of an upstream receptor is also consistent with the observed result. For example, either α-<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> or β-adrenergic<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> receptor blockade (<b>13c</b> β1AR IC<sub>50</sub> = 2351 nM, antagonist) controls high salt-induced cardiac hypertrophy in the DSS rat at subantihypertensive doses. Further, lower doses of <b>13c</b> (15 or 5 (mg/kg)/day) maintained 6700 and 1000 nM cardiac exposures in the DSS rat, respectively, well in excess of the cellular HDAC export IC<sub>50</sub> in isolated rat cardiac myocytes. Therefore, even the lowest observed cardiac exposure of <b>13c</b> exceeds the effective concentration in the myocytes by more than an order of magnitude. While these exposures are likely to produce pharmacologic inhibition of the PKDs, the strongest evidence of PKD inhibition comes from the corroborating biomarker evidence.</div><div class="NLM_p">In addition to the availability of the compounds in the target organ, biomarker evidence generated from PBMCs isolated from the in vivo model affords a direct measure of pharmacologic PKD inhibition. Most importantly, all doses of <b>13c</b> blunted PMA-stimulated phosphorylation of native HDAC in the PBMCs. The coupling of the micromolar concentrations in cardiac tissue to the biomarker PBMC data is consistent with pharmacological inhibition of the target in the heart at all three doses of <b>13c</b>. Likewise, a second PKD inhibitor, <b>13y</b>, which exhibits limited receptor affinity and higher kinase selectivity vs a set of putative HDAC kinases, reached micromolar concentrations in cardiac tissue and blunted PMA-stimulated HDAC phosphorylation in the PBMCs, again in the absence of an effect on cardiac hypertrophy in the DSS rat. Therefore, in contrast to the target hypothesis, no direct correlation between pHDAC levels and cardiac hypertrophy was observed. That is, the reduced HDAC phosphorylation observed in the PBMCs with both test compounds at all test doses was not linked to control of high salt-induced cardiac hypertrophy in the DSS rat. If (1) the cardiac exposure of <b>13c</b> and <b>13y</b> and the pHDAC reduction observed in the PBMCs accurately model reduced cardiac pHDAC levels and (2) the DSS and TAB rat models accurately predict clinical success for PKD inhibitors as antihypertrophic agents for the treatment of heart failure, then the in vivo responses of compounds <b>13c</b> and <b>13y</b> separate control of cardiac pHDAC with therapeutic potential in heart failure.</div><div class="NLM_p">In the rodent cardiac hypertrophy model studies, PKD inhibition may not be functionally equivalent to loss of PKD1. A possible rationale lies in the protocol differences between the relevant rat and mouse TAB experiments. That is, loss of PKD1 is complete and consistent over the course of the experiment where PKD inhibition is initiated postsurgery and potentially variable. Alternatively, HDAC may represent only one of multiple relevant PKD substrates. For example, in the DSS rat model, the only case in which blockade of PKD autophosphorylation was statistically significant, in vivo antihypertrophic activity was also observed (50 (mg/kg)/day <b>13c</b> in the DSS rat). While inconsistent with the target hypothesis of pHDAC/MEF2 signaling, failure to completely block phosphorylation of multiple PKD substrates (e.g., HDAC and PKD itself) could account for the disconnect between PKD inhibition and PKD1 knockout in banded rodents.</div><div class="NLM_p last">On the basis of potency, tissue exposure, and biomarker evidence, the aggregate data support that the prototype PKD inhibitors <b>13c</b> and <b>13y</b> were able to block phosphorylation and nuclear export of the MEF2 repressor HDAC in the target tissue in vivo. Still, the moderate kinase selectivity of the naphthyridine PKD inhibitors (especially <b>13c</b>) complicates interpretation of the hypertrophic response (or lack thereof) in both models, since pleiotropic effects (e.g., inhibition of an antihypertrophic kinase such as GSK3β<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) cannot be ruled out. To shed further light on this question, the identification and in vivo profiling of exquisitely potent pan-PKD inhibitors with enhanced selectivity vs a broad kinase panel are reported in the following paper.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Taken in combination with the present study, in vivo results from the second chemotype were utilized to investigate further the therapeutic potential of PKD inhibition as an antihypertrophic target.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> PKD1 Assay</h3><div class="NLM_p last">The assay to measure protein kinase D1 (PKD1) activity was a time-resolved fluorescence resonance energy transfer (TR-FRET) assay using PerkinElmer’s LANCE technology. In this case, a biotinylated syntide-2 peptide (with sequence PLARTLSVAGLPGKK) was used as the substrate in this reaction. Phosphorylation of the syntide-2 substrate (at the serine residue) was detected by a specific antibody that recognizes the phosphorylated peptide and a europium labeled secondary antibody. A second fluorophore, allophycocyanin (APC), was conjugated to streptavidin that binds the biotinylated syntide-2 peptide. For detection, the europium fluorophore can be excited by 340 nm light which then emits at 615 nm. Therefore, when the europium labeled secondary antibody binds on the phosphorylated peptide, it is brought into close contact with the APC and excites this fluorophore. The APC emission is at 665 nm, and the (665 nm)/(615 nm) ratio is a readout of PKD1 activity. This assay was performed with full length wild-type enzyme that is expressed and purified from Sf9 insect cells. The reaction buffer consists of 35 mM Tris-HCl, pH7.5, 5 mM MgCl<sub>2</sub>, 0.02% Tween-20, 20 μM ATP, 1 mM DTT, and 0.2 μg/mL PKD1 enzyme. The enzyme reaction was initiated by the addition of 2 μM syntide-2 peptide substrate and the reaction carried out for 50 min at room temperature. The reaction was stopped by a stop/detection buffer consisting of 50 mM EDTA, 0.18 mg/mL rabbit polyclonal anti-phospho syntide-2 antibody, 0.5 nM europium labeled anti-rabbit IgG, and 10 nM streptavidin conjugated APC. After a 1 h incubation with the stop/detection buffer, the reaction was read on an Envision 2100 reader using a LANCE Eu/APC dual protocol. As described above, a (665 nm)/(615 nm) ratio was determined to measure substrate phosphorylation and enzyme activity. Compounds are typically tested in an 11-point dose response fashion in triplicate for each concentration used. IC<sub>50</sub> values are calculated using an activity base (IDBS) software program.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> PKD2 Assay</h3><div class="NLM_p">The assay to measure protein kinase D2 (PKD2) activity was a time-resolved fluorescence resonance energy transfer (TR-FRET) assay using PerkinElmer’s LANCE technology. In this case, a biotinylated syntide-2 peptide was used as the substrate in this reaction. Phosphorylation of the syntide-2 substrate was detected by a specific antibody that recognizes the phosphorylated peptide. A second fluorophore, APC, was conjugated to streptavidin that binds the biotinylated syntide-2 peptide. For detection, the europium fluorophore can be excited by 340 nm light which then emits at 615 nm. Therefore, when the europium labeled secondary antibody binds on the phosphorylated peptide, it was brought into close contact with the APC and excites this fluorophore. The APC emission was at 665 nm, and the (665 nm)/(615 nm) ratio was a readout of PKD2 activity.</div><div class="NLM_p last">The assay was performed with full length wild-type enzyme purchase from Invitrogen. The reaction buffer consists of 35 mM Tris-HCl, pH7.5, 5 mM MgCl<sub>2</sub>, 0.02% Tween-20, 20 μM ATP, 1 mM DTT, and 0.2 μg/mL PKD2 enzyme. The enzyme reaction was initiated by the addition of 2 μM syntide-2 peptide substrate and the reaction carried out for 50 min at room temperature. The reaction was stopped by a stop/detection buffer consisting of 50 mM EDTA, 0.18 mg/mL rabbit polyclonal anti-phospho syntide-2 antibody, 0.5 nM europium labeled anti-rabbit IgG, and 10 nM streptavidin conjugated APC. After a 1 h incubation with the stop/detection buffer, the reaction was read on an Envision 2100 reader using a LANCE Eu/APC dual protocol. As described above, a (665 nm)/(615 nm) ratio was determined to measure substrate phosphorylation and enzyme activity. Compounds are typically tested in an 11-point dose response fashion in triplicate for each concentration used. IC<sub>50</sub> values are calculated using an activity base (IDBS) software program.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> PKD3 Assay</h3><div class="NLM_p last">The assay to measure protein kinase D3 (PKD3) activity was a time-resolved fluorescence resonance energy transfer (TR-FRET) assay using PerkinElmer’s LANCE technology. In this case, a biotinylated syntide-2 peptide was used as the substrate in this reaction. Phosphorylation of the syntide-2 substrate was detected by a specific antibody that recognizes the phosphorylated peptide. A second fluorophore, APC, was conjugated to streptavidin that binds the biotinylated syntide-2 peptide. For detection, the europium fluorophore can be excited by 340 nM light which then emits at 615 nm. Therefore, when the europium labeled secondary antibody binds on the phosphorylated peptide, it was brought into close contact with the APC and excites this fluorophore. The APC emission was at 665 nm, and the (665 nm)/(615 nm) ratio was a readout of PKD3 activity.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> PKC Assays</h3><div class="NLM_p last">The compounds of the invention are tested for their activity on different PKC isotypes according to the following method. Assay was performed in a white with clear bottom 384-well microtiter plate with nonbinding surface. The reaction mixture (25 μL) contains 1.5 μM tridecapeptide acceptor substrate that mimics the pseudo substrate sequence of PKCα with the Ala → Ser replacement, 10 μM <sup>33</sup>P-ATP, 10 mM Mg(NO<sub>3</sub>)<sub>2</sub>, 0.2 mM CaCl<sub>2</sub>, PKC at a protein concentration varying from 25 to 400 ng/mL (depending on the isotype used), lipid vesicles (containing 30 mol % phosphatidylserine, 5 mol % DAG, and 65 mol % phosphatidylcholine) at a final lipid concentration of 0.5 mM, in 20 mM Tris-HCl buffer, pH 7.4, and 0.1% BSA. Incubation was performed for 60 min at room temperature. Reaction was stopped by adding 50 μL of stop mix (100 mM EDTA, 200 μM ATP, 0.1% Triton X-100, 0.375 mg/well streptavidin-coated SPA beads in phosphate buffered saline without Ca, Mg. After 10 min of incubation at room temperature, the suspension was spun down for 10 min at 300<i>g</i>. Incorporated radioactivity was measured in a Trilux counter for 1 min. IC<sub>50</sub> measurement was performed on a routine basis by incubating a serial dilution of inhibitor at concentrations ranging between 1 and 1000 nM. IC<sub>50</sub> values are calculated from the graph by curve fitting with XL fit software. Human recombinant PKCα was obtained from Oxford Biomedical Research and was used under the assay conditions as described above. Human recombinant PKCδ was obtained from Oxford Biomedical Research and was used under the assay conditions as described above.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> HDAC Export Assay</h3><div class="NLM_p last">Compounds are evaluated in the HDAC5 nuclear exposrt assay, a 384-well plate-based assay that enables HTS to identify small molecules that block agonist-dependent nuclear export of HDAC5. This assay employs the Cellomics High Content Imaging platform (Giuliano and Taylor, 1998) and adenovirus encoding green fluorescent protein (GFP) tagged HDAC5. Neonatal rat ventricular myocytes (NRVMs) are infected with GFP-HDAC5 encoding virus and plated on gelatin-coated 384-well dishes. Cells are exposed to compound and stimulated with a prostaglandin (PGF2α), which is a potent stimulus for HDAC5 nuclear export. Following 2 h of stimulation, cells are fixed and GFP-HDAC5 localization is quantified using the Cellomics system, which provides a readout of relative fluorescence intensity in the cytoplasmic versus nuclear compartment.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Determination of Compound Exposure</h3><div class="NLM_p last">Adult male Sprague−Dawley rats, with in-dwelling jugular vein cannulae, were obtained from Harlan (Indianapolis, IN). The animals were fasted overnight prior to dosing and were fed 4 h after administration of dose. The rats were administered either a single intravenous (iv) dose (2 mg/kg, <i>n</i> = 3) or via oral (po) gavage (5 mg/kg, <i>n</i> = 3). Compound <b>13c</b> was administered as a solution in 10% NMP, 10% Cremophor EL, and 80% D5W, whereas <b>13y</b> was administered in solution formulation consisting of 10% NMP, 10% Cremophor EL, 7.8% HCl (1 N), and 70% phosphate buffer (pH 7.4), with pH adjustment made by adding 1 N NaOH. Blood samples were collected at 0.08, 0.25, 0.5, 1, 2, 4, 6, and 8 h after the iv dose and at 0.25, 0.5, 1, 2, 4, 6, and 8 h after the po dose into tubes containing EDTA. Plasma was prepared from the blood samples and analyzed for drug concentrations by LC−MS/MS.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> DSS Rat Model</h3><div class="NLM_p last">The 6−7 week-old male Dahl salt-sensitive (DSS) rats (<i>n</i> = 50) from Harlan Labs were fed base diet (0.49% NaCl) and allowed to acclimate for 1 week prior being separated into five weight-matched groups. Rats were maintained on the grain based diet (0.49% NaCl) or switched to grain diet containing 8.0% NaCl for 2 consecutive weeks. Coincident with diet switch rats were administered (po, 5 mL/kg) vehicle (0.5% methylcellulose, 0.5% Tween-80) or test compound <b>13c</b> or <b>13y</b> (5, 15, or 50 mg/kg) suspended in vehicle. At the completion of study, steady-state hemodynamics were determined. The rats were then sacrificed and tissues were collected for morphological and biochemical analysis.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> TAB Rat Model</h3><div class="NLM_p last">The 7−8 week-old male Sprague−Dawley rats (<i>n</i> = 30) from Charles River Labs were allowed normal chow and water ad libitum and allowed to acclimate for 1 week. Rats were then instrumented with an aortic occlusion cuff or underwent sham surgery. Coincident with the surgical procedure, rats were administered (sc, 1.0 mL/kg) vehicle (acidified captisol) or <b>13c</b> (15 mg/kg/day sc) solved in vehicle for two weeks. On the final day of study, end-point cardiac performance and steady-state hemodynamics were determined by ultrasound and direct cardiac catheterization, respectively. Following completion of the measurement protocol, the rats were sacrificed, and tissues were collected for morphological and biochemical analysis.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General</h4><div class="NLM_p last">NMR spectra were recorded on a Bruker Avance II 400 MHz spectrometer. All chemical shifts are reported in parts per million (δ) relative to tetramethylsilane. The following abbreviations are used to denote signal patterns: s = singlet, d = doublet, t = triplet, m = multiplet, and br = broad. Flash chromatography was conducted using grade 60 230−400 mesh silica gel from Fisher Chemical (S825-1) or by utilizing the CombiFlash Companion from Teledyne Isco, Inc. and RediSep Rf disposable normal phase silica gel columns (4−120 g). Thin layer chromatography was performed using 2.5 cm × 7.5 cm glass-backed TLC silica gel 60 F<sub>254</sub> plates from EMD Chemicals, Inc. (15341-1) and visualized by UV light. HPLC purifications were performed on a Gilson preparative HPLC system controlled by Unipoint software using X-Bridge phenyl, C8, C18, or RP18 30 mm × 50 mm columns with 5 μm particle size. The purity of all compounds was ≥95% unless otherwise noted. Low-resolution mass spectra were recorded using an Agilent 1100 series LC−MS spectrometer. <i>N</i>-<i>tert</i>-Butyl-2-methylnicotinamide <b>14d</b> was purchased from Astatech (catalog no. 30048).</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-Methylisonicotinonitrile (<b>4</b>)</h4><div class="NLM_p last">To 3-methylpyridine 1-oxide <b>3</b> (15.90 g, 150 mmol) was added at 0 °C during 30 min dimethyl sulfate (15.60 mL). The resulting reaction mixture was stirred overnight at 40 °C. A solution of KCN (10.75 g, 165 mmol) in a mixture of EtOH/water 1:1 (120 mL) was added, and the reaction mixture was stirred overnight at 40 °C. The reaction mixture was concentrated in vacuo, and the residue was partitioned between EtOAc and water. The aqueous phase was extracted with EtOAc, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated at reduced pressure. Purification by flash column chromatography (silica gel, cyclohexane/EtOAc 85:15) afforded the title compound as orange crystals (6.00 g, 50.80 mmol, 34%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.76 (s, 1H), 8.64 (d, <i>J</i> = 4.9 Hz, 1H), 7.80 (d, <i>J</i> = 4.9 Hz, 1H).</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-<i>tert</i>-Butyl-3-methylisonicotinamide (<b>5</b>)</h4><div class="NLM_p">To the solution of <b>4</b> (18.90 g, 159.92 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added <i>t</i>-BuOAc (72.63 mL, 538.84 mmol), followed by concentrated H<sub>2</sub>SO<sub>4</sub> (12.32 mL, 874.46 mmol). The mixture was stirred for 8 h at room temperature, then diluted with a solution of saturated aqueous NaHCO<sub>3</sub> and CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The organic layer was washed with H<sub>2</sub>O, brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and then evaporated under reduced pressure to provide the title compound as a white solid (29.30 g, 152.44 mmol, 95%).</div><div class="NLM_p">Alternatively, the title compound was prepared from isonicotinic acid <b>6</b>. Acid <b>6</b> (10 g, 80.4 mmol) was added to a 750 mL five-necked flask equipped with an overhead stirrer, internal thermometer, and nitrogen supply. Dichloromethane (300 mL) was added, and the suspension was cooled to 0 °C. Triethylamine (17.6 mL, 121 mmol) was added maintaining a temperature under 0 °C, at which time the starting material dissolved. To the clear solution, ethyl chloroformate (9.5 mL, 98.1 mmol) was added dropwise over 25 min maintaining a temperature under 0 °C. The reaction mixture was stirred at 0 °C for 30 min. <i>tert</i>-Butylamine (10.4 mL, 96.5 mmol) was added slowly to the reaction mixture at 0 °C, and the solution was allowed to warm to room temperature and stirred for 3.5 h. The reaction mixture was diluted with water (100 mL), and the dichloromethane layer was separated. The organic phase was washed with 1 M HCl (100 mL) and the aqueous phase, containing the product, neutralized to pH 9 with NaOH solution. The aqueous phase was washed twice with ethyl acetate (2 × 100 mL) and the combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give <i>N</i>-<i>tert</i>-butylisonicotinamide as a pale-yellow solid (9.8 g, 68.4%). MS (ESI) <i>m</i>/<i>z</i> 179 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.66 (s, 2 H), 8.02 (br s, 1 H), 7.70 (s, 2 H), 1.37 (s, 9 H).</div><div class="NLM_p last"><i>N</i>-<i>tert</i>-butylisonicotinamide (9 g, 50.5 mmol) was added to a 750 mL five-necked flask equipped with an overhead stirrer, internal thermometer, and nitrogen supply. Tetrahydrofuran (225 mL) was added, and the clear solution was cooled to −75 °C. A solution of <i>n</i>-butyllithium 1.6 M in hexane (69 mL, 110 mmol) was added dropwise over 40 min while maintaining the temperature under −70 °C. The reaction mixture was stirred at −70 °C for 1 h. Methyl iodide (3.5 mL, 55 mmol) was added while maintaining the temperature under −70 °C. The solution was stirred at −75 °C for 30 min and then allowed to warm to room temperature and stirred overnight. The reaction mixture was cooled to 0 °C, and a saturated aqueous solution of ammonium chloride (50 mL) was added. The reaction mixture was diluted with water (150 mL) and ethyl acetate (150 mL) and the organic layer separated. The aqueous phase was extracted with fresh ethyl acetate (150 mL). The combined organic phases were washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give a pale-yellow solid. The yellow solid was first triturated with hexane (30 mL) and then recrystallized with <i>tert</i>-butyl methyl ether (20 mL) to give <b>5</b> as a pale-yellow solid (5.1 g, 53.1%): MS (ESI) <i>m</i>/<i>z</i> 193 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.45 (dd, <i>J</i> = 8.2, 4.1 Hz, 2 H), 7.17 (d, <i>J</i> = 8.2 Hz, 1 H), 5.60 (br s, 1 H), 2.39 (s, 3 H), 1.46 (s, 9 H).</div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-<i>tert</i>-Butyl-3-(2-(pyridin-4-yl)-2-oxoethyl)isonicotinamide (<b>8a</b>)</h4><div class="NLM_p last">To <b>5</b> (10.4 g, 51.4 mmol) in THF (220 mL) was added <i>n</i>-BuLi (69.0 mL, 110 mmol, 1.6 M in hexanes) at −45 °C under an inert atmosphere. The reaction mixture was stirred for 60 min at −45 °C to obtain a bright-red suspension. Then isonicotinic acid methyl ester (6.54 mL, 54.8 mmol) was added in one portion. The cooling bath was removed, and stirring was continued for 2 h at room temperature. The reaction mixture was diluted with EtOAc and washed with saturated aqueous NH<sub>4</sub>Cl solution. The organic layer was separated, and the aqueous layer was extracted with EtOAc (3×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by column chromatography (SiO<sub>2</sub>, gradient elution, EtOAc/MeOH 100:0 → 90:10) to yield the title compound (11.6 g, 37.1 mmol, 72%) as a pale-yellow solid: MS (ESI) <i>m</i>/<i>z</i> 298.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.83 (d, 2 H), 8.56 (d, 1 H), 8.51 (s, 1 H), 8.11 (s, NH), 7.86 (d, 2 H), 7.38 (d, 1 H), 4.63 (d, 2 H), 1.21 (s, 9 H).</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-<i>tert</i>-Butyl-3-(2-(2-chloropyridin-4-yl)-2-oxoethyl)isonicotinamide (<b>8b</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>5</b> above and 2-chloroisonicotinic acid methyl ester by the method described above for the synthesis of <b>8a</b>: MS (ESI) <i>m</i>/<i>z</i> 332.8 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.63 (m, 2 H), 8.48 (s, 1 H), 7.84 (s, 1 H), 7.74 (dd, <i>J</i> = 5.1, 1.5 Hz, 1 H), 7.33 (d, <i>J</i> = 5.1 Hz, 1 H), 5.90 (br s, 1 H), 4.57 (s, 2 H).</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-Bromo-3-pyridin-4-yl[2,6]naphthyridine (<b>9a</b>)</h4><div class="NLM_p">A solution of <b>8a</b> (6.50 g, 20.8 mmol) in DMF (12 mL) was heated to 220 °C for 5 min in a microwave oven. The product, 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one, precipitated from the reaction mixture and was isolated by filtration. The filtrate was heated two more times to 220 °C for 5 min in a microwave oven to give two other crops of the product. The precipitates were combined to yield 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one (4.05 g, 17.2 mmol, 83%) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 225.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.09 (s, 1H), 8.83 (d, 1H), 8.74 (d, 2H), 8.04 (d, 1H), 7.85 (m, 3H).</div><div class="NLM_p">A suspension of 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one (6.70 g, 28.4 mmol) in NH<sub>3</sub> (7 M in MeOH) was stirred for 2 h at room temperature. The reaction mixture was evaporated to dryness to yield 3-hydroxy-3-pyridin-4-yl-3,4-dihydro-2<i>H</i>-[2,6]naphthyridin-1-one (7.12 g, 28.0 mmol, 99%) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 242.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.11 (s, NH), 8.65 (d, 1H), 8.60 (m, 3H), 7.79 (d, 1H), 7.58 (d, 2H), 6.72 (s, OH), 3.36 (m, 1H), 3.14 (m, 1H).</div><div class="NLM_p last">3-Hydroxy-3-pyridin-4-yl-3,4-dihydro-2<i>H</i>-[2,6]naphthyridin-1-one (1.20 g, 5.38 mmol) and POBr<sub>3</sub> (3.95 g, 13.7 mmol) were mixed under argon and heated to 130 °C for 6 h. After the mixture was cooled, ice was added and the pH adjusted to 8 with 2 N Na<sub>2</sub>CO<sub>3</sub>. The precipitate was filtered, washed with water, and dried to yield the title compound (1.20 g, 4.19 mmol, 78%) as brown powder: MS (ESI) <i>m</i>/<i>z</i> 287 (M + 1). The crude product was used without further purification.</div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-Chloro-3-pyridin-4-yl[2,6]naphthyridine (<b>9b</b>)</h4><div class="NLM_p">A solution of <b>8a</b> (6.50 g, 20.8 mmol) in DMF (12 mL) was heated to 220 °C for 5 min in a microwave oven. The product, 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one, precipitated from the reaction mixture and was isolated by filtration. The filtrate was heated two more times to 220 °C for 5 min in a microwave oven to give two other crops of the product. The precipitates were combined to yield 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one (4.05 g, 17.2 mmol, 83%) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 225.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.09 (s, 1H), 8.83 (d, 1H), 8.74 (d, 2H), 8.04 (d, 1H), 7.85 (m, 3H).</div><div class="NLM_p">A suspension of 3-pyridin-4-ylpyrano[4,3-<i>c</i>]pyridin-1-one (6.70 g, 28.4 mmol) in NH<sub>3</sub> (7 M in MeOH) was stirred for 2 h at room temperature. The reaction mixture was evaporated to dryness to yield 3-hydroxy-3-pyridin-4-yl-3,4-dihydro-2<i>H</i>-[2,6]naphthyridin-1-one (7.12 g, 28.0 mmol, 99%) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 242.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.11 (s, NH), 8.65 (d, 1H), 8.60 (m, 3H), 7.79 (d, 1H), 7.58 (d, 2H), 6.72 (s, OH), 3.36 (m, 1H), 3.14 (m, 1H).</div><div class="NLM_p last">A suspension of 3-hydroxy-3-pyridin-4-yl-3,4-dihydro-2<i>H</i>-[2,6]naphthyridin-1-one (3.00 g, 11.8 mmol) in POCl<sub>3</sub> (50 mL) was heated to 80 °C for 24 h. The reaction mixture was concentrated under reduced pressure to remove excess POCl<sub>3</sub>. The residual oil was treated with ice-cold H<sub>2</sub>O, and the suspension thus obtained was basified to pH 14 with 10 N NaOH while keeping the temperature below room temperature. The mixture was filtered and the aqueous filtrate was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness to yield a first crop of the crude title compound. The gluey precipitate obtained from the filtration was extracted with CH<sub>2</sub>Cl<sub>2</sub> (stirring for 10 min at room temperature, 2×) to yield a second crop of the crude title compound. The combined crude products were purified by column chromatography (SiO<sub>2</sub>, gradient elution, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 100:0 → 94:6) to yield the title compound (932 mg, 3.78 mmol, 32%) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 242.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.56 (s, 1H), 8.89 (m, 2H), 8.76 (m, 2H), 8.11 (m, 3H).</div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-Chloro-3-(2-chloropyridin-4-yl)-2,6-naphthyridine (<b>9c</b>)</h4><div class="NLM_p">Compound <b>8b</b> above (6.83 g, 20.46 mmol) was suspended in acetic acid and heated at 100 °C overnight. The mixture was cooled to room temperature and evaporated under reduced pressure. To the residue was added H<sub>2</sub>O, and the product was extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and then concentrated. The solid was triturated with Et<sub>2</sub>O to give 3-(2-chloropyridin-4-yl)-1<i>H</i>-pyrano[4,3-<i>c</i>]pyridin-1-one as an off-white solid (60%): MS (ESI) <i>m</i>/<i>z</i> 259.7 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.12 (s, 1 H), 8.86 (d, <i>J</i> = 5.5 Hz, 1 H), 8.56 (d, <i>J</i> = 5.5 Hz, 1 H), 8.18 (d, <i>J</i> = 5.1 Hz, 1 H), 8.03 (s, 1 H), 7.93 (d, <i>J</i> = 5.1 Hz, 1 H), 7.77 (s, 1 H).</div><div class="NLM_p">3-(2-Chloropyridin-4-yl)-1<i>H</i>-pyrano[4,3-<i>c</i>]pyridin-1-one (1.66 g, 6.41 mmol) was suspended in EtOH (35 mL). To the suspension was added 28.5% NH<sub>4</sub>OH (26 mL) at room temperature, and the mixture was stirred overnight. The solvent was then evaporated, and the residue was dried under reduced pressure at 45 °C for 30 min to provide a white solid. The crude product was suspended in EtOH (35 mL), treated with 4 N HCl (8.7 mL), and stirred overnight at room temperature. The mixture was filtered, and the solid obtained was dried under high vacuum (1.50 g, 91%): MS (ESI) <i>m</i>/<i>z</i> 257.7 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.51 (s, 1 H), 8.84 (d, <i>J</i> = 6.1 Hz, 1 H), 8.72 (d, <i>J</i> = 6.1 Hz, 1 H), 8.62 (d, <i>J</i> = 5.0 Hz, 1 H), 7.95 (s, 1 H), 7.80 (d, <i>J</i> = 5.0 Hz, 1 H), 7.38 (s, 1 H).</div><div class="NLM_p last">A mixture of 3-(2-chloropyridin-4-yl)-2,6-naphthyridin-1-ol (1.29 g, 5.02 mmol), POCl<sub>3</sub> (35 mL), and tetramethylammonium chloride (2.6 g, 23.72 mmol) was refluxed at 110 °C for 36 h. The POCl<sub>3</sub> was removed by distillation, and ice cold 10% K<sub>2</sub>CO<sub>3</sub> was added carefully. The mixture was extracted with EtOAc, washed with water and then brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude residue was washed with cold methanol (5 mL) to give the title compound as a greenish brown solid (1.05 g, 3.80 mmol, 76%): MS (ESI) <i>m</i>/<i>z</i> 277.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.55 (s, 1 H), 8.88 (d, <i>J</i> = 6.1 Hz, 1 H), 8.75 (s, 1 H), 8.55 (d, <i>J</i> = 5.6 Hz, 1 H), 8.27 (s, 1 H), 8.25 (d, <i>J</i> = 6.1 Hz, 1 H), 8.18 (d, <i>J</i> = 5.5 Hz, 1 H).</div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(2-Chloropyridin-4-yl)-1-methoxy[2,6]naphthyridine (<b>23</b>)</h4><div class="NLM_p last">To a solution of <b>9c</b> (0.91 g, 3.3 mmol) in methanol (20 mL) was added sodium methoxide (0.27 g, 5 mmol). The mixture was refluxed for 3 h and cooled to room temperature. Volatiles were removed by rotary evaporation, and the residue was partitioned between water and CH<sub>2</sub>Cl<sub>2</sub>. The separated aqueous phase was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organics were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was chromatographed on silica gel to give a light-yellow solid (0.80 g, 89%): MS (ESI) <i>m</i>/<i>z</i> 272.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.3 (s, 1 H), 8.75 (d, <i>J</i> = 6.3 Hz, 1 H), 8.5 (s, 1 H), 8.08 (s, 1 H), 8.02 (d, <i>J</i> = 5.6 Hz, 1 H), 7.93 (dd, <i>J</i> = 5.1, 1.4 Hz, 1 H), 7.86 (s, 1 H), 4.28 (s, 3 H).</div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> [4-(1-Chloro[2,6]naphthyridin-3-yl)pyridin-2-yl]cyclohexylamine (<b>24</b>)</h4><div class="NLM_p">To a solution of methoxynaphthyridine <b>23</b> (0.43 g, 1.29 mmol) in wet <i>tert</i>-butyl alcohol (10 mL) is added potassium <i>tert</i>-butoxide (1 M in THF, 6.4 mL, 6.4 mmol), and the mixture was heated at 100 °C overnight. After the volatiles were removed under reduced pressure, the residue was suspended in water. The pH was adjusted to 7, and the resulting solid was filtered and air-dried. The crude solid (406 mg, 94%) was pure by LCMS and used directly in the next step without further purification: MS (ESI) <i>m</i>/<i>z</i> 321.3 (M + 1).</div><div class="NLM_p last">A mixture of the naphthyridinone above (360 mg, 1.1 mmol) and tetramethylammonium chloride (100 mg) in POCl<sub>3</sub> (15 mL) was heated at 110 °C overnight. Volatiles were removed by evaporation, and the residue was treated with ice, basified with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was chromatographed on silica gel to give the product (260 mg, 68%): MS (ESI) <i>m</i>/<i>z</i> 339.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.26 (s, 1 H), 8.61 (d, <i>J</i> = 5.4 Hz, 1 H), 8.18 (d, <i>J</i> = 5.2 Hz, 1 H), 7.79 (d, <i>J</i> = 6.0 Hz, 1 H), 7.75 (s, 1 H), 7.21 (s, 1 H), 7.20 (d, <i>J</i> = 5.4 Hz, 1 H), 4.64 (d, <i>J</i> = 8.0 Hz, 1 H), 3.69 (br 1 H), 2.12 (m, 2 H), 1.79 (m, 2 H), 1.67 (m, 1 H), 1.6−1.4 (m, 5 H).</div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> [2-(3-Pyridin-4-yl[2,6]naphthyridin-1-ylamino)ethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>10a</b>)</h4><div class="NLM_p last">Bromide <b>9a</b> (200 mg, 0.70 mmol) and (2-aminoethyl)carbamic acid <i>tert</i>-butyl ester (172 mg, 1.05 mmol) in dioxane (30 mL) was heated with 5 drops of 40% NaOH to 110 °C for 3 days. After cooling, the reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated. The residue was purified by chromatography (ethyl acetate/ethanol 9:12), yielding the title compound (110 mg, 0.30 mmol, 42%) as a light-brown powder: MS (ESI) <i>m</i>/<i>z</i> 366.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.23 (s, 1 H), 8.69 (d, <i>J</i> = 6.0 Hz, 2 H), 8.63 (d, <i>J</i> = 6.6 Hz, 1 H), 8.18 (d, <i>J</i> = 6.0 Hz, 2 H), 8.12 (d, <i>J</i> = 6.6 Hz, 1 H), 7.96 (md, 1 H), 7.88 (s, 1 H), 7.05 (m, 1 H), 3.68 (m, 2 H), 3.33 (m, 2 H), 1.39 (s, 9 H).</div></div><div id="sec7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(3-Pyridin-4-yl[2,6]naphthyridin-1-ylamino)propan-1-ol (<b>10b</b>)</h4><div class="NLM_p last">Bromide <b>9a</b> (250 mg, 0.87 mmol) and 1-hydroxypropylamine (657 mg, 8.74 mmol) in THF (10 mL) were heated to 45 °C for 2 h. After cooling, the reaction mixture was concentrated under reduced pressure and the residue purified by chromatography (ethyl acetate/ethanol 8:2), yielding the title compound (50 mg, 0.18 mmol, 20%) as a yellow powder: MS (ESI) <i>m</i>/<i>z</i> 281.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.24 (s, 1 H), 8.73 (d, <i>J</i> = 6.0 Hz, 2 H), 8.64 (d, <i>J</i> = 6.6 Hz, 1 H), 8.17 (d, <i>J</i> = 6.6 Hz, 1 H), 8.15 (d, <i>J</i> = 6.0 Hz, 2 H), 7.91 (m, 1 H), 7.87 (s, 1 H), 4.54 (m, 1 H), 3.70 (m, 2 H), 3.58 (m, 2 H), 1.92 (m, 2 H).</div></div><div id="sec7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>*1*-(3-Pyridin-4-yl[2,6]naphthyridin-1-yl)ethane-1,2-diamine (<b>2</b>)</h4><div class="NLM_p last">Compound <b>10a</b> (80 mg, 0.22 mmol) was stirred in TFA (0.7 mL) and CH<sub>2</sub>Cl<sub>2</sub> (20 mL) for 10 min at 0 °C and at room temperature for 4 h. The reaction mixture was concentrated. Twice CH<sub>2</sub>Cl<sub>2</sub> was added and the mixture concentrated. The residue was crystallized from diethyl ether to yield the title compound (94 mg, 0.17 mmol, 78%) as yellow crystals (TFA salt): MS (ESI) <i>m</i>/<i>z</i> 266.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.32 (s, 1 H), 8.88 (d, <i>J</i> = 6.0 Hz, 2 H), 8.74 (d, <i>J</i> = 6.6 Hz, 1 H), 8.49 (d, <i>J</i> = 6.0 Hz, 2 H), 8.17 (m, 3 H), 7.94 (m, 2 H), 3.91 (m, 2 H), 3.25 (m, 2 H).</div></div><div id="sec7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-Piperazin-1-yl-3-pyridin-4-yl[2,6]naphthyridine (<b>11</b>)</h4><div class="NLM_p last">To a solution of chloride <b>9b</b> (50 mg, 0.197 mmol) in DMF (0.5 mL) was added piperazine-1-carboxylic acid <i>tert</i>-butyl ester (77 mg, 0.393 mmol) and K<sub>2</sub>CO<sub>3</sub> (55 mg, 0.393 mmol) at room temperature. The reaction mixture was heated to 90 °C and stirred for 5 h. The reaction mixture was cooled to room temperature, diluted with EtOAc, and washed with H<sub>2</sub>O (1×). The organic layer was separated, and the aqueous layer was extracted with EtOAc (3×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by silica gel chromatography (4 g of SiO<sub>2</sub>, gradient hexane/EtOAc 80:20 → 0:100) to afford 4-(3-pyridin-4-yl[2,6]naphthyridin-1-yl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester <b>(10c)</b> as a pale-yellow solid. Compound <b>10c</b> was dissolved in TFA (0.5 mL) and CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) and was stirred for 1 h at room temperature. The reaction mixture was concentrated under reduced pressure. The residue was purified by preparative reverse phase HPLC (Waters) to yield the title compound as a yellow solid (25 mg, 0.048 mmol, 25% over two steps, 2TFA salt): MS (ESI) <i>m</i>/<i>z</i> 292.3 (M + 1); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.46 (s, 1 H), 9.06 (br s, 2 H), 8.88 (d, <i>J</i> = 6.3 Hz, 2 H), 8.74 (d, <i>J</i> = 5.7 Hz, 1 H), 8.57 (s, 1 H), 8.42 (d, <i>J</i> = 6.1 Hz, 2 H), 8.06 (d, <i>J</i> = 5.9 Hz, 1 H), 3.75 (br s, 4 H), 3.43 (br s, 4 H).</div></div><div id="sec7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>12b</b>)</h4><div class="NLM_p last">To a suspension of <b>9c</b> (2.00 g, 7.20 mmol) in anhydrous ethanol (24 mL) in a dried pressure vessel was added triethylamine (3.20 mL, 23 mmol) followed by piperazine-1-carboxylic acid <i>tert</i>-butyl ester (1.70 g, 9.10 mmol). The vessel was flushed with nitrogen and then sealed. The suspension was heated in a 100 °C oil bath for 20 h. The dark-brown, nearly homogeneous reaction mixture was cooled to room temperature, then concentrated in vacuo. The residue was diluted with dichloromethane and water. The layers were agitated and separated, and the aqueous layer was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over sodium sulfate, filtered, and concentrated. The material was purified by silica gel chromatography (120 g SiO<sub>2</sub>, gradient 0% → 2.5% methanol/dichloromethane) to afford a brownish yellow solid, which was refluxed in 60 mL of diethyl ether. The mixture was cooled to room temperature and filtered to provide the title compound as a white solid (2.2 g, 71%): MS (ESI) <i>m</i>/<i>z</i> 426.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.39 (d, <i>J</i> = 0.8 Hz, 1 H), 8.70 (d, <i>J</i> = 5.8 Hz, 1 H), 8.55 (dd, <i>J</i> = 5.3, 0.5 Hz, 1 H), 8.24 (dd, <i>J</i> = 1.5, 0.8 Hz, 1 H), 8.18 (dd, <i>J</i> = 5.3, 1.5 Hz, 1 H), 7.96 (d, <i>J</i> = 5.8 Hz, 1 H), 3.64 (br m, 4 H), 3.52 (m, 4 H), 1.45 (s, 9 H).</div></div><div id="sec7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(2-Chloropyridin-4-yl)-1-piperazin-1-yl[2,6]naphthyridine (<b>12c</b>)</h4><div class="NLM_p last">A solution of compound <b>9c</b> above (700 mg, 2.53 mmol) and piperazine (262 mg, 3.04 mmol) in NMP (12 mL) was heated to 70 °C overnight. After the mixture was cooled, a yellow solid was collected by filtration and washed with MeOH (5 mL) to afford the title compound: MS (ESI) <i>m</i>/<i>z</i> 326.2, 328.2 (M + 1); <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 10.00 (s, 1 H), 9.28 (d, <i>J</i> = 5.6 Hz, 1 H), 9.07 (d, <i>J</i> = 5.1 Hz, 1 H), 8.79 (m, 4 H), 4.43 (m, 4 H), 4.11 (m, 4 H).</div></div><div id="sec7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(2-Chloropyridin-4-yl)-1-(4-cyclopropylmethylpiperazin-1-yl)[2,6]naphthyridine (<b>12d</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> (200 mg, 0.72 mmol) and <i>N</i>-cyclopropylmethylpiperazine (140 μL, 0.94 mmol) by heating in Et<sub>3</sub>N (6 μL, 4.3 mmol) and EtOH (5 mL) in a sealed tube at 100 °C overnight. The volatiles were removed in vacuo and the residue was purified by flash chromatography, eluting with 0−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to afford the title compound in 68% yield as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 380.3 (M + 1).</div></div><div id="sec7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(2-Chloropyridin-4-yl)-1-(4-cyclopropylpiperazin-1-yl)[2,6]naphthyridine (<b>12e</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> and <i>N</i>-cyclopropylpiperazine by analogy to the method outlined in example <b>12b</b>: MS (ESI) <i>m</i>/<i>z</i> 366.3 (M + 1).</div></div><div id="sec7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-{4-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperazin-1-yl}ethanone (<b>12f</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> and <i>N</i>-acetylpiperazine by analogy to the method outlined in example <b>12b</b>: MS (ESI) <i>m</i>/<i>z</i> 368.1 (M + 1).</div></div><div id="sec7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-ylamino]ethanol (<b>12g</b>)</h4><div class="NLM_p last">A solution of compound <b>9c</b> (536 mg, 1.94 mmol) and 2-aminoethanol (1.50 mL, 25.2 mmol) in NMP (15 mL) was heated to 100 °C overnight. After the mixture was cooled, the volatiles were removed in vacuo and the residue was purified by RP-HPLC (3−50% CH<sub>3</sub>CN in H<sub>2</sub>O) to afford the title compound as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 301.1 (M + 1); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.55 (m, 1 H), 8.83 (m, 1 H), 8.71 (m, 1 H), 8.57 (d, <i>J</i> = 5.3 Hz, 1 H), 8.17 (m, 1 H), 8.12 (dd,, <i>J</i> = 5.3, 1.4 Hz, 1 H), 8.10 (s, 1 H), 3.75−3.76 (m, 4 H).</div></div><div id="sec7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperazin-2-one (<b>12h</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> and piperazin-2-one by analogy to the method outlined in example <b>12b</b>: MS (ESI) <i>m</i>/<i>z</i> 340.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.78 (s, 1 H), 9.10 (d, <i>J</i> = 5.6 Hz, 1 H), 8.96 (d, <i>J</i> = 5.1 Hz, 1 H), 8.85 (s, 1 H), 8.64 (s, 1 H), 8.59 (m, 1 H), 8.59 (m, 1 H), 8.41 (m, 2 H), 4.54 (m, 2 H), 4.22 (m, 2 H), 3.83 (m, 2 H).</div></div><div id="sec7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> {1-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidin-4-ylmethyl}carbamic Acid <i>tert</i>-Butyl Ester (<b>12i</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> and piperidin-4-ylmethylcarbamic acid <i>tert</i>-butyl ester by analogy to the method outlined in <b>12b</b>: MS (ESI) <i>m</i>/<i>z</i> 454.3 (M + 1).</div></div><div id="sec7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Amide (<b>12j</b>)</h4><div class="NLM_p last">To a suspension of <b>9c</b> (200 mg, 0.72 mmol) in anhydrous ethanol (2.4 mL) in a sealable vial was added triethylamine (0.32 mL, 2.3 mmol) followed by isonipecotamide (120 mg, 0.90 mmol). The vial was flushed with nitrogen and then sealed. The mixture was heated in a 100 °C oil bath for 16 h. The heterogeneous mixture was cooled to room temperature, then filtered. The filtrate was washed with ethanol and dried under high vacuum to give the title compound as a yellowish brown solid (230 mg, 87%): MS (ESI) <i>m</i>/<i>z</i> 368.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.68 (d, <i>J</i> = 5.8 Hz, 1 H), 8.55 (d, <i>J</i> = 5.8 Hz, 1 H), 8.38 (s, 1H), 8.23 (s, 1 H), 8.18 (dd, <i>J</i> = 5.3, 1.5 Hz, 1 H), 7.89 (d, <i>J</i> = 5.8 Hz, 1 H), 7.34 (br s, 1 H), 6.82 (br s, 1 H), 4.05 (d, <i>J</i> = 12.6 Hz, 2 H), 3.09 (m, 2 H), 2.43 (m, 1 H), 1.91 (br m, 4 H).</div></div><div id="sec7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Methylamide. (<b>12k</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>9c</b> and <i>N</i>-methylisonipecotamide by analogy to the method outlined in example <b>12b</b>: MS (ESI) <i>m</i>/<i>z</i> 382.1 (M + 1).</div></div><div id="sec7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-[3-(2-Chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Methyl Ester (<b>12l</b>)</h4><div class="NLM_p last">A solution of <b>9c</b> (1.0 g, 3.62 mmol), Et<sub>3</sub>N (1.50 mL, 10.9 mmol), methyl isonipecotate (0.74 mL, 5.43 mmol), and DMSO (4 mL) was heated to 80 °C for 3 h. At that time, the solution was allowed to cool to room temperature and was slurried with 15 mL of water. The mixture was then poured into 200 mL of ice water. After 10 min the solid was collected via filtration. The solid was then dried under vacuum to give (1.25 g) the title compound as a brown solid: MS (ESI) <i>m</i>/<i>z</i> 383.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.29 (s, 1 H), 8.67 (d, <i>J</i> = 5.8 Hz, 1 H), 8.49 (d, <i>J</i> = 4.8 Hz, 1 H), 8.07 (s, 1 H), 7.95 - 7.91 (m, 1 H), 7.83 (s, 1 H), 7.79 (d, <i>J</i> = 5.8 Hz, 1 H), 4.07 - 3.96 (m, 2 H), 3.76 (s, 3 H), 3.27−3.14 (m, 2 H), 2.73−2.61 (m, 1 H), 2.23−2.01 (m, 4 H).</div></div><div id="sec7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(3-Hydroxypropylamino-3-(2-methylaminopyridin-4-yl)[2,6]naphthyridine (<b>13a</b>)</h4><div class="NLM_p last">Compound <b>12a</b> (120 mg, 0.36 mmol) and methylamine (5 mL, 33% in ethanol) were heated in an autoclave at 135 °C for 4 d. The reaction mixture was cooled, concentrated, and purified by chromatography (ethyl acetate/ethanol 8:2) to give the title compound (90 mg, 0.29 mmol, 82%) as a yellow powder: MS (ESI) <i>m</i>/<i>z</i> 310.4 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.22 (s, 1 H), 8.59 (d, <i>J</i> = 6.6 Hz, 1 H), 8.14 (d, <i>J</i> = 6.6 Hz, 1 H), 8.08 (d, <i>J</i> = 6.0 Hz, 1 H), 7.82 (t, <i>J</i> = 4.5 Hz, 1 H), 7.64 (s, 1 H), 7.27 (s, 1 H), 7.21 (d, <i>J</i> = 6.0 Hz, 1 H), 6.60 (d, <i>J</i> = 3.0 Hz, 1 H), 4.53 (t, <i>J</i> = 5.2 Hz, 1 H), 3.69 (m, 2 H), 3.59 (m, 2 H), 2.85 (d, <i>J</i> = 3.6 Hz, 3 H), 1.90 (m, 2 H).</div></div><div id="sec7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>13b</b>)</h4><div class="NLM_p last">Compound <b>12b</b> (2.30 g, 5.4 mmol), cyclohexylamine (1.24 mL, 10.8 mmol), NaO-<i>t</i>-Bu (1.04 g, 10.8 mmol), and Pd(P-<i>t</i>-Bu<sub>3</sub>)<sub>2</sub> in dioxane (54 mL) were heated under an Ar atmosphere in a sealed tube at 130 °C overnight. After cooling, the mixture was concentrated under reduced pressure. The residue was diluted with 20% acetone/CH<sub>2</sub>Cl<sub>2</sub> and filtered through Celite. The filter cake was washed successively with EtOH, acetone, CH<sub>3</sub>CN, and MeOH. The combined filtrate was concentrated under reduced pressure. The residue was diluted with EtOAc (400 mL) and washed with water (3 × 100 mL). The separated EtOAc layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by column chromatography using 20% acetone/CH<sub>2</sub>Cl<sub>2</sub> to afford the title compound: MS (ESI) <i>m</i>/<i>z</i> 489.2 (M + 1).</div></div><div id="sec7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Cyclohexyl-[4-(1-piperazin-1-yl[2,6]naphthyridin-3-yl)pyridin-2-yl]amine (<b>13c</b>)</h4><div class="NLM_p last">To a solution of <b>13b</b> (1.34 g, 2.74 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (33 mL) was added TFA (6.6 mL). After 1 h and complete removal of the BOC group as judged by TLC, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and a 1 M soluton of NaOH (100 mL). The separated organic phase was washed with fresh 1 M NaOH. The combined aqueous phases were extracted with fresh CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The combined organic phasese were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to afford the title compound: MS (ESI) <i>m</i>/<i>z</i> 389.3 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.35 (s, 1 H), 8.62 (d, <i>J</i> = 6.1 Hz, 1 H), 8.07 (s, 1 H), 8.05 (d, <i>J</i> = 5.5 Hz, 1 H), 8.02 (d, <i>J</i> = 5.6 Hz, 1 H), 7.44 (s, 1 H), 7.30 (d, <i>J</i> = 5.6 Hz, 1 H), 3.80−3.71 (m, 1 H), 3.71 (s, 1 H), 3.63 (t, <i>J</i> = 4.8 Hz, 4 H), 3.20 (t, <i>J</i> = 4.8 Hz, 4 H), 2.15 - 2.08 (m, 2 H), 1.90−1.82 (m, 2 H), 1.78−1.71 (m, 1 H), 1.58−1.46 (m, 2 H), 1.40−1.09 (m, 3 H).</div></div><div id="sec7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Cyclohexyl-{4-[1-(4-isobutylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}amine (<b>13d</b>)</h4><div class="NLM_p last">To a solution of <b>13c</b> (260 mg, 0.62 mmol) and 2-methylpropionaldehyde (54 mg, 0.76 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added NaBH(OAc)<sub>3</sub> (540 mg, 2.7 mmol). The suspension was stirred at room temperature for 24 h. A saturated aqueous solution of NaHCO<sub>3</sub> (5 mL) was added, and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The oily residue was purified by RP-HPLC (30−90% CH<sub>3</sub>CN in H<sub>2</sub>O to afford the title compound as a white solid: HRMS (ESI) <i>m</i>/<i>z</i> 445.3087 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.26 (s, 1 H), 8.61 (d, <i>J</i> = 5.7 Hz, 1 H), 8.20−8.14 (m, 1 H), 7.81 (d, <i>J</i> = 5.8 Hz, 1 H), 7.75 (s, 1 H), 7.24−7.18 (m, 2 H), 4.61 (d, <i>J</i> = 7.7 Hz, 1 H), 3.77−3.65 (m, 1 H), 3.65−3.57 (m, 4 H), 2.74−2.65 (m, 3 H), 2.22 (d, <i>J</i> = 7.3 Hz, 2 H), 2.13 (dd, <i>J</i> = 12.6, 3.2 Hz, 2 H), 1.98−1.74 (m, 4 H), 1.73−1.62 (m, 1 H), 1.54−1.38 (m, 2 H), 1.35−1.20 (m, 3 H), 0.96 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>13e</b>)</h4><div class="NLM_p last">To a dried sealable vial was added <b>12b</b> (180 mg, 0.43 mmol), sodium <i>tert</i>-butoxide (120 mg, 1.30 mmol), and dioxane (6.1 mL). The dark-red solution was sparged with argon for 10 min. 4-Aminotetrahydropyran (0.16 mL, 1.30 mmol) was added via syringe, followed by palladium(0)tris(tri-<i>tert</i>-butylphosphine) (44 mg, 0.09 mmol). The vial was flushed with argon, then sealed and heated in a 120 °C oil bath for 14 h. The dark-brown solution was cooled to room temperature, then diluted with water and CH<sub>2</sub>Cl<sub>2</sub>. The layers were agitated and separated. The aqueous layer was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over sodium sulfate, filtered, and concentrated to give a brown residue. Purification via silica gel chromatography (40 g of SiO<sub>2</sub>, gradient 70% → 100% ethyl acetate/hexanes followed by 0% → 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a brown solid (120 mg, 80% pure) as judged by <sup>1</sup>H NMR: MS (ESI) <i>m</i>/<i>z</i> 491.5 (M + 1).</div></div><div id="sec7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(1-Piperazin-1-yl[2,6]naphthyridin-3-yl)pyridin-2-yl](tetrahydropyran-4-yl)amine (<b>13f</b>)</h4><div class="NLM_p last">To a suspension of <b>13e</b> (120 mg, 0.25 mmol) in 1.80 mL of CH<sub>2</sub>Cl<sub>2</sub> at 0 °C is added 0.60 mL of TFA drop by drop via pipet. The resulting brownish orange solution is warmed to room temperature and stirred for 1 h and then concentrated in vacuo to afford an amber oil. The residue was dissolved in MeOH and a small amount of water, then purified via preparative reverse-phase HPLC (X-Bridge C<sub>18</sub> column, flow rate = 40 mL/min, gradient 10% → 80% acetonitrile/5 mM aqueous ammonium hydroxide over 20 min) to give the title compound as a pale-yellow solid (66 mg, 68%): MS (ESI) <i>m</i>/<i>z</i> 391.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.30 (d, <i>J</i> = 1.0 Hz, 1 H), 8.58 (d, <i>J</i> = 5.8 Hz, 1 H), 8.03 (m, 2 H), 7.98 (d, <i>J</i> = 5.8 Hz, 1 H), 7.42 (s, 1H), 7.29 (dd, <i>J</i> = 5.7, 1.6 Hz, 1 H), 3.99 (m, 3 H), 3.59 (m, 6H), 3.14 (dd, <i>J</i> = 5.6, 4.0 Hz, 4 H), 2.03 (dd, <i>J</i> = 12.2, 2.8 Hz, 2 H), 1.58 (m, 2 H).</div></div><div id="sec7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> {4-[1-(4-Isobutylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}(tetrahydropyran-4-yl)amine (<b>13g</b>)</h4><div class="NLM_p last">The title compound is prepared by reductive amination of <b>13f</b> commercially with available 2-methylpropionaldehyde. Thus, sodium triacetoxyborohydride (339 mg, 1.59 mmol) is added to a solution of <b>13f</b> (148 mg, 0.38 mmol) and 2-methylpropionaldehyde (42 μL, 0.46 mmol) in methylene chloride (8 mL) and stirred for 12 h. The mixture is concentrated on a rotary evaporator and partially purified on a 12 g (Redisep, Isco) silica gel column with a 0−10% methanol/methylene chloride gradient. The resulting product is further purified by reverse phase HPLC using a 30−95% acetonitrile/water gradient. This yields 41.2 mg (24%) after consolidation and concentration of fractions: HRMS (ESI) <i>m</i>/<i>z</i> 447.2717 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.29 (s, 1 H), 8.64 (d, <i>J</i> = 5.8 Hz, 1 H), 8.22 (d, <i>J</i> = 5.3 Hz, 1 H), 7.84 (d, <i>J</i> = 5.8 Hz, 1 H), 7.78 (s, 1 H), 7.30−7.28 (m, 1 H), 7.27 (s, 1 H), 4.57 (d, <i>J</i> = 8.0 Hz, 1 H), 4.15−3.98 (m, 3 H), 3.73−3.53 (m, 6 H), 2.73 (t, <i>J</i> = 4.6 Hz, 4 H), 2.25 (d, <i>J</i> = 7.3 Hz, 2 H), 2.15 (dd, <i>J</i> = 12.6, 2.1 Hz, 2 H), 1.98−1.77 (m, 1 H), 1.70−1.54 (m, 2 H), 0.99 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Cyclohexyl-{4-[1-((<i>cis</i>-3,5-dimethylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}amine (<b>13h</b>)</h4><div class="NLM_p last">The title compound was prepared from chloride <b>24</b> and <i>cis</i>-3,5-dimethylpiperazine by analogy to the preparation of <b>13i</b> below: MS (ESI) <i>m</i>/<i>z</i> 417.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.3 (s, 1 H), 8.6 (d, 1 H), 8.2 (d, 1 H), 7.8 (d, 1 H), 7.7 (s, 1 H), 7.2 (m, 2 H), 4.7 (br s, 1 H), 3.9 (d, 2 H), 3.7 (br s, 5 H), 3.3 (br s, 2 H), 2.7 (t, 2 H), 2.1 (m, 2 H), 1.5 (m, 8 H), 1.2 (d, 6 H).</div></div><div id="sec7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Cyclohexyl-{4-[1-(4-methylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}amine (<b>13i</b>)</h4><div class="NLM_p last">A solution of chloronaphthyridine <b>24</b> (34 mg, 0.1 mmol) and 1-methylpiperazine (0.033 mL, 0.3 mmol) in 2-methoxyethanol (4 mL) was heated by microwave at 200 °C for 30 min. The mixture was then poured onto a solid phase extraction (SPE) cartridge containing strong cation exchanger (SCX) as the media (2 g). After the sample was washed with MeOH (10 mL), the product was eluted with 20:2:1 EtOAc−MeOH−Et<sub>3</sub>N. The eluent was concentrated in vacuo and the residue was chromatographed on silica gel to give the product (40 mg, 99%): MS (ESI) <i>m</i>/<i>z</i> 403.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.3 (s, 1 H), 8.6 (d, 1 H), 8.2 (d, 1 H), 7.8 (m, 2 H), 7.2 (m, 2 H), 4.8 (br s, 1 H), 3.6 (br s, 5 H), 2.8 (br s, 4 H), 2.4 (s, 3 H), 2.1 (m, 2 H), 1.8 (m, 2 H), 1.7 (m, 1 H), 1.5 (m, 2 H), 1.3 (m, 3 H).</div></div><div id="sec7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidin-4-ol (<b>13j</b>)</h4><div class="NLM_p last">The title compound was prepared from chloride <b>24</b> and 4-hydroxypiperidine by analogy to the preparation of <b>13i</b> above: MS (ESI) <i>m</i>/<i>z</i> 404.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.3 (s, 1 H), 8.6 (d, 1 H), 8.1 (d, 1 H), 7.8 (m, 2 H), 7.2 (m, 2 H), 5.6 (br s, 1 H), 4.0 (m, 1 H), 3.9 (m, 2 H), 3.6 (m, 1 H), 3.4 (m, 2 H), 2.1−1.2 (m, 14 H).</div></div><div id="sec7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Cyclohexyl-{4-[1-(4-cyclopropylmethylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}amine (<b>13k</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12d</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: HRMS (ESI) <i>m</i>/<i>z</i> 443.2924 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.27 (s, 1 H), 8.61 (d, <i>J</i> = 5.8 Hz, 1 H), 8.18 (d, <i>J</i> = 5.3 Hz, 1 H), 7.80 (d, <i>J</i> = 5.8 Hz, 1 H), 7.76 (s, 1 H), 7.25−7.16 (m, 2 H), 4.59 (d, <i>J</i> = 8.1 Hz, 1 H), 3.79−3.57 (m, 5 H), 2.84 (t, <i>J</i> = 4.6 Hz, 4 H), 2.40 (d, <i>J</i> = 6.6 Hz, 2 H), 2.19−2.06 (m, 2 H), 1.88−1.73 (m, 2 H), 1.73−1.61 (m, 1 H), 1.55−1.37 (m, 2 H), 1.36−1.19 (m, 3 H), 1.03−0.87 (m, 1 H), 0.64−0.51 (m, 2 H), 0.18 (q, <i>J</i> = 4.9 Hz, 2 H).</div></div><div id="sec7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Cyclohexyl-{4-[1-(4-cyclopropylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}amine (<b>13l</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12e</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: HRMS (ESI) <i>m</i>/<i>z</i> 429.2768 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.27 (s, 1 H), 8.62 (d, <i>J</i> = 5.8 Hz, 1 H), 8.18 (d, <i>J</i> = 5.4 Hz, 1 H), 7.81 (d, <i>J</i> = 5.8 Hz, 1 H), 7.76 (s, 1 H), 7.24−7.17 (m, 2 H), 4.60 (d, <i>J</i> = 7.9 Hz, 1 H), 3.76−3.63 (m, 1 H), 3.63−3.52 (m, 3 H), 2.98−2.85 (m, 4 H), 2.19−2.07 (m, 2 H), 1.90−1.73 (m, 4 H), 1.70 (d, <i>J</i> = 3.4 Hz, 1 H), 1.55−1.38 (m, 2 H), 1.35−1.19 (m, 3 H), 0.60−0.46 (m, 4 H).</div></div><div id="sec7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-{4-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperazin-1-yl}ethanone (<b>13m</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12f</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 431.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.31 (d, 1 H), 8.60 (d, 1 H), 8.04 (s, 1 H), 8.00 (m, 2 H), 7.37 (d, 1 H), 7.22 (d, 1 H), 3.88 (br d, 4 H), 3.70 (m, 1 H), 3.61 (br d, 4 H), 2.19 (s, 3 H), 2.08 (br m, 2 H), 1.80 (m, 2 H), 1.69 (br d, 1 H), 1.47 (m, 2 H), 1.28 (m, 3 H).</div></div><div id="sec7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-ylamino]ethanol (<b>13n</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12g</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 363.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.21 (s, 1 H), 8.56 (d, 1 H), 8.04 (m, 2 H), 7.66 (s, 1 H), 7.22 (m, 2 H), 3.93 (m, 4 H), 3.74 (m, 2 H), 2.08 (m, 2 H), 1.84 (m, 2 H), 1.73 (m, 1 H), 1.51 (m, 2 H), 1.32 (m, 4 H).</div></div><div id="sec7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperazin-2-one (<b>13o</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12h</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 403.3 (M + 1).</div></div><div id="sec7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> {1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidin-4-ylmethyl}carbamic Acid <i>tert</i>-Butyl Ester (<b>13p</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12i</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 417.2 (M + 1).</div></div><div id="sec7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Piperidin-4-ylamide (<b>13q</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>13p</b> by reaction with TFA/CH<sub>2</sub>Cl<sub>2</sub> according to the method outlined for the preparation of <b>13c</b> above: MS (ESI) <i>m</i>/<i>z</i> 514.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.61 (d, <i>J</i> = 5.8 Hz, 1 H), 8.05 (d, <i>J</i> = 5.6 Hz, 1 H), 8.03 (s, 1 H), 7.86 (d, <i>J</i> = 5.8 Hz, 1 H), 7.80 (d, <i>J</i> = 7.8 Hz, 1 H), 7.28 (s, 1 H), 7.14 (dd, <i>J</i> = 5.4, 1.5 Hz, 1 H), 6.50 (d, <i>J</i> = 7.8 Hz, 1 H), 4.03 (m, 2 H), 374 (m, 1 H), 3.63 (m, 1 H), 3.00 (m, 4 H), 2.58 (m, 2 H), 2.40 (m, 1 H), 1.89 (m, 6 H), 1.72 (m, 4 H), 1.59 (m, 1 H), 1.26 (m, 8 H).</div></div><div id="sec7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Amino-1-(4-{3-[2-(tetrahydropyran-4-ylamino)pyridin-4-yl]-[2,6]naphthyridin-1-yl}piperazin-1-yl)ethanone (<b>13r</b>)</h4><div class="NLM_p">Compound <b>13f</b> (250 mg, 0.64 mmol) and HBTU (366 mg, 0.97 mmol) were dissolved in DMF (3 mL). Triethylamine (89 μL, 0.64 mmol) was added, and the mixture was stirred for 12 h. The mixture was concentrated under reduced pressure, and the residue was purified by flash chromatography to afford [2-oxo-2-(4-{3-[2-(tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperazin-1-yl)ethyl]carbamic acid <i>tert</i>-butyl ester.</div><div class="NLM_p last">The BOC-protected amine above (267 mg, 0.49 mmol) was stirred in formic acid (5 mL) at room temperature. After 20 h, the mixture was concentrated under reduced pressure. The residue was purified by HPLC to afford the title compound: HRMS (ESI) <i>m</i>/<i>z</i> 448.2459 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.31 (s, 1 H), 8.66 (d, <i>J</i> = 5.8 Hz, 1 H), 8.21 (d, <i>J</i> = 5.4 Hz, 1 H), 7.83 (s, 1 H), 7.80 (d, <i>J</i> = 5.8 Hz, 1 H), 7.23 (dd, <i>J</i> = 5.4, 0.9 Hz, 1 H), 7.16 (s, 1 H), 4.55 (d, <i>J</i> = 7.9 Hz, 1 H), 4.11−3.98 (m, 3 H), 3.98−3.91 (m, 2 H), 3.74−3.66 (m, 2 H), 3.64−3.53 (m, 8 H), 2.11 (dd, <i>J</i> = 12.5, 1.9 Hz, 2 H), 1.70 (br s, 2 H), 1.63−1.51 (m, 2 H).</div></div><div id="sec7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Amide (<b>13s</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12j</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 431.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.22 (d, 1 H), 8.56 (d, 1 H), 7.98 (d, 1 H), 7.90 (br m, 2 H), 7.31 (d, 1 H), 7.18 (d, 1 H), 4.01 (br d, 2 H), 3.61 (m, 1 H), 3.08 (dd, 2 H), 2.58 (m, 1 H), 2.01−1.92 (br m, 6 H), 1.71 (br d, 2 H), 1.60 (d, 1 H), 1.37 (m, 2 H), 1.19 (m, 3 H).</div></div><div id="sec7_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid Amide (<b>13t</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12j</b> and 4-aminotetrahydropyran by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 433.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.63 (d, <i>J</i> = 6.1 Hz, 1 H), 8.07 (m, 2 H), 7.86 (d, <i>J</i> = 5.6 Hz, 1 H), 7.34 (s, 2 H), 7.19 (d, <i>J</i> = 4.0 Hz, 1 H), 6.83 (s, 1 H), 6.70 (br s, 1 H), 4.00 (m, 3 H), 3.89 (br dt, <i>J</i> = 8.0, 3.2 Hz, 2 H), 3.43 (td, <i>J</i> = 11.0, 2.0 Hz, 2 H), 3.40 (m, 1 H), 3.06 (m, 2 H), 2.42 (m, 1 H), 1.91 (br m, 5 H), 1.47 (m, 2 H).</div></div><div id="sec7_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Methylamide (<b>13u</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>12k</b> and cyclohexylamine by analogy to the method described for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 445.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.28 (s, 1 H), 8.57 (d, 1 H), 8.00 (m, 2 H), 7.99 (d, 1 H), 7.38 (s, 1 H), 7.26 (d, 1 H), 4.13 (br d, 2 H), 3.68 (m, 1 H), 3.14 (dd, 2 H), 2.77 (s, 3 H), 2.50 (m, 1 H), 2.07 (br m, 4 H), 1.95 (m, 2 H), 1.80, (m, 2 H), 1.69 (br d, 1 H), 1.46 (m, 2 H), 1.29 (m, 3 H).</div></div><div id="sec7_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid (2-Pyrrolidin-1-ylethyl)amide (<b>13v</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12l</b> by the method outlined for the preparation of <b>13y</b> below: MS (ESI) <i>m</i>/<i>z</i> 528.4 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.62 (d, <i>J</i> = 5.3 Hz, 1 H), 8.03 (m, 2 H), 7.83 (m, 2 H), 7.29 (s, 1 H), 7.14 (d, <i>J</i> = 5.8 Hz, 1 H), 6.51 (d, <i>J</i> = 7.6 Hz, 1 H), 4.01 (m, 2 H), 3.74 (br s, 1 H), 3.18 (m, 2 H), 3.03 (m, 2 H), 1.92 (m, 8 H), 1.79−1.56 (m, 8 H), 1.42−1.10 (m, 8 H).</div></div><div id="sec7_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> {1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidin-4-yl}-(4-hydroxypiperidin-1-yl)methanone (<b>13w</b>)</h4><div class="NLM_p">A mixture of ester <b>12k</b> (500 mg, 1.3 mmol), 4-hydroxycyclohexylamine (400 mg, 3.9 mmol), and Me<sub>3</sub>Al (4 mL of a 2 M solution, 8 mmol) in toluene (10 mL) was heated for 6 h at 110 °C. After cooling, the mixture was poured into MeOH (250 mL) and stirred for 10 min. The mixture was filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (1−2% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the amide as a yellow solid.</div><div class="NLM_p last">The amide above was converted to the target by coupling to cyclohexylamine using the method outlined for the preparation of <b>13e</b> above: MS (ESI) <i>m</i>/<i>z</i> 515.4 (M + 1); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.27 (s, 1 H), 8.56 (d, <i>J</i> = 5.8 Hz, 1 H), 8.02−7.90 (m, 3 H), 7.37 (s, 1 H), 7.25 (d, <i>J</i> = 5.6 Hz, 1 H), 4.18−4.07 (m, 2 H), 4.02−3.93 (m, 1 H), 3.92−3.83 (m, 1 H), 3.75−3.63 (m, 1 H), 3.45−3.34 (m, 1 H), 3.27−3.10 (m, 3 H), 3.09−2.98 (m, 1 H), 2.17−1.96 (m, 4 H), 2.00−1.76 (m, 6 H), 1.75−1.62 (m, 1 H), 1.59−1.38 (m, 4 H), 1.36−1.21 (m, 4 H).</div></div><div id="sec7_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid Ethylamide (<b>13x</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12l</b> by the method outlined for the preparation of <b>13y</b> below: MS (ESI) 461.2 <i>m</i>/<i>z</i> (M + 1); <sup>1</sup>H NMR (400 MHz, MeOD) (TFA salt) δ ppm 8.68 (d, <i>J</i> = 5.8 Hz, 1 H), 8.22 (s, 1 H), 8.02 (d, <i>J</i> = 6.1 Hz, 1 H), 8.00−7.96 (m, 1 H), 7.95−7.86 (m, 1 H), 7.69−7.61 (m, 1 H), 4.26−4.16 (m, 2 H), 4.09−3.99 (m, 2 H), 3.96−3.84 (m, 1 H), 3.63−3.53 (m, 2 H), 3.29−3.14 (m, 4 H), 2.58−2.45 (m, 1 H), 2.15−2.01 (m, 4 H), 1.98−1.88 (m, 2 H), 1.79−1.64 (m, 2 H), 1.14 (t, <i>J</i> = 7.3 Hz, 3 H).</div></div><div id="sec7_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid Isopropylamide (<b>13y</b>)</h4><div class="NLM_p">To a solution of <b>12k</b> (2.65 g, 6.93 mmol), THF (30 mL), and H<sub>2</sub>O (10 mL) was added LiOH·H<sub>2</sub>O (1.45 g, 34.6 mmol). After 20 min, an additional 30 mL of THF was added. After 5 h, the mixture was complete as judged by LCMS. At that point, 1 M HCl in Et<sub>2</sub>O (35 mL) was added. The mixture was stirred for 10 min and then concentrated in vacuo. The residue was then azeotroped with toluene (3 × 150 mL) to give 1-[3-(2-chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic acid. The crude 1-[3-(2-chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic acid was taken up in DMF (60 mL) before DIEA (5.75 mL, 34.60 mmol), <i>i</i>-PrNH<sub>2</sub> (2.9 mL, 34.6 mmol), PyBOP (10.80 g, 20.80 mmol), and HOBt (0.94 g, 6.93 mmol) were added in sequence. The mixture was stirred at room temperature for 24 h, then concentrated in vacuo. The residue was taken up in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) and H<sub>2</sub>O (500 mL). The layers were mixed and then separated. The aqueous layer was extracted further with CH<sub>2</sub>Cl<sub>2</sub> (2 × 500 mL), and each organic layer was washed with an aliquot of H<sub>2</sub>O (500 mL). The combined organic layers were then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was stirred with hot EtOAc (50 mL) and then filtered. The filtrate was then washed several times with cold EtOAc to give 1-[3-(2-chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic acid isopropylamide as a white solid: MS (ESI) <i>m</i>/<i>z</i> 410.2 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.68 (d, <i>J</i> = 5.8 Hz, 1 H), 8.56 (d, <i>J</i> = 5.3 Hz, 1 H), 8.38 (s, 1 H), 8.23 (s, 1 H), 8.20−8.15 (m, 1 H), 7.90 (d, <i>J</i> = 5.8 Hz, 1 H), 7.71 (d, <i>J</i> = 7.6 Hz, 1 H), 4.06 (d, <i>J</i> = 13.1 Hz, 2 H), 3.94−3.79 (m, 1 H), 3.13−3.02 (m, 2 H), 2.47−2.34 (m, 1 H), 2.00−1.81 (m, 4 H), 1.07 (d, <i>J</i> = 6.6 Hz, 6 H).</div><div class="NLM_p last">A pressure reaction vessel was charged with 1-[3-(2-chloropyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic acid isopropylamide (0.50 g, 1.22 mmol), 4-aminotetrahydropyran (0.25 g, 2.44 mmol), Pd(<i>t</i>-Bu<sub>3</sub>P)<sub>2</sub> (0.06 g, 0.12 mmol), <i>t-</i>BuONa (0.35 g, 3.66 mmol), and 1,4-dioxane. The mixture was sparged with argon for 10 min, and the vessel is then sealed and heated to 130 °C for 2.5 h. The contents of the vessel are allowed to cool to room temperature before being diluted with CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and brine (150 mL). The layers were mixed and then separated. The aqueous layer was extracted further with CH<sub>2</sub>Cl<sub>2</sub> (3 × 150 mL), and the combined organic layers were then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was then separated via RP-HPLC (5−60% CH<sub>3</sub>CN/H<sub>2</sub>O/0.1%NH<sub>4</sub>OH gradient) to give the title compound: MS (ESI) 475.1 <i>m</i>/<i>z</i> (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.62 (d, <i>J</i> = 5.6 Hz, 1 H), 8.08 (d, <i>J</i> = 5.3 Hz, 1 H), 8.04 (s, 1 H), 7.86 (d, <i>J</i> = 5.8 Hz, 1 H), 7.70 (d, <i>J</i> = 7.6 Hz, 1 H), 7.31 (s, 1 H), 7.22−7.14 (m, 1 H), 6.66 (d, <i>J</i> = 7.6 Hz, 1 H), 4.09−3.93 (m, 3 H), 3.94−3.77 (m, 3 H), 3.49−3.36 (m, 2 H), 3.05 (t, <i>J</i> = 12.0 Hz, 2 H), 2.46−2.31 (m, 1) H, 2.01−1.78 (m, 6 H), 1.56−1.38 (m, 2 H), 1.07 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec7_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid Isobutylamide (<b>13z</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12k</b> by the method outlined for the preparation of <b>13y</b> above: MS (ESI) <i>m</i>/<i>z</i> 489.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.27 (s, 1 H), 8.62 (d, <i>J</i> = 5.8 Hz, 1 H), 8.20 (d, <i>J</i> = 5.6 Hz, 1 H), 7.79 (d, <i>J</i> = 5.8 Hz, 1 H), 7.76 (s, 1 H), 7.26−7.22 (m, 1 H), 7.20 (s, 1 H), 5.58 (t, <i>J</i> = 5.6 Hz, 1 H), 4.50 (d, <i>J</i> = 8.1 Hz, 1 H), 4.14−3.98 (m, 5 H), 3.65−3.54 (m, 2 H), 3.19−3.07 (m, 4 H), 2.46−2.33 (m, 1 H), 2.22−2.01 (m, 6 H), 1.87−1.75 (m, 1 H), 0.95 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec7_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid (2-Pyrrolidin-1-ylethyl)amide (<b>13aa</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12k</b> by the method outlined for the preparation of <b>13y</b> above: MS (ESI) <i>m</i>/<i>z</i> 530.4 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>) δ ppm 9.29 (s, 1 H), 8.55 (d, <i>J</i> = 5.8 Hz, 1 H), 8.00 (d, <i>J</i> = 5.6 Hz, 1 H), 7.98 (s, 1 H), 7.84−7.71 (m, 2 H), 7.25 (s, 1 H), 7.11 (d, <i>J</i> = 5.6 Hz, 1 H), 6.59 (d, <i>J</i> = 7.6 Hz, 1 H), 3.87−4.01 (m, 3 H), 3.87−3.78 (m, 2 H), 3.41−3.30 (m, 2 H), 3.12 (d, <i>J</i> = 19.2 Hz, 2 H), 2.99 (d, <i>J</i> = 23.2 Hz, 2 H), 1.92−1.74 (m, 8 H), 1.60 (br s, 4 H), 1.49−1.28 (m, 6 H).</div></div><div id="sec7_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid (2-<i>tert</i>-Butoxyethyl)amide (<b>13ab</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12k</b> by the method outlined for the preparation of <b>13y</b> above: MS (ESI) <i>m</i>/<i>z</i> 533.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.27 (s, 1 H), 8.63 (d, <i>J</i> = 5.8 Hz, 1 H), 8.20 (d, <i>J</i> = 5.3 Hz, 1 H), 7.79 (d, <i>J</i> = 5.8 Hz, 1 H), 7.76 (s, 1 H), 7.25−7.22 (m, 1 H), 7.20 (s, 1 H), 6.01 (br s, 1 H), 4.54−4.46 (m, 1 H), 4.15−3.97 (m, 5 H), 3.65−3.54 (m, 2 H), 3.49−3.44 (m, 4 H), 3.19−3.07 (m, 2 H), 2.49−2.34 (m, 1 H), 2.18−1.97 (m, 6 H), 1.21 (s, 9 H).</div></div><div id="sec7_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-{3-[2-(Tetrahydropyran-4-ylamino)pyridin-4-yl][2,6]naphthyridin-1-yl}piperidine-4-carboxylic Acid (2-Hydroxyethyl)amide (<b>13ac</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>13ab</b> above by acidic deprotection (TFA in CH<sub>2</sub>Cl<sub>2</sub>) of the <i>tert</i>-butyl ether to afford the title alcohol: MS (ESI) <i>m</i>/<i>z</i> 477.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.29 (s, 1 H), 8.65 (d, <i>J</i> = 5.6 Hz, 1 H), 8.22−8.15 (m, 1 H), 7.83−7.76 (m, 2 H), 7.27−7.24 (m, 2 H), 6.08−5.99 (m, 1 H), 4.17−3.98 (m, 5 H), 3.84−3.76 (m, 2 H), 3.67−3.57 (m, 2 H), 3.56−3.47 (m, 2 H), 3.20−3.09 (m, 2 H), 2.53−2.41 (m, 1 H), 2.39−2.26 (m, 1 H), 2.23−2.02 (m, 7 H), 1.70−1.60 (m, 2 H).</div></div><div id="sec7_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-({1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carbonyl}amino)piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>13ad</b>)</h4><div class="NLM_p last">The title compound was prepared from ester <b>12k</b> by the method outlined for the preparation of <b>13y</b> above: MS (ESI) <i>m</i>/<i>z</i> 614.4 (M + 1).</div></div><div id="sec7_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidine-4-carboxylic Acid Piperidin-4-ylamide (<b>13ae</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>13ad</b> above by acidic deprotection (TFA in CH<sub>2</sub>Cl<sub>2</sub>) to afford the title amine: MS (ESI) <i>m</i>/<i>z</i> 514.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.36 (s, 1 H), 8.61 (d, <i>J</i> = 5.8 Hz, 1 H), 8.05 (d, <i>J</i> = 5.6 Hz, 1 H), 8.03 (s, 1 H), 7.86 (d, <i>J</i> = 5.8 Hz, 1 H), 7.80 (d, <i>J</i> = 7.8 Hz, 1 H), 7.28 (s, 1 H), 7.14 (dd, <i>J</i> = 5.4, 1.5 Hz, 1 H), 6.50 (d, <i>J</i> = 7.8 Hz, 1 H), 4.09−3.96 (m, 2 H), 3.82−3.66 (m, 1 H), 3.69−3.57 (m, 1 H), 3.11−2.92 (m, 4 H), 2.64−2.52 (m, 2 H), 2.46−2.34 (m, 1 H), 2.00−1.79 (m, 6 H), 1.78−1.66 (m, 4 H), 1.66−1.53 (m, 1 H), 1.40−1.12 (m, 8 H).</div></div><div id="sec7_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-<i>tert</i>-Butyl-2-methylbenzamide (<b>14a</b>)</h4><div class="NLM_p last">To an ice-cold solution of aqueous Na<sub>2</sub>CO<sub>3</sub> (1 M, 30 mL) containing <i>tert</i>-butylamine (3.2 mL, 30 mmol) was added 2-methylbenzoyl chloride (3.9 g, 25 mmol) in dioxane (5 mL) slowly dropwise. After the addition, the mixture was allowed to warm to room temperature and further stirred for 4 h. The resulting slurry was diluted with water and the precipitate was filtered and air-dried to give <b>14a</b> as a white solid (3.6 g, 75%) matching the reported <sup>1</sup>H NMR data.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec7_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-Methylpyridine-2-carboxylic Acid <i>tert</i>-Butylamide (<b>14b</b>)</h4><div class="NLM_p last">To a solution of 2-cyano-3-methylpyridine (1.2 g, 12 mmol) in <i>tert</i>-butyl acetate (10 mL) was added concentrated H<sub>2</sub>SO<sub>4</sub> (1 mL), and the mixture was stirred at room temperature overnight before it was diluted with water. The mixture was then carefully neutralized by adding NH<sub>4</sub>OH at 0 °C and then extracted twice with 1:1 hexane−EtOAc. The combined organics were washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was chromatographed on silica gel to give <b>14b</b> as a colorless oil (1.85 g, 95%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.35 (d, <i>J</i> = 4.3 Hz, 1 H), 8.2 (br s, 1 H), 7.55 (m, 1 H), 7.27 (m, 1 H), 2.74 (s, 3 H), 1.48 (s, 9 H).</div></div><div id="sec7_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-<i>tert</i>-Butyl-4-methylnicotinamide (<b>14c</b>)</h4><div class="NLM_p last">The title compound was prepared in an analogous manner to the method described for the preparation of <b>14b</b> above: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.52 (s, 1 H), 8.46 (d, <i>J</i> = 5.1 Hz, 1 H), 7.13 (d, <i>J</i> = 5.1 Hz, 1 H), 5.63 (br s, 1 H), 2.45 (s, 3 H), 1.48 (s, 9 H).</div></div><div id="sec7_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 3-(2-Chloropyridin-4-yl)isochromen-1-one (<b>15a</b>)</h4><div class="NLM_p last">To a solution of <b>14a</b> (3.4 g, 18 mmol) in THF (60 mL) at −78 °C was added <i>n</i>-butyllithium (2.5 M in hexane, 16 mL, 40 mmol) slowly dropwise. After 30 min at −78 °C, ethyl 2-chloroisonicotinate (3.0 g, 17.4 mmol) in THF (10 mL) was added rapidly dropwise. The mixture was further stirred at −78 °C for 30 min before being quenched with AcOH (10 mL). The mixture was allowed to warm to room temperature and then concentrated in vacuo to remove volatiles. The residue was dissolved in AcOH (50 mL), and the mixture was heated at 80 °C with stirring. After cooling to room temperature, the resulting slurry was diluted with MeOH (50 mL) and the precipitate was collected by filtration, washed with MeOH, and air-dried to give <b>15a</b> as a white powder (2.8 g, 63%): MS (ESI) <i>m</i>/<i>z</i> 258.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.72 (d, <i>J</i> = 5.3 Hz, 1 H), 8.38 (d, <i>J</i> = 7.9 Hz, 1 H), 8.2−8.0 (m, 4 H), 8.0−7.8 (m, 2 H).</div></div><div id="sec7_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 3-[2-(2-Chloropyridin-4-yl)-2-oxoethyl]pyridine-2-carboxylic Acid <i>tert</i>-Butylamide (<b>15b</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>14b</b> in a manner analogous to the method described above for the preparation of <b>15a</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.83 (s, 1 H), 8.58 (d, <i>J</i> = 5.2 Hz, 1 H), 8.35 (d, <i>J</i> = 8.3 Hz, 1 H), 8.22 (s, 1 H), 8.20−8.15 (m, 2 H), 8.00−7.90 (m, 2 H).</div></div><div id="sec7_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-<i>tert</i>-Butyl-4-[2-(2-chloropyridin-4-yl)-2-oxoethyl]nicotinamide (<b>15c</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>14c</b> in a manner analogous to the method described above for the preparation of <b>15a</b>: MS (ESI) <i>m</i>/<i>z</i> 259.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.68 (s, 1 H), 9.3 (d, <i>J</i> = 4.8 Hz, 1 H), 8.96 (d, <i>J</i> = 5.3 Hz, 1 H), 8.34 (s, 1 H), 8.24 (m, 2 H), 8.00 (d, <i>J</i> = 5.3 Hz, 1 H).</div></div><div id="sec7_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-<i>tert</i>-Butyl-2-[2-(2-chloropyridin-4-yl)-2-oxoethyl]nicotinamide (<b>15d</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>14d</b> in a manner analogous to the method described above for the preparation of <b>15a</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.38 (dd, <i>J</i> = 4.4, 1.5 Hz, 1 H), 8.90 (d, 5.2 Hz, 1 H), 8.86 (d, <i>J</i> = 8.0 Hz, 1 H), 8.38 (s, 1 H), 8.29 (dd, <i>J</i> = 5.2, 1.5 Hz, 1 H), 8.21 (s, 1 H), 8.0 (dd, <i>J</i> = 8.0, 4.4 Hz, 1 H).</div></div><div id="sec7_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 3-(2-Chloropyridin-4-yl)isoquinolin-1-ol (<b>16a</b>)</h4><div class="NLM_p last">To a suspension of <b>15a</b> (2.8 g, 11 mmol) in MeOH (10 mL) was added a 2 M solution of NH<sub>3</sub> in MeOH (40 mL). The mixture was heated to 80 °C in a sealed tube, and after it was cooled, the precipitate was collected by filtration. The crude product, which LCMS analysis indicated to be a 1:1 mixture of <b>16a</b> and uncyclized amide, was resuspended in MeOH. Concentrated HCl (0.1 mL) was added, and the mixture was heated to 60 °C for 1 h. The resulting slurry was cooled to 0 °C, filtered, washed with cold MeOH, and air-dried to give <b>16a</b> as a yellowish solid (2.6 g, 93%): MS (ESI) <i>m</i>/<i>z</i> 257.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.65 (br, 1 H), 8.52 (d, <i>J</i> = 5.3 Hz, 1 H), 8.24 (d, <i>J</i> = 8.0 Hz, 1 H), 8.00 (s, 1 H), 7.87 (d, <i>J</i> = 5.5 Hz, 1 H), 7.77 (m, 2 H), 7.58 (m, 1 H), 7.3 (s, 1 H).</div></div><div id="sec7_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 6-(2-Chloropyridin-4-yl)[1,7]naphthyridin-8-ol (<b>16b</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>15b</b> by analogy to the method described above for the preparation of <b>16a</b>: MS (ESI) <i>m</i>/<i>z</i> 258.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.22 (br s, 1 H), 9.15 (d, <i>J</i> = 4.0 Hz, 1 H), 8.87 (d, <i>J</i> = 5.6 Hz, 1 H), 8.51 (d, <i>J</i> = 8.1 Hz, 1 H), 8.32 (s, 1 H), 8.18 (d, <i>J</i> = 5.1 Hz, 1 H), 8.07 (dd, <i>J</i> = 8.1, 4.0 Hz, 1 H), 7.58 (s, 1 H).</div></div><div id="sec7_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-(2-Chloropyridin-4-yl)[2,7]naphthyridin-1-ol (<b>16c</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>15c</b> by analogy to the method described above for the preparation of <b>16a</b>: MS (ESI) <i>m</i>/<i>z</i> 258.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.38 (br s, 1 H), 9.75 (s, 1 H), 9.17 (d, <i>J</i> = 4.6 Hz, 1 H), 8.95 (d, <i>J</i> = 5.6 Hz, 1 H), 8.38 (s, 1 H), 8.24 (d, <i>J</i> = 5.1 Hz, 1 H), 8.04 (d, <i>J</i> = 5.6 Hz, 1 H), 7.61 (s, 1 H).</div></div><div id="sec7_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 7-(2-Chloropyridin-4-yl)[1,6]naphthyridin-5-ol (<b>16d</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>15d</b> by analogy to the method described above for the preparation of <b>16a</b>: MS (ESI) <i>m</i>/<i>z</i> 258.1 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.27 (br s, 1 H), 9.18 (d, 1 H), 8.89 (d, <i>J</i> = 5.1 Hz, 1 H), 8.53 (d, <i>J</i> = 8.1 Hz, 1 H), 8.34 (s, 1 H), 8.20 (d, <i>J</i> = 5.6 Hz, 1 H), 8.09 (dd, <i>J</i> = 8.1, 4.6 Hz, 1 H), 7.60 (s, 1 H).</div></div><div id="sec7_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-(2-Chloropyridin-4-yl)quinazolin-4-ol (<b>20</b>)</h4><div class="NLM_p last">To a solution of <b>17</b> (6 g, 43 mmol) in dioxane (50 mL) was added MeOH (7 mL, 172 mmol), followed by 4 M HCl in dioxane (50 mL, 200 mmol). The mixture was stirred at room temperature overnight, and the resulting slurry was filtered, washed with dioxane, and air-dried to give crude imidate salt <b>18</b>. To an ice-cold solution of the crude <b>18</b> obtained as above in MeOH (50 mL) was added Na metal (2 g, 86 mmol) slowly in small pieces. After the addition, the mixture was heated to reflux with <b>19</b> for 6 h before it was allowed to cool to room temperature and filtered, washed with water, and air-dried to give the quinazolone <b>20</b>, which was used in the next step without further purification (4.6 g, 42%).</div></div><div id="sec7_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1-(1-Piperazinyl)-3-(2-cyclohexylaminopyrid-4-yl)isoquinoline (<b>22a</b>)</h4><div class="NLM_p">A suspension of the above <b>16a</b> (510 mg, 1.99 mmol) in POCl<sub>3</sub> was heated at 100 °C with stirring for 2 h. After cooling to room temperature, the mixture was concentrated under reduced pressure, triturated with water, filtered, and air-dried to a yellow solid. The solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with a saturated aqueous solution of NaHCO<sub>3</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered through silica gel to afford 1-chloro-3-(2-chloropyridin-4-yl)isoquinoline (0.47 g, 86%): MS (ESI) <i>m</i>/<i>z</i> 259.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.83 (s, 1 H), 8.58 (d, <i>J</i> = 5.2 Hz, 1 H), 8.35 (d, <i>J</i> = 8.3 Hz, 1 H), 8.22 (s, 1 H), 8.20−8.15 (m, 2 H), 7.99 (dd, <i>J</i> = 8.3, 7.0 Hz, 1 H), 7.91 (dd, <i>J</i> = 8.3, 7.1 Hz, 1 H).</div><div class="NLM_p">The 1-chloroisoquinoline above (360 mg, 1.3 mmol) and <i>N</i>-BOC piperazine (300 mg, 1.6 mmol) in NMP (1 mL) were heated to 180 °C in a microwave reactor for 45 min. After cooling, the mixture was poured into water and the resulting precipitate was isolated by filtration. The collected tan solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and purified by column chromatography using a gradient of 0−20% EtOAc/CH<sub>2</sub>Cl<sub>2</sub>. Compound <b>21a</b> was isolated as a solid 285 mg (51%): MS (ESI) <i>m</i>/<i>z</i> 425.3 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.47 (d, <i>J</i> = 5.2 Hz, 1 H), 8.11 (d, <i>J</i> = 8.1 Hz, 1 H), 8.08 (s, 1 H), 7.94 (dd, <i>J</i> = 5.2, 1.5 Hz, 1 H), 7.87 (d, <i>J</i> = 8.1 Hz, 1 H), 7.82 (s, 1 H), 7.68 (dd, <i>J</i> = 7.5, 6.9 Hz, 1 H), 7.59 (dd, <i>J</i> = 8.1, 7.6 Hz, 1 H), 3.74 (m, 4 H), 3.50 (m, 4 H), 1.52 (s, 9 H).</div><div class="NLM_p">A vial containing <b>21a</b> (42 mg, 0.1 mmol) in toluene (0.5 mL) and cyclohexylamine (12 mg, 0.12 mmol) in toluene (0.6 mL) was degassed with N<sub>2</sub>. To the vial was added Pd(OAc)<sub>2</sub> and BINAP (0.25 mL of a 0.01 M solution in toluene, 2.5 × 10<sup>−3</sup> mmol) followed by <i>t</i>-BuOK (0.12 mL of a 1 M solution in THF, 0.12 mmol). The vial was heated at 80 °C overnight. After cooling, the mixture was partitioned between toluene and water. The toluene layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The residue was purified by flash chromatography and then by preparative TLC to afford cyclohexylaminopyridine.</div><div class="NLM_p last">The pure fractions of the above compound were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and TFA (0.4 mL). After being stirred at room temperature overnight, the mixture was concentrated in vacuo and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and a saturated aqueous solution of NaHCO<sub>3</sub>. The phases were separated using a Biotage phase separator cartridge. The organic layer was concentrated in vacuo. The residue was purified using silica gel solid phase extraction to afford the title compound <b>22a</b>: MS (ESI) <i>m</i>/<i>z</i> 388.3 (M + H); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.52 (d, <i>J</i> = 8.1 Hz, 1 H), 8.44 (d, <i>J</i> = 5.1 Hz, 1 H), 8.42−8.35 (m, 2 H), 8.13 (t, <i>J</i> = 8.1 Hz, 1 H), 8.03 (t, <i>J</i> = 8.1 Hz, 1 H), 7.68 (s, 1 H), 7.55 (d, <i>J</i> = 5.6 Hz, 1 H), 6.85 (d, <i>J</i> = 7.6 Hz, 1 H), 4.22−4.08 (m, 1 H), 3.96−3.86 (m, 4 H), 3.67−3.59 (m, 4 H), 3.29−3.16 (m, 1 H), 2.40−2.31 (m, 2 H), 2.19−2.07 (m, 2 H), 2.06−1.95 (m, 1 H), 1.82−1.67 (m, 2 H), 1.68−1.53 (m, 3 H).</div></div><div id="sec7_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Cyclohexyl-[4-(8-piperazin-1-yl[1,7]naphthyridin-6-yl)pyridin-2-yl]amine (<b>22b</b>)</h4><div class="NLM_p">The title compound was prepared from <b>16b</b> by analogy to the method described for the preparation of <b>22a</b>. The intermediate <b>21b</b> was generated under milder conditions than <b>21a</b> above (80 °C, overnight): MS (ESI) <i>m</i>/<i>z</i> 259.1 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.87 (dd, <i>J</i> = 4.2, 1.8 Hz, 1 H), 8.48 (d, <i>J</i> = 5.2 Hz, 1 H), 8.11 (dd, <i>J</i> = 8.3, 1.9 Hz, 1 H), 8.04 (d, <i>J</i> = 1.6 Hz, 1 H), 7.91 (dd, <i>J</i> = 5.2, 1.6 Hz, 1 H), 7.6 (s, 1 H), 7.56 (dd, <i>J</i> = 8.3, 4.2 Hz, 1 H), 4.12 (br, 4 H), 3.72 (m, 4 H), 1.51 (s, 9 H).</div><div class="NLM_p last">The title compound was prepared from <b>21b</b> by Buchwald amination followed by acidic deprotection: MS (ESI) <i>m</i>/<i>z</i> 389.4 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.99 (d, <i>J</i> = 4.0 Hz, 1 H), 8.45 (d, <i>J</i> = 8.1 Hz, 1 H), 8.18 (d, <i>J</i> = 5.1 Hz, 1 H), 7.88 (s, 1 H), 7.82 (dd, <i>J</i> = 8.6, 3.54 Hz, 1 H), 7.41 (s, 1 H), 7.25 (d, <i>J</i> = 5.1 Hz, 1 H), 6.61 (d, <i>J</i> = 7.6 Hz, 1 H), 4.22−4.10 (m, 4 H), 3.98−3.84 (m, 1 H), 3.16−3.04 (m, 4 H), 2.16−2.05 (m, 2 H), 1.95−1.83 (m, 2 H), 1.80−1.70 (m, 1 H), 1.56−1.25 (m, 5 H).</div></div><div id="sec7_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Cyclohexyl-[4-(1-piperazin-1-yl[2,7]naphthyridin-3-yl)pyridin-2-yl]amine (<b>22c</b>)</h4><div class="NLM_p">The title compound was prepared from <b>16c</b> by analogy to the method described for the preparation of <b>22b</b>. The intermediate <b>21c</b> was isolated as a solid: MS (ESI) <i>m</i>/<i>z</i> 426.2 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.48 (s, 1 H), 8.69 (d, <i>J</i> = 5.7 Hz, 1 H), 8.50 (d, <i>J</i> = 5.2 Hz, 1 H), 8.05 (d, <i>J</i> = 1.5 Hz, 1 H), 7.91 (dd, <i>J</i> = 5.2, 1.5 Hz, 1 H), 7.69 (s, 1 H), 7.64 (d, <i>J</i> = 5.7 Hz, 1 H), 3.75 (m, 4 H), 3.65 (m, 4 H), 1.52 (s, 9 H).</div><div class="NLM_p last">Buchwald amination of <b>21c</b> followed by deprotection under acidic conditions afforded the title compound <b>22c</b>: MS (ESI) <i>m</i>/<i>z</i> 389.4 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.67 (s, 1 H), 9.08 (br s, 2 H), 8.90−8.85 (m, 1 H), 8.24−8.17 (m, 2 H), 8.03 (d, <i>J</i> = 5.56 Hz, 1 H), 7.54 (br s, 1 H), 7.37 (br s, 1 H), 3.93 (br s, 4 H), 3.59 (br s, 4 H), 3.30−3.19 (m, 1 H), 2.13−2.07 (m, 2 H), 1.94−1.85 (m, 2 H), 1.82−1.72 (m, 1 H), 1.59−1.34 (m, 5 H).</div></div><div id="sec7_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Cyclohexyl-[4-(5-piperazin-1-yl[1,6]naphthyridin-7-yl)pyridin-2-yl]amine (<b>22d</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>16d</b> by analogy to the method described for the preparation of <b>22a</b>: MS (ESI) <i>m</i>/<i>z</i> 389.3 (M + 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.02 (dd, <i>J</i> = 4.2, 1.6 Hz, 1 H), 8.50−8.39 (m, 1 H), 8.05 (d, <i>J</i> = 5.3 Hz, 1 H), 7.90 (s, 1 H), 7.57 (dd, <i>J</i> = 8.5, 4.2 Hz, 1 H), 7.32 (d, <i>J</i> = 0.8 Hz, 1 H), 7.19 (dd, <i>J</i> = 5.4, 1.5 Hz, 1 H), 6.50 (d, <i>J</i> = 7.8 Hz, 1 H), 3.83−3.71 (m, 1 H), 3.47−3.39 (m, 4 H), 3.05−2.95 (m, 4 H), 2.02−1.90 (m, 2 H), 1.80−1.67 (m, 2 H), 1.66−1.57 (m, 1 H), 1.43−1.13 (m, 5 H).</div></div><div id="sec7_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Cyclohexyl-[4-(4-piperazin-1-ylquinazolin-2-yl)pyridin-2-yl]amine (<b>22e</b>)</h4><div class="NLM_p">The title compound was prepared from <b>20</b> by analogy to the method described for the preparation of <b>22a</b>. The intermediate <b>21e</b> was isolated as a solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.52 (d, <i>J</i> = 5.2 Hz, 1 H), 8.41 (s, 1 H), 8.31 (dd, <i>J</i> = 5.1, 1.3 Hz, 1 H), 8.01 (d, <i>J</i> = 8.4 Hz, 1 H), 7.93 (d, <i>J</i> = 8.3 Hz, 1 H), 7.80 (app t, <i>J</i> = 8.3 Hz, 1 H), 7.52 (app t, <i>J</i> = 8.2 Hz, 1 H), 3.86 (m, 4 H), 3.71 (m, 4 H), 1.51 (s, 9 H).</div><div class="NLM_p last">Deprotection of <b>21e</b> was effected under acidic conditions to afford the title compound <b>22e</b> as a solid: MS (ESI) <i>m</i>/<i>z</i> 389.3 (M + 1); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.19 (d, <i>J</i> = 5.1 Hz, 1 H), 7.98 (d, <i>J</i> = 8.1 Hz, 1 H), 7.91 (d, <i>J</i> = 8.6 Hz, 1 H), 7.74 (t, <i>J</i> = 7.3 Hz, 1 H), 7.61 (d, <i>J</i> = 6.1 Hz, 1 H), 7.52 (s, 1 H), 4.67 (br s, 1 H), 3.89−3.80 (m, 4 H), 3.80−3.68 (m, 1 H), 3.17−3.08 (m, 4 H), 2.17−2.07 (m, 2 H), 1.87−1.61 (m, 3 H), 1.33−1.19 (m, 3 H), 1.52−1.38 (m, 2 H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/jm100075z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figures S1 and S2 showing the PK iv and po curves for <b>13c</b> and <b>13y</b>; Table T1 listing percent activity remaining for kinases. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100075z/suppl_file/jm100075z_si_001.pdf">jm100075z_si_001.pdf (157.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100075z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren G. Monovich</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1c707d696e797232717372736a757f745c72736a7d6e68756f327f7371"><span class="__cf_email__" data-cfemail="0a666b7f786f6424676564657c6369624a64657c6b787e637924696567">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik L. Meredith</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ophelia Ardayfio</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Beattie</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus R. Dobler</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Istvan Enyedy</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph Gaul</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinayak Hosagrahara</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Jewell</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Koch</span> - <span class="hlFld-Affiliation affiliation">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Lee</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">HansJoerg Lehmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy A. McKinsey</span> - <span class="hlFld-Affiliation affiliation">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl Miranda</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikos Pagratis</span> - <span class="hlFld-Affiliation affiliation">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret Pancost</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anup Patnaik</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dillon Phan</span> - <span class="hlFld-Affiliation affiliation">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Plato</span> - <span class="hlFld-Affiliation affiliation">Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Qian</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vasumathy Rajaraman</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang Rao</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Rozhitskaya</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Ruppen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Shi</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah J. Siska</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clayton Springer</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurice van Eis</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard B. Vega</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anette von Matt</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lihua Yang</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taeyoung Yoon</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji-Hu Zhang</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Na Zhu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Patrick Cronan for high resolution mass spectrometry data, Analytical Sciences for LCMS and NMR support, and Angela Mackay for the preparation of <b>12g</b>. We thank the Metabolism and Pharmacokinetics Group for the in vivo and bioanalytical support in the pharmacokinetic studies.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chatterjee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, B.</span><span> </span><span class="NLM_article-title">Systolic and diastolic heart failure: differences and similarities</span> <span class="citation_source-journal">J. Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.cardfail.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=17826648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A280%3ADC%252BD2srivFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=569&author=K.+Chatterjeeauthor=B.+Massie&title=Systolic+and+diastolic+heart+failure%3A+differences+and+similarities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Systolic and diastolic heart failure: differences and similarities</span></div><div class="casAuthors">Chatterjee Kanu; Massie Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiac failure</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">569-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Diastolic heart failure (DHF) and systolic heart failure (SHF) are 2 clinical subsets of the syndrome of chronic heart failure that are most commonly encountered in clinical practice.  METHODS AND RESULTS:  The clinically overt DHF and SHF appear to be 2 separate syndromes with distinctive morphologic and functional changes although signs, symptoms, and prognosis are very similar.  In DHF, the left ventricle is not dilated and the ejection fraction is preserved.  In contrast in SHF, it is dilated and the ejection fraction is reduced.  The neurohormonal abnormalities in DHF and SHF appear to be similar.  The stimuli and the signals that ultimately produce these 2 different phenotypes of chronic heart failure remain, presently, largely unknown.  CONCLUSIONS:  Although there has been considerable progress in the management of SHF, the management of DHF remains mostly empirical because of lack of knowledge of the molecular and biochemical mechanisms which produce myocardial structural and functional changes in this syndrome.  Further research and investigations are urgently required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbW9bU7wRYxkBuFdjgVNKSfW6udTcc2eZ3Pge6srQ2LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srivFShsg%253D%253D&md5=b9441494a7af8ba487321134a17e8efd</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.cardfail.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardfail.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DMassie%26aufirst%3DB.%26atitle%3DSystolic%2520and%2520diastolic%2520heart%2520failure%253A%2520differences%2520and%2520similarities%26jtitle%3DJ.%2520Card.%2520Failure%26date%3D2007%26volume%3D13%26spage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koitabashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurabayashi, M.</span><span> </span><span class="NLM_article-title">Mechanisms that underlie diastolic heart failure and diastolic dysfunction</span> <span class="citation_source-journal">J Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=S142&issue=Suppl.+1&author=M.+Araiauthor=N.+Koitabashiauthor=A.+Watanabeauthor=K.+Niwanoauthor=H.+Matsuiauthor=Y.+Ohyamaauthor=M.+Kurabayashi&title=Mechanisms+that+underlie+diastolic+heart+failure+and+diastolic+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%26aulast%3DKoitabashi%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DNiwano%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DOhyama%26aufirst%3DY.%26aulast%3DKurabayashi%26aufirst%3DM.%26atitle%3DMechanisms%2520that%2520underlie%2520diastolic%2520heart%2520failure%2520and%2520diastolic%2520dysfunction%26jtitle%3DJ%2520Card.%2520Failure%26date%3D2008%26volume%3D14%26issue%3DSuppl.%25201%26spage%3DS142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> For WHO mortality data by country or region, see <a href="http://www.who.int/whosis/whostat2006_mortality.pdf" class="extLink">http://www.who.int/whosis/whostat2006_mortality.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+WHO+mortality+data+by+country+or+region%2C+see+http%3A%2F%2Fwww.who.int%2Fwhosis%2Fwhostat2006_mortality.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: cardiac plasticity</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1056%2FNEJMra072139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=18367740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFOnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=1370-1380&author=J.+A.+Hillauthor=E.+N.+Olson&title=Mechanisms+of+disease%3A+cardiac+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cardiac plasticity</span></div><div class="casAuthors">Hill, Joseph A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1370-1380</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include: (1) dynamics of myocardial growth; (2) changing ideas about cardiac hypertrophy; (3) the hypertrophic phenotype; (4) contrasting phenotypes of myocardial growth; (5) functional decompensation in pathol. cardiac hypertrophy; (6) myocardial atrophy; (7) signal transduction in cardiac growth; (8) cardiac plasticity in heart disease; (9) prospects for therapy; and (10) limitation and perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3rNhNyM1_7Vg90H21EOLACvtfcHk0liZZr3p4SRMwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFOnsb8%253D&md5=758ba9dd5ef2172918ae146f018494e9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra072139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra072139%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DMechanisms%2520of%2520disease%253A%2520cardiac%2520plasticity%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D1370%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gosse, P.</span><span> </span><span class="NLM_article-title">Left ventricular hypertrophy as a predictor of cardiovascular risk</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S27</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=S27-S33&issue=Suppl.+1&author=P.+Gosse&title=Left+ventricular+hypertrophy+as+a+predictor+of+cardiovascular+risk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGosse%26aufirst%3DP.%26atitle%3DLeft%2520ventricular%2520hypertrophy%2520as%2520a%2520predictor%2520of%2520cardiovascular%2520risk%26jtitle%3DJ.%2520Hypertens.%26date%3D2005%26volume%3D23%26issue%3DSuppl.%25201%26spage%3DS27%26epage%3DS33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Devereux, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachtell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieminen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papademetriou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokkedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahloef, B.</span><span> </span><span class="NLM_article-title">Prognostic significance of left ventricular mass change during treatment of hypertension</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">2350</span><span class="NLM_x">–</span> <span class="NLM_lpage">2356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=2350-2356&author=R.+B.+Devereuxauthor=K.+Wachtellauthor=E.+Gerdtsauthor=K.+Bomanauthor=M.+S.+Nieminenauthor=V.+Papademetriouauthor=J.+Rokkedalauthor=K.+Harrisauthor=P.+Aurupauthor=B.+Dahloef&title=Prognostic+significance+of+left+ventricular+mass+change+during+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevereux%26aufirst%3DR.%2BB.%26aulast%3DWachtell%26aufirst%3DK.%26aulast%3DGerdts%26aufirst%3DE.%26aulast%3DBoman%26aufirst%3DK.%26aulast%3DNieminen%26aufirst%3DM.%2BS.%26aulast%3DPapademetriou%26aufirst%3DV.%26aulast%3DRokkedal%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DK.%26aulast%3DAurup%26aufirst%3DP.%26aulast%3DDahloef%26aufirst%3DB.%26atitle%3DPrognostic%2520significance%2520of%2520left%2520ventricular%2520mass%2520change%2520during%2520treatment%2520of%2520hypertension%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2004%26volume%3D292%26spage%3D2350%26epage%3D2356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Aurigemma, G. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zile, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaasch, W. H.</span><span> </span><span class="NLM_article-title">Contractile behavior of the left ventricle in diastolic heart failure with emphasis on regional systolic function</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=296-304&author=G.+P+Aurigemmaauthor=M.+R.+Zileauthor=W.+H.+Gaasch&title=Contractile+behavior+of+the+left+ventricle+in+diastolic+heart+failure+with+emphasis+on+regional+systolic+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAurigemma%26aufirst%3DG.%2BP%26aulast%3DZile%26aufirst%3DM.%2BR.%26aulast%3DGaasch%26aufirst%3DW.%2BH.%26atitle%3DContractile%2520behavior%2520of%2520the%2520left%2520ventricle%2520in%2520diastolic%2520heart%2520failure%2520with%2520emphasis%2520on%2520regional%2520systolic%2520function%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D296%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Frey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Cardiac hypertrophy: the good, the bad, and the ugly</span> <span class="citation_source-journal">Annu. Rev. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1146%2Fannurev.physiol.65.092101.142243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=12524460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Glt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=45-79&author=N.+Freyauthor=E.+N.+Olson&title=Cardiac+hypertrophy%3A+the+good%2C+the+bad%2C+and+the+ugly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac hypertrophy: The good, the bad, and the ugly</span></div><div class="casAuthors">Frey, N.; Olson, E. N.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-79</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Cardiac hypertrophy is the heart response to a variety of extrinsic and intrinsic stimuli that impose increased biomech. stress.  While hypertrophy can eventually normalize wall tension, it is assocd. with an unfavorable outcome and threatens affected patients with sudden death or progression to overt heart failure.  Accumulating evidence from studies in human patients and animal models suggests that in most instances hypertrophy is not a compensatory response to the change in mech. load, but rather is a maladaptive process.  Accordingly, modulation of myocardial growth without adversely affecting contractile function is increasingly recognized as a potentially auspicious approach in the prevention and treatment of heart failure.  In this review, we summarize recent insights into hypertrophic signaling and consider several novel antihypertrophic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzRYVovNsyZLVg90H21EOLACvtfcHk0liLJY56GWL3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Glt74%253D&md5=4b526e04a29f2a8707b2a2e85d86fdf1</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.physiol.65.092101.142243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.physiol.65.092101.142243%26sid%3Dliteratum%253Aachs%26aulast%3DFrey%26aufirst%3DN.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DCardiac%2520hypertrophy%253A%2520the%2520good%252C%2520the%2520bad%252C%2520and%2520the%2520ugly%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2003%26volume%3D65%26spage%3D45%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, D. A.</span><span> </span><span class="NLM_article-title">Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=617-635&author=T.+A.+McKinseyauthor=D.+A.+Kass&title=Small-molecule+therapies+for+cardiac+hypertrophy%3A+moving+beneath+the+cell+surface"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DSmall-molecule%2520therapies%2520for%2520cardiac%2520hypertrophy%253A%2520moving%2520beneath%2520the%2520cell%2520surface%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D617%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Potthoff, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">MEF2: a central regulator of diverse developmental programs</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">4131</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=4131-4140&author=M.+J.+Potthoffauthor=E.+N.+Olson&title=MEF2%3A+a+central+regulator+of+diverse+developmental+programs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotthoff%26aufirst%3DM.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DMEF2%253A%2520a%2520central%2520regulator%2520of%2520diverse%2520developmental%2520programs%26jtitle%3DDevelopment%26date%3D2007%26volume%3D134%26spage%3D4131%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rooij, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnally, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassel-Duby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=124-132&author=Y.+Kimauthor=D.+Phanauthor=E.+van+Rooijauthor=D.-Z.+Wangauthor=J.+McAnallyauthor=X.+Qiauthor=J.+A.+Richardsonauthor=J.+A.+Hillauthor=R.+Bassel-Dubyauthor=E.+N.+Olson&title=The+MEF2D+transcription+factor+mediates+stress-dependent+cardiac+remodeling+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPhan%26aufirst%3DD.%26aulast%3Dvan%2BRooij%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.-Z.%26aulast%3DMcAnally%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DBassel-Duby%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DThe%2520MEF2D%2520transcription%2520factor%2520mediates%2520stress-dependent%2520cardiac%2520remodeling%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D124%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8467</span><span class="NLM_x">–</span> <span class="NLM_lpage">8476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.19.8467-8476.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15367668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8467-8476&author=S.+Changauthor=T.+A.+McKinseyauthor=C.+L.+Zhangauthor=J.+A.+Richardsonauthor=J.+A.+Hillauthor=E.+N.+Olson&title=Histone+deacetylases+5+and+9+govern+responsiveness+of+the+heart+to+a+subset+of+stress+signals+and+play+redundant+roles+in+heart+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development</span></div><div class="casAuthors">Chang, Shurong; McKinsey, Timothy A.; Zhang, Chun Li; Richardson, James A.; Hill, Joseph A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8467-8476</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The adult heart responds to stress signals by hypertrophic growth, which is often accompanied by activation of a fetal cardiac gene program and eventual cardiac demise.  We showed previously that histone deacetylase 9 (HDAC9) acts as a suppressor of cardiac hypertrophy and that mice lacking HDAC9 are sensitized to cardiac stress signals.  Here we report that mice lacking HDAC5 display a similar cardiac phenotype and develop profoundly enlarged hearts in response to pressure overload resulting from aortic constriction or constitutive cardiac activation of calcineurin, a transducer of cardiac stress signals.  In contrast, mice lacking either HDAC5 or HDAC9 show a hypertrophic response to chronic β-adrenergic stimulation identical to that of wild-type littermates, suggesting that these HDACs modulate a specific subset of cardiac stress response pathways.  We also show that compd. mutant mice lacking both HDAC5 and HDAC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium.  These findings reveal central roles for HDACs 5 and 9 in the suppression of a subset of cardiac stress signals as well as redundant functions in the control of cardiac development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTFYzR2fShqLVg90H21EOLACvtfcHk0liLJY56GWL3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7g%253D&md5=5f4115eb485d70a0e39ef5d4bf513e9a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8467-8476.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8467-8476.2004%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DHistone%2520deacetylases%25205%2520and%25209%2520govern%2520responsiveness%2520of%2520the%2520heart%2520to%2520a%2520subset%2520of%2520stress%2520signals%2520and%2520play%2520redundant%2520roles%2520in%2520heart%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8467%26epage%3D8476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation</span> <span class="citation_source-journal">Novartis Found. Symp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">Heart Failure</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1002%2F0470029331.ch2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=17019803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2006&pages=3-19&issue=Heart+Failure&author=E.+N.+Olsonauthor=J.+Backsauthor=T.+A.+McKinsey&title=Control+of+cardiac+hypertrophy+and+heart+failure+by+histone+acetylation%2Fdeacetylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation</span></div><div class="casAuthors">Olson, Eric N.; Backs, Johannes; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Novartis Foundation Symposium</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">Heart Failure</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">NFSYF7</span>;
        ISSN:<span class="NLM_cas:issn">1528-2511</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The adult heart responds to acute and chronic stresses by a remodelling process that is accompanied by myocyte hypertrophy, impaired contractility, and pump failure, often culminating in sudden death.  Pathol. growth and remodelling of the adult heart is often assocd. with the reactivation of a fetal cardiac gene program that further weakens cardiac performance.  Recent studies have revealed key roles for histone deacetylases (HDACs) in the control of pathol. cardiac growth.  Class II HDACs assoc. with the MEF2 transcription factor, and other factors, to maintain normal cardiac size and function.  Stress signals lead to the phosphorylation of class II HDACs and their export from the nucleus to the cytoplasm, with consequent activation of genes involved in cardiac growth.  HDAC knockout mice are hypersensitive to stress signalling and develop massively enlarged hearts in response to various pathol. stress stimuli due to an inability to counteract pathol. signalling to MEF2.  Strategies for normalizing gene expression in the failing heart by regulating HDAC phosphorylation and function represent potentially powerful therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-O4mbpi8Em7Vg90H21EOLACvtfcHk0liLJY56GWL3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslGktLs%253D&md5=f729c73b12d5200d8955793c4649a9a5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2F0470029331.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0470029331.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DBacks%26aufirst%3DJ.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DControl%2520of%2520cardiac%2520hypertrophy%2520and%2520heart%2520failure%2520by%2520histone%2520acetylation%252Fdeacetylation%26jtitle%3DNovartis%2520Found.%2520Symp.%26date%3D2006%26volume%3D274%26issue%3DHeart%2520Failure%26spage%3D3%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Harrison, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">The CRM1 nuclear export receptor controls pathological cardiac gene expression</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">10636</span><span class="NLM_x">–</span> <span class="NLM_lpage">10649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.24.10636-10649.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15572669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10636-10649&author=B.+C.+Harrisonauthor=C.+R.+Robertsauthor=D.+B.+Hoodauthor=M.+Sweeneyauthor=J.+M.+Gouldauthor=E.+W.+Bushauthor=T.+A.+McKinsey&title=The+CRM1+nuclear+export+receptor+controls+pathological+cardiac+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The CRM1 nuclear export receptor controls pathological cardiac gene expression</span></div><div class="casAuthors">Harrison, Brooke C.; Roberts, Charles R.; Hood, David B.; Sweeney, Meghan; Gould, Jody M.; Bush, Erik W.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10636-10649</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Diverse pathol. insults trigger a cardiac remodeling process during which myocytes undergo hypertrophy, with consequent decline in cardiac function and eventual heart failure.  Multiple transcriptional regulators of pathol. cardiac hypertrophy are controlled at the level of subcellular distribution.  For example, prohypertrophic transcription factors belonging to the nuclear factor of activated T cells (NFAT) and GATA families are subject to CRM1-dependent nuclear export but are rapidly relocalized to the nucleus in response to cues for hypertrophic growth.  Here, we demonstrate that the antihypertrophic chromatin-modifying enzyme histone deacetylase 5 (HDAC5) is shuttled out of the cardiomyocyte nucleus via a CRM1-mediated pathway in response to diverse signals for hypertrophy.  CRM1 antagonists block the agonist-mediated nuclear export of HDAC 5 and repress pathol. gene expression and assocd. hypertrophy of cultured cardiomyocytes.  Conversely, CRM1 activity is dispensable for nonpathol. cardiac gene activation mediated by thyroid hormone and insulin-like growth factor 1, agonists that fail to trigger the nuclear export of HDAC5.  These results suggest a selective role for CRM1 in derepression of pathol. cardiac genes via its neutralizing effects on antihypertrophic factors such as HDAC5.  Pharmacol. approaches targeting CRM1-dependent nuclear export in heart muscle may have salutary effects on cardiac function by suppressing maladaptive changes in gene expression evoked by stress signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeYOqfQy_PrVg90H21EOLACvtfcHk0lh9L6zpf_b0DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7fN&md5=9249c0679a51cb5046ecc3c99d9eae9b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10636-10649.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10636-10649.2004%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DB.%2BC.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DHood%26aufirst%3DD.%2BB.%26aulast%3DSweeney%26aufirst%3DM.%26aulast%3DGould%26aufirst%3DJ.%2BM.%26aulast%3DBush%26aufirst%3DE.%2BW.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DThe%2520CRM1%2520nuclear%2520export%2520receptor%2520controls%2520pathological%2520cardiac%2520gene%2520expression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10636%26epage%3D10649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fielitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassel-Duby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Requirement of protein kinase D1 for pathological cardiac remodeling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3059</span><span class="NLM_x">–</span> <span class="NLM_lpage">3063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3059-3063&author=J.+Fielitzauthor=M.-S.+Kimauthor=J.+M.+Sheltonauthor=X.+Qiauthor=J.+A.+Hillauthor=J.+A.+Richardsonauthor=R.+Bassel-Dubyauthor=E.+N.+Olson&title=Requirement+of+protein+kinase+D1+for+pathological+cardiac+remodeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFielitz%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.-S.%26aulast%3DShelton%26aufirst%3DJ.%2BM.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DBassel-Duby%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DRequirement%2520of%2520protein%2520kinase%2520D1%2520for%2520pathological%2520cardiac%2520remodeling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3059%26epage%3D3063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ha, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhun, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfizenmaier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.-G.</span><span> </span><span class="NLM_article-title">Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">14590</span><span class="NLM_x">–</span> <span class="NLM_lpage">14599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=14590-14599&author=C.+H.+Haauthor=W.+Wangauthor=B.+S.+Jhunauthor=C.+Wongauthor=A.+Hausserauthor=K.+Pfizenmaierauthor=T.+A.+McKinseyauthor=E.+N.+Olsonauthor=Z.-G.+Jin&title=Protein+kinase+D-dependent+phosphorylation+and+nuclear+export+of+histone+deacetylase+5+mediates+vascular+endothelial+growth+factor-induced+gene+expression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJhun%26aufirst%3DB.%2BS.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHausser%26aufirst%3DA.%26aulast%3DPfizenmaier%26aufirst%3DK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DJin%26aufirst%3DZ.-G.%26atitle%3DProtein%2520kinase%2520D-dependent%2520phosphorylation%2520and%2520nuclear%2520export%2520of%2520histone%2520deacetylase%25205%2520mediates%2520vascular%2520endothelial%2520growth%2520factor-induced%2520gene%2520expression%2520and%2520angiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D14590%26epage%3D14599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Backs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backs, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezprozvannaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3437</span><span class="NLM_x">–</span> <span class="NLM_lpage">3445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.01611-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=18332106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFeqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3437-3445&author=J.+Backsauthor=T.+Backsauthor=S.+Bezprozvannayaauthor=T.+A.+McKinseyauthor=E.+N.+Olson&title=Histone+deacetylase+5+acquires+calcium%2Fcalmodulin-dependent+kinase+II+responsiveness+by+oligomerization+with+histone+deacetylase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4</span></div><div class="casAuthors">Backs, Johannes; Backs, Thea; Bezprozvannaya, Svetlana; McKinsey, Timothy A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3437-3445</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates histone deacetylase 4 (HDAC4), a class IIa HDAC, resulting in the cytosolic accumulation of HDAC4 and the derepression of the transcription factor myocyte enhancer factor 2.  Phosphorylation by CaMKII requires docking of the kinase to a specific domain of HDAC4 not present in other HDACs.  Paradoxically, however, CaMKII signaling can also promote the nuclear export of other class IIa HDACs, such as HDAC5.  Here, we show that HDAC4 and HDAC5 form homo- and hetero-oligomers via a conserved coiled-coil domain near their amino termini.  Whereas HDAC5 alone is unresponsive to CaMKII, it becomes responsive to CaMKII in the presence of HDAC4.  The acquisition of CaMKII responsiveness by HDAC5 is mediated by HDAC5's direct assocn. with HDAC4 and can occur by phosphorylation of HDAC4 or by transphosphorylation by CaMKII bound to HDAC4.  Thus, HDAC4 integrates upstream Ca2+-dependent signals via its assocn. with CaMKII and transmits these signals to HDAC5 by protein-protein interactions.  We conclude that HDAC4 represents a point of convergence for CaMKII signaling to downstream HDAC-regulated genes, and we suggest that modulation of the interaction of CaMKII and HDAC4 represents a means of regulating CaMKII-dependent gene programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_bAGWW1eqrVg90H21EOLACvtfcHk0lh9L6zpf_b0DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFeqs7o%253D&md5=e8f7d2bade53387f54d47ee53ac25a11</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1128%2FMCB.01611-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01611-07%26sid%3Dliteratum%253Aachs%26aulast%3DBacks%26aufirst%3DJ.%26aulast%3DBacks%26aufirst%3DT.%26aulast%3DBezprozvannaya%26aufirst%3DS.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DHistone%2520deacetylase%25205%2520acquires%2520calcium%252Fcalmodulin-dependent%2520kinase%2520II%2520responsiveness%2520by%2520oligomerization%2520with%2520histone%2520deacetylase%25204%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3437%26epage%3D3445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huynh, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2006&pages=141-148&author=Q.+K.+Huynhauthor=T.+A.+McKinsey&title=Protein+kinase+D+directly+phosphorylates+histone+deacetylase+5+via+a+random+sequential+kinetic+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DQ.%2BK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinase%2520D%2520directly%2520phosphorylates%2520histone%2520deacetylase%25205%2520via%2520a%2520random%2520sequential%2520kinetic%2520mechanism%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D450%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vega, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papst, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8374</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.19.8374-8385.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15367659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8374-8385&author=R.+B.+Vegaauthor=B.+C.+Harrisonauthor=E.+Meadowsauthor=C.+R.+Robertsauthor=P.+J.+Papstauthor=E.+N.+Olsonauthor=T.+A.+McKinsey&title=Protein+kinases+C+and+D+mediate+agonist-dependent+cardiac+hypertrophy+through+nuclear+export+of+histone+deacetylase+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5</span></div><div class="casAuthors">Vega, Rick B.; Harrison, Brooke C.; Meadows, Eric; Roberts, Charles R.; Papst, Philip J.; Olson, Eric N.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8374-8385</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A variety of stress signals stimulate cardiac myocytes to undergo hypertrophy.  Persistent cardiac hypertrophy is assocd. with elevated risk for the development of heart failure.  Recently, we showed that class II histone deacetylases (HDACs) suppress cardiac hypertrophy and that stress signals neutralize this repressive function by triggering phosphorylation- and CRM1-dependent nuclear export of these chromatin-modifying enzymes.  However, the identities of cardiac HDAC kinases have remained unclear.  Here, we demonstrate that signaling by protein kinase C (PKC) is sufficient and, in some cases, necessary to drive nuclear export of class II HDAC5 in cardiomyocytes.  Inhibition of PKC prevents nucleocytoplasmic shuttling of HDAC5 in response to a subset of hypertrophic agonists.  Moreover, a nonphosphorylatable HDAC5 mutant is refractory to PKC signaling and blocks cardiomyocyte hypertrophy mediated by pharmacol. activators of PKC.  We also demonstrate that protein kinase D (PKD), a downstream effector of PKC, directly phosphorylates HDAC5 and stimulates its nuclear export.  These findings reveal a novel function for the PKC/PKD axis in coupling extracellular cues to chromatin modifications that control cellular growth, and they suggest potential utility for small-mol. inhibitors of this pathway in the treatment of pathol. cardiac gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVy-E3aJHSD7Vg90H21EOLACvtfcHk0lgR6yJmltmn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVaktrk%253D&md5=a7ac41a59512a2e64fbbb0b6e4261257</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8374-8385.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8374-8385.2004%26sid%3Dliteratum%253Aachs%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DHarrison%26aufirst%3DB.%2BC.%26aulast%3DMeadows%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DPapst%26aufirst%3DP.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinases%2520C%2520and%2520D%2520mediate%2520agonist-dependent%2520cardiac%2520hypertrophy%2520through%2520nuclear%2520export%2520of%2520histone%2520deacetylase%25205%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8374%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Monovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemon, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=631-637&author=L.+Monovichauthor=R.+B.+Vegaauthor=E.+Meredithauthor=K.+Mirandaauthor=C.+Raoauthor=M.+Capparelliauthor=D.+D.+Lemonauthor=D.+Phanauthor=K.+A.+Kochauthor=J.+A.+Chapoauthor=D.+B.+Hoodauthor=T.+A.+McKinsey&title=A+novel+kinase+inhibitor+establishes+a+predominant+role+for+protein+kinase+D+as+a+cardiac+class+IIa+histone+deacetylase+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DMeredith%26aufirst%3DE.%26aulast%3DMiranda%26aufirst%3DK.%26aulast%3DRao%26aufirst%3DC.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DLemon%26aufirst%3DD.%2BD.%26aulast%3DPhan%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DK.%2BA.%26aulast%3DChapo%26aufirst%3DJ.%2BA.%26aulast%3DHood%26aufirst%3DD.%2BB.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%2520establishes%2520a%2520predominant%2520role%2520for%2520protein%2520kinase%2520D%2520as%2520a%2520cardiac%2520class%2520IIa%2520histone%2520deacetylase%2520kinase%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D631%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gschwendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, F.-J.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase c isoenzymes</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1996&pages=77&author=M.+Gschwendtauthor=S.+Dieterichauthor=J.+Renneckeauthor=W.+Kittsteinauthor=H.-J.+Muellerauthor=F.-J.+Johannes&title=Inhibition+of+protein+kinase+C+%CE%BC+by+various+inhibitors.+Differentiation+from+protein+kinase+c+isoenzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGschwendt%26aufirst%3DM.%26aulast%3DDieterich%26aufirst%3DS.%26aulast%3DRennecke%26aufirst%3DJ.%26aulast%3DKittstein%26aufirst%3DW.%26aulast%3DMueller%26aufirst%3DH.-J.%26aulast%3DJohannes%26aufirst%3DF.-J.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520C%2520%25CE%25BC%2520by%2520various%2520inhibitors.%2520Differentiation%2520from%2520protein%2520kinase%2520c%2520isoenzymes%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D392%26spage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Singh, R.; Li, H.; Zhao, H.; Payan, D. G.; Kolluri, R.; Tso, K.; Ramphal, J.; Gu, S.</span><span> </span><span class="NLM_article-title">Preparation of Cyclic Amine Substituted Pyrimidinediamines as PKC Inhibitors</span>. WO 2009012421,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+Singh&author=H.+Li&author=H.+Zhao&author=D.+G.+Payan&author=R.+Kolluri&author=K.+Tso&author=J.+Ramphal&author=S.+Gu&title=Preparation+of+Cyclic+Amine+Substituted+Pyrimidinediamines+as+PKC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520Cyclic%2520Amine%2520Substituted%2520Pyrimidinediamines%2520as%2520PKC%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">AP2 Inhibitor</span> WO 2008088006,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Yokoyama&title=AP2+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DAP2%2520Inhibitor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raynham, T. M.; Hammonds, T. R.; Charles, M. D.; Pave, G. A.; Foxton, C. H.; Blackaby, W. P.; Stevens, A. P.; Ekwuru, C. T.</span><span> </span><span class="NLM_article-title">Pyridine Benzamides and Pyrazine Benzamides as PKD Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>, WO 2008074997,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+M.+Raynham&author=T.+R.+Hammonds&author=M.+D.+Charles&author=G.+A.+Pave&author=C.+H.+Foxton&author=W.+P.+Blackaby&author=A.+P.+Stevens&author=C.+T.+Ekwuru&title=Pyridine+Benzamides+and+Pyrazine+Benzamides+as+PKD+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26atitle%3DPyridine%2520Benzamides%2520and%2520Pyrazine%2520Benzamides%2520as%2520PKD%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raynham, T. M.; Hammonds, T. R.; Gilliatt, J. H.; Charles, M. D.; Pave, G. A.; Foxton, C. H.; Carr, J. L.; Mistry, N. S.</span><span> </span><span class="NLM_article-title">Aminoethylamino-aryl (AEAA) Compounds as PKD Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of PKD-Mediated Diseases</span>. WO 2007125331,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+M.+Raynham&author=T.+R.+Hammonds&author=J.+H.+Gilliatt&author=M.+D.+Charles&author=G.+A.+Pave&author=C.+H.+Foxton&author=J.+L.+Carr&author=N.+S.+Mistry&title=Aminoethylamino-aryl+%28AEAA%29+Compounds+as+PKD+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+PKD-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26atitle%3DAminoethylamino-aryl%2520%2528AEAA%2529%2520Compounds%2520as%2520PKD%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520PKD-Mediated%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gschwendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, F.-J.</span><span> </span><span class="NLM_article-title">Differential effects of suramin on protein kinase C isoenzymes, a novel tool for discriminating protein kinase C activities</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=1998&pages=165-168&author=M.+Gschwendtauthor=W.+Kittsteinauthor=F.-J.+Johannes&title=Differential+effects+of+suramin+on+protein+kinase+C+isoenzymes%2C+a+novel+tool+for+discriminating+protein+kinase+C+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGschwendt%26aufirst%3DM.%26aulast%3DKittstein%26aufirst%3DW.%26aulast%3DJohannes%26aufirst%3DF.-J.%26atitle%3DDifferential%2520effects%2520of%2520suramin%2520on%2520protein%2520kinase%2520C%2520isoenzymes%252C%2520a%2520novel%2520tool%2520for%2520discriminating%2520protein%2520kinase%2520C%2520activities%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D421%26spage%3D165%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sharlow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaValle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimgruber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo-Altamirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. J.</span><span> </span><span class="NLM_article-title">Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33516</span><span class="NLM_x">–</span> <span class="NLM_lpage">33526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33516-33526&author=E.+R.+Sharlowauthor=K.+V.+Giridharauthor=C.+R.+LaValleauthor=J.+Chenauthor=S.+Leimgruberauthor=R.+Barrettauthor=K.+Bravo-Altamiranoauthor=P.+Wipfauthor=J.+S.+Lazoauthor=Q.+J.+Wang&title=Potent+and+selective+disruption+of+protein+kinase+D+functionality+by+a+benzoxoloazepinolone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharlow%26aufirst%3DE.%2BR.%26aulast%3DGiridhar%26aufirst%3DK.%2BV.%26aulast%3DLaValle%26aufirst%3DC.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLeimgruber%26aufirst%3DS.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DBravo-Altamirano%26aufirst%3DK.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DQ.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520disruption%2520of%2520protein%2520kinase%2520D%2520functionality%2520by%2520a%2520benzoxoloazepinolone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33516%26epage%3D33526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Slater, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stagliano, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzas, C. J.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase C by resveratrol</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1637</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2FS0925-4439%2802%2900214-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=12527408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1SmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1637&publication_year=2003&pages=59-69&author=S.+J.+Slaterauthor=J.+L.+Seizauthor=A.+C.+Cookauthor=B.+A.+Staglianoauthor=C.+J.+Buzas&title=Inhibition+of+protein+kinase+C+by+resveratrol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein kinase C by resveratrol</span></div><div class="casAuthors">Slater, Simon J.; Seiz, Jodie L.; Cook, Anthony C.; Stagliano, Brigid A.; Buzas, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1637</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Resveratrol (RV), a polyphenolic phytoalexin present in dietary sources such as red wine, may protect against atherosclerosis and cardiovascular disease by enhancing the integrity of vascular endothelium.  Such beneficial effects of RV may arise from modulation of protein kinase C (PKC)-mediated signaling.  This was investigated by detg. the effects of RV on in vitro activities of recombinant PKC isoenzymes (PKCα, PKCβ1, and PKCε) obtained in Sf9 insect cell expression system.  The Ca2+-dependent activities of membrane-assocd. PKCα induced by phorbol ester or diacylglycerol were potently inhibited by RV (IC50 ∼2 μM each compd.).  The inhibitory effect of RV was also obsd. for conventional PKCβI, whereas the activities of novel PKCε and atypical PKCζ were not affected.  The inhibition of PKCα activity was competitive with respect to phorbol ester concn., but noncompetitive with respect to Ca2+ and phosphatidylserine concns., suggesting that RV may compete for phorbol ester binding to the C1 domains.  Supporting this, it was found that RV bound to a fusion peptide contg. the C1A and C1B domains of PKCα.  Similar to the effects of diacylglycerol and phorbol ester, the interaction of RV with the C1 domains induced the assocn. of PKCα with membrane lipid vesicles, although this did not result in activation.  The inhibitory effect of RV on PKC activity and on the assocd. signaling networks may underlie the mechanism(s) by which this agent exerts its beneficial effects on endothelial and cardiovascular functions.  The effects of RV on these signaling networks may differ according to the cellular localization and the regulating PKC isoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoocPDllWO2bbVg90H21EOLACvtfcHk0ljnExIc1ARCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1SmsA%253D%253D&md5=372a5e1f9dd63a099a434153277123df</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2802%2900214-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252802%252900214-4%26sid%3Dliteratum%253Aachs%26aulast%3DSlater%26aufirst%3DS.%2BJ.%26aulast%3DSeiz%26aufirst%3DJ.%2BL.%26aulast%3DCook%26aufirst%3DA.%2BC.%26aulast%3DStagliano%26aufirst%3DB.%2BA.%26aulast%3DBuzas%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520C%2520by%2520resveratrol%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2003%26volume%3D1637%26spage%3D59%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Haworth, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase D by resveratrol</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1647</span><span class="NLM_x">–</span> <span class="NLM_lpage">1651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1647-1651&author=R.+S.+Haworthauthor=M.+Avkiran&title=Inhibition+of+protein+kinase+D+by+resveratrol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaworth%26aufirst%3DR.%2BS.%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520D%2520by%2520resveratrol%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1647%26epage%3D1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Storz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toker, A.</span><span> </span><span class="NLM_article-title">Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=870-879&author=P.+Storzauthor=H.+Dopplerauthor=A.+Toker&title=Activation+loop+phosphorylation+controls+protein+kinase+D-dependent+activation+of+nuclear+factor+kappaB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DActivation%2520loop%2520phosphorylation%2520controls%2520protein%2520kinase%2520D-dependent%2520activation%2520of%2520nuclear%2520factor%2520kappaB%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D870%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rozengurt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, T.</span><span> </span><span class="NLM_article-title">Protein kinase D signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13205</span><span class="NLM_x">–</span> <span class="NLM_lpage">13208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13205-13208&author=E.+Rozengurtauthor=O.+Reyauthor=T.+Waldron&title=Protein+kinase+D+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozengurt%26aufirst%3DE.%26aulast%3DRey%26aufirst%3DO.%26aulast%3DWaldron%26aufirst%3DT.%26atitle%3DProtein%2520kinase%2520D%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13205%26epage%3D13208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1093%2Fbioinformatics%2Fbtp650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=19942586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=198-204&author=D.+Huangauthor=T.+Zhouauthor=K.+Lafleurauthor=C.+Nevadoauthor=A.+Caflisch&title=Kinase+selectivity+potential+for+inhibitors+targeting+the+ATP+binding+site%3A+a+network+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span></div><div class="casAuthors">Huang, Danzhi; Zhou, Ting; Lafleur, Karine; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Small-mol. inhibitors targeting the ATP binding pocket of the catalytic domain of protein kinases have potential to become drugs devoid of (major) side effects, particularly if they bind selectively.  Here, the sequences of the 518 human kinases are first mapped onto the structural alignment of 116 kinases of known three-dimensional structure.  The multiple structure alignment is then used to encode the known strategies for developing selective inhibitors into a fingerprint.  Finally, a network anal. is used to partition the kinases into clusters according to similarity of their fingerprints, i.e., physico-chem. characteristics of the residues responsible for selective binding.  For each kinase the network anal. reveals the likelihood to find selective inhibitors targeting the ATP binding site.  Systematic guidelines are proposed to develop selective inhibitors.  Importantly, the network anal. suggests that the tyrosine kinase EphB4 has high selectivity potential, which is consistent with the selectivity profile of two novel EphB4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVQsrpqB_ILVg90H21EOLACvtfcHk0li9i22cuvIfRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D&md5=b6c63ccd4654219a56752f9cfc1356a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp650%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DKinase%2520selectivity%2520potential%2520for%2520inhibitors%2520targeting%2520the%2520ATP%2520binding%2520site%253A%2520a%2520network%2520analysis%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D198%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wang, Q. J.</span><span> </span><span class="NLM_article-title">PKD at the crossroads of DAG and PKC signaling</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=317-323&author=Q.+J.+Wang&title=PKD+at+the+crossroads+of+DAG+and+PKC+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BJ.%26atitle%3DPKD%2520at%2520the%2520crossroads%2520of%2520DAG%2520and%2520PKC%2520signaling%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D317%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Huynh, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinase D directly phoshporylates histone deacetylase 5 via a random sequential kinetic mechansim</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2006&pages=141-148&author=Q.+K.+Huynhauthor=T.+A.+McKinsey&title=Protein+kinase+D+directly+phoshporylates+histone+deacetylase+5+via+a+random+sequential+kinetic+mechansim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DQ.%2BK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinase%2520D%2520directly%2520phoshporylates%2520histone%2520deacetylase%25205%2520via%2520a%2520random%2520sequential%2520kinetic%2520mechansim%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D450%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Izumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanmatsuse, K.</span><span> </span><span class="NLM_article-title">Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the α 1-adrenergic antagonist bunazosin in Dahl salt-sensitive rats</span> <span class="citation_source-journal">Hypertens. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1291%2Fhypres.19.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=8891742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADyaK28XmsVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=147-150&author=Y.+Izumiauthor=M.+Matsuokaauthor=A.+Kuboauthor=T.+Nakayamaauthor=N.+Fukudaauthor=Y.+Watanabeauthor=M.+Somaauthor=K.+Kanmatsuse&title=Prevention+of+cardiac+hypertrophy+by+a+sub-antihypertensive+dose+of+the+%CE%B1+1-adrenergic+antagonist+bunazosin+in+Dahl+salt-sensitive+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the α1-adrenergic antagonist bunazosin in Dahl salt-sensitive rats</span></div><div class="casAuthors">Izumi, Yoichi; Matsuoka, Masako; Kubo, Atsusi; Nakayama, Tomohiro; Fukuda, Noboru; Watanabe, Yoshiyasu; Soma, Masayoshi; Kanmatsuse, Katsuo</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-150</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Hypertension</span>)
        </div><div class="casAbstract">To assess the protective effect of an α1-blocker on the development of cardiac hypertrophy, the selective α1-receptor antagonist bunazosin (2 mg/kg/d, by oral gavage and in drinking water) was given to male Dahl salt-sensitive rats fed a 4% NaCl diet for 7 wk.  Control animals received water only by the same method.  Treatment with bunazosin was started when the animals were 7 wk of age.  Blood pressure, pulse rates, and body wt. were measured every week during the expt.  Urine was collected for 24 h on the final day of the expt.  All animals were killed by decapitation, blood was collected, and the heart was removed.  In both the treated and control groups, time-dependent increases in blood pressure and body wt. were obsd., and there were no significant differences between the groups in blood pressure or body wt. during the expt.  Pulse rate remained unchanged in both groups throughout the expt.  The left ventricular wt./body wt. ratio and the left ventricular tissue DNA content were significantly lower in the rats receiving bunazosin than in the control rats.  Plasma renin activity, plasma aldosterone, and plasma atrial natriuretic peptide did not differ significantly between the two groups.  No significant differences in glomerular filtration rate, urine vol., sodium excretion, urinary metanephrine excretion, and urinary normetanephrine excretion were noted between the two groups.  The results indicate that a sub-antihypertensive dose of bunazosin can inhibit the development of cardiac hypertrophy without suppression of the pressure load, suggesting an important role of α1-adrenergic receptors in the pathogenesis of cardiac hypertrophy following the development of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEGyLYtavRLbVg90H21EOLACvtfcHk0li9i22cuvIfRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVaisLk%253D&md5=d21ef76dacf40b5c49ba42e983694a24</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1291%2Fhypres.19.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1291%252Fhypres.19.147%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DSoma%26aufirst%3DM.%26aulast%3DKanmatsuse%26aufirst%3DK.%26atitle%3DPrevention%2520of%2520cardiac%2520hypertrophy%2520by%2520a%2520sub-antihypertensive%2520dose%2520of%2520the%2520%25CE%25B1%25201-adrenergic%2520antagonist%2520bunazosin%2520in%2520Dahl%2520salt-sensitive%2520rats%26jtitle%3DHypertens.%2520Res.%26date%3D1996%26volume%3D19%26spage%3D147%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, Y.</span><span> </span><span class="NLM_article-title">β-Blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.amjhyper.2004.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15607617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyqsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1112-1119&author=M.+Kobayashiauthor=N.+Machidaauthor=M.+Mitsuishiauthor=Y.+Yamane&title=%CE%B2-Blocker+improves+survival%2C+left+ventricular+function%2C+and+myocardial+remodeling+in+hypertensive+rats+with+diastolic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">β-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure</span></div><div class="casAuthors">Kobayashi, Masayuki; Machida, Noboru; Mitsuishi, Megumi; Yamane, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">1112-1119</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Chronic β-blocker therapy improves survival and left ventricular (LV) systolic function in patients with congestive heart failure.  However, its efficacy in diastolic heart failure (DHF) with preserved normal LV systolic function remains uncertain.  Methods: Dahl salt-sensitive hypertensive rats fed a high-salt diet from 7 wk of age were randomized to groups that were either not treated (DHF; n = 20) or treated with metoprolol (MP) from 7 wk of age (DHF+7wkMP; n = 22) or from 17 wk of age (DHF+17wkMP; n = 8).  Both LV function and remodeling were evaluated by serial echocardiog., followed by hemodynamic and pathol. studies.  Results: Hypertension and pressure-overload LV hypertrophy were established by 17 wk of age in DHF rats.  At about 20 wk of age DHF rats experienced overt heart failure, which was accompanied not by a decrease in LV fractional shortening but by diastolic filling abnormalities.  The LV concentric hypertrophy was strikingly attenuated in DHF+7wkMP rats but not in DHF+17wkMP rats.  However, LV myocardial fibrosis and the further progression of diastolic dysfunction were prevented in both MP-treated groups.  Survival at 21 wk of age was significantly improved in DHF+7wkMP (86%) and DHF+17wkMP (75%) rats compared with DHF rats (25%).  Conclusions: In this study, MP prevented not only the development of LV hypertrophy but also the progression of diastolic dysfunction, and improved survival in rats with DHF.  The preventive effect of MP on myocardial fibrosis is suggested as one of the mechanisms contributing to halt the progression of diastolic dysfunction, a finding that may lead to clin. benefits in regard to DHF caused by hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcHDw2HXKN7Vg90H21EOLACvtfcHk0li9i22cuvIfRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyqsrjK&md5=2d9f6b6d3cc6e481ceabda26c8672038</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2004.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2004.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMachida%26aufirst%3DN.%26aulast%3DMitsuishi%26aufirst%3DM.%26aulast%3DYamane%26aufirst%3DY.%26atitle%3D%25CE%25B2-Blocker%2520improves%2520survival%252C%2520left%2520ventricular%2520function%252C%2520and%2520myocardial%2520remodeling%2520in%2520hypertensive%2520rats%2520with%2520diastolic%2520heart%2520failure%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2004%26volume%3D17%26spage%3D1112%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hardt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoshima, J.</span><span> </span><span class="NLM_article-title">Negative regulators of cardiac hypertrophy</span> <span class="citation_source-journal">Cardiovas. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.cardiores.2004.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15276475" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=500-509&author=S.+E.+Hardtauthor=J.+Sadoshima&title=Negative+regulators+of+cardiac+hypertrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DHardt%26aufirst%3DS.%2BE.%26aulast%3DSadoshima%26aufirst%3DJ.%26atitle%3DNegative%2520regulators%2520of%2520cardiac%2520hypertrophy%26jtitle%3DCardiovas.%2520Res.%26date%3D2004%26spage%3D500%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Meredith, E. L.; Beattie, K.; Burgis, R.; Capparelli, M.; Chapo, J.; DiPietro, L.; Gamber, G.; Enyedy, I.; Hood, D. B.; Hosagrahara, V.; Jewell, C.; Koch, K. A.; Lee, W.; Lemon, D. D.; McKinsey, T. A.; Miranda, K.; Pagratis, N.; Phan, D.; Plato, C.; Rao, C.; Rozhitskaya, O.; Soldermann, N.; Springer, C.; Van Eis, M.; Vega, R. B.; Yan, W.; Zhu, Q.; Monovich, L.</span><span> </span><span class="NLM_article-title">Identification of potent and selective amidobipyridyl inhibitors of protein kinase D</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm100076w</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm100076w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Meredith%2C+E.+L.%3B+Beattie%2C+K.%3B+Burgis%2C+R.%3B+Capparelli%2C+M.%3B+Chapo%2C+J.%3B+DiPietro%2C+L.%3B+Gamber%2C+G.%3B+Enyedy%2C+I.%3B+Hood%2C+D.+B.%3B+Hosagrahara%2C+V.%3B+Jewell%2C+C.%3B+Koch%2C+K.+A.%3B+Lee%2C+W.%3B+Lemon%2C+D.+D.%3B+McKinsey%2C+T.+A.%3B+Miranda%2C+K.%3B+Pagratis%2C+N.%3B+Phan%2C+D.%3B+Plato%2C+C.%3B+Rao%2C+C.%3B+Rozhitskaya%2C+O.%3B+Soldermann%2C+N.%3B+Springer%2C+C.%3B+Van+Eis%2C+M.%3B+Vega%2C+R.+B.%3B+Yan%2C+W.%3B+Zhu%2C+Q.%3B+Monovich%2C+L.+Identification+of+potent+and+selective+amidobipyridyl+inhibitors+of+protein+kinase+D.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm100076w."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100076w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100076w%26sid%3Dliteratum%253Aachs%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520amidobipyridyl%2520inhibitors%2520of%2520protein%2520kinase%2520D%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm100076w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrino, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, D. A.</span><span> </span><span class="NLM_article-title">Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-<i>a</i>]isoquinoline platelet activating factor receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3098</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00073a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3098-3102&author=W.+J.+Houlihanauthor=S.+H.+Cheonauthor=V.+A.+Parrinoauthor=D.+A.+Handleyauthor=D.+A.+Larson&title=Structural+modification+of+5-aryl-2%2C3-dihydroimidazo%5B2%2C1-a%5Disoquinoline+platelet+activating+factor+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00073a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00073a008%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCheon%26aufirst%3DS.%2BH.%26aulast%3DParrino%26aufirst%3DV.%2BA.%26aulast%3DHandley%26aufirst%3DD.%2BA.%26aulast%3DLarson%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520modification%2520of%25205-aryl-2%252C3-dihydroimidazo%255B2%252C1-a%255Disoquinoline%2520platelet%2520activating%2520factor%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3098%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Fan</span>, <span class="hlFld-ContribAuthor ">Qin  Ye</span>, <span class="hlFld-ContribAuthor ">Hai-Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Shu-Liang  Wang</span>, and <span class="hlFld-ContribAuthor ">Shu-Jiang  Tu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Double [3 + 2 + 1] Heteroannulation for Forming Unprecedented Dipyrazolo-Fused 2,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (9)
                                     , 2258-2261. <a href="https://doi.org/10.1021/ol4008266" title="DOI URL">https://doi.org/10.1021/ol4008266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol4008266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol4008266%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNovel%252BDouble%252B%25255B3%252B%25252B%252B2%252B%25252B%252B1%25255D%252BHeteroannulation%252Bfor%252BForming%252BUnprecedented%252BDipyrazolo-Fused%252B2%25252C6-Naphthyridines%26aulast%3DFan%26aufirst%3DWei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26032013%26date%3D18042013%26date%3D03052013%26volume%3D15%26issue%3D9%26spage%3D2258%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karla  Bravo-Altamirano</span>, <span class="hlFld-ContribAuthor ">Kara M.  George</span>, <span class="hlFld-ContribAuthor ">Marie-Céline  Frantz</span>, <span class="hlFld-ContribAuthor ">Courtney R.  LaValle</span>, <span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">Stephanie  Leimgruber</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>, <span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Q. Jane  Wang</span>, and <span class="hlFld-ContribAuthor ">Peter  Wipf</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure−Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (2)
                                     , 154-159. <a href="https://doi.org/10.1021/ml100230n" title="DOI URL">https://doi.org/10.1021/ml100230n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100230n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100230n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationships%252Bof%252BBenzothienothiazepinone%252BInhibitors%252Bof%252BProtein%252BKinase%252BD%26aulast%3DBravo-Altamirano%26aufirst%3DKarla%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D28092010%26date%3D06122010%26date%3D14122010%26date%3D10022011%26volume%3D2%26issue%3D2%26spage%3D154%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik L.  Meredith</span>, <span class="hlFld-ContribAuthor ">Kimberly  Beattie</span>, <span class="hlFld-ContribAuthor ">Robin  Burgis</span>, <span class="hlFld-ContribAuthor ">Michael  Capparelli</span>, <span class="hlFld-ContribAuthor ">Joseph  Chapo</span>, <span class="hlFld-ContribAuthor ">Lucian  DiPietro</span>, <span class="hlFld-ContribAuthor ">Gabriel  Gamber</span>, <span class="hlFld-ContribAuthor ">Istvan  Enyedy</span>, <span class="hlFld-ContribAuthor ">David B.  Hood</span>, <span class="hlFld-ContribAuthor ">Vinayak  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Charles  Jewell</span>, <span class="hlFld-ContribAuthor ">Keith A.  Koch</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Douglas D.  Lemon</span>, <span class="hlFld-ContribAuthor ">Timothy A.  McKinsey</span>, <span class="hlFld-ContribAuthor ">Karl  Miranda</span>, <span class="hlFld-ContribAuthor ">Nikos  Pagratis</span>, <span class="hlFld-ContribAuthor ">Dillon  Phan</span>, <span class="hlFld-ContribAuthor ">Craig  Plato</span>, <span class="hlFld-ContribAuthor ">Chang  Rao</span>, <span class="hlFld-ContribAuthor ">Olga  Rozhitskaya</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>, <span class="hlFld-ContribAuthor ">Clayton  Springer</span>, <span class="hlFld-ContribAuthor ">Maurice  van Eis</span>, <span class="hlFld-ContribAuthor ">Richard B.  Vega</span>, <span class="hlFld-ContribAuthor ">Wanlin  Yan</span>, <span class="hlFld-ContribAuthor ">Qingming  Zhu</span> and <span class="hlFld-ContribAuthor ">Lauren G.  Monovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (15)
                                     , 5422-5438. <a href="https://doi.org/10.1021/jm100076w" title="DOI URL">https://doi.org/10.1021/jm100076w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100076w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100076w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252Band%252BSelective%252BAmidobipyridyl%252BInhibitors%252Bof%252BProtein%252BKinase%252BD%26aulast%3DMeredith%26aufirst%3DErik%2BL.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D18012010%26date%3D14072010%26date%3D12082010%26volume%3D53%26issue%3D15%26spage%3D5422%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Gilles</span>, <span class="hlFld-ContribAuthor ">Lauren  Voets</span>, <span class="hlFld-ContribAuthor ">Johan  Van Lint</span>, <span class="hlFld-ContribAuthor ">Wim M.  De Borggraeve</span>. </span><span class="cited-content_cbyCitation_article-title">Developments in the Discovery and Design of Protein Kinase D Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (14)
                                     , 2158-2171. <a href="https://doi.org/10.1002/cmdc.202100110" title="DOI URL">https://doi.org/10.1002/cmdc.202100110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100110%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopments%252Bin%252Bthe%252BDiscovery%252Band%252BDesign%252Bof%252BProtein%252BKinase%252BD%252BInhibitors%26aulast%3DGilles%26aufirst%3DPhilippe%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D14%26spage%3D2158%26epage%3D2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Die  Lv</span>, <span class="hlFld-ContribAuthor ">Hongli  Chen</span>, <span class="hlFld-ContribAuthor ">Yun  Feng</span>, <span class="hlFld-ContribAuthor ">Bomiao  Cui</span>, <span class="hlFld-ContribAuthor ">Yingzhu  Kang</span>, <span class="hlFld-ContribAuthor ">Ping  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Luo</span>, <span class="hlFld-ContribAuthor ">Jiao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.680221" title="DOI URL">https://doi.org/10.3389/fonc.2021.680221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.680221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.680221%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DSmall-Molecule%252BInhibitor%252BTargeting%252BProtein%252BKinase%252BD%25253A%252BA%252BPotential%252BTherapeutic%252BStrategy%26aulast%3DLv%26aufirst%3DDie%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuejing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jaclyn  Connelly</span>, <span class="hlFld-ContribAuthor ">Yapeng  Chao</span>, <span class="hlFld-ContribAuthor ">Qiming Jane  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 483. <a href="https://doi.org/10.3390/biom11030483" title="DOI URL">https://doi.org/10.3390/biom11030483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11030483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11030483%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMultifaceted%252BFunctions%252Bof%252BProtein%252BKinase%252BD%252Bin%252BPathological%252BProcesses%252Band%252BHuman%252BDiseases%26aulast%3DZhang%26aufirst%3DXuejing%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Gong</span>, <span class="hlFld-ContribAuthor ">Zhi-Cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yan-Guang  Tian</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Neng-Fang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5667. <a href="https://doi.org/10.3390/molecules25235667" title="DOI URL">https://doi.org/10.3390/molecules25235667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235667%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DGrignard%252BReagent%252BUtilization%252BEnables%252Ba%252BPractical%252Band%252BScalable%252BConstruction%252Bof%252B3-Substituted%252B5-Chloro-1%25252C6-naphthyridin-4-one%252BDerivatives%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Gilles</span>, <span class="hlFld-ContribAuthor ">Rudra S.  Kashyap</span>, <span class="hlFld-ContribAuthor ">Maria João  Freitas</span>, <span class="hlFld-ContribAuthor ">Sam  Ceusters</span>, <span class="hlFld-ContribAuthor ">Koen  Van Asch</span>, <span class="hlFld-ContribAuthor ">Anke  Janssens</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Leentje  Persoons</span>, <span class="hlFld-ContribAuthor ">Mathias  Cobbaut</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Johan  Van Lint</span>, <span class="hlFld-ContribAuthor ">Arnout R.D.  Voet</span>, <span class="hlFld-ContribAuthor ">Wim M.  De Borggraeve</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112638. <a href="https://doi.org/10.1016/j.ejmech.2020.112638" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112638%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine-based%252Bprotein%252Bkinase%252BD%252Binhibitors%26aulast%3DGilles%26aufirst%3DPhilippe%26date%3D2020%26volume%3D205%26spage%3D112638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye Jin  Jeong</span>, <span class="hlFld-ContribAuthor ">Sein  Min</span>, <span class="hlFld-ContribAuthor ">Keunhong  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of 1-aminoisoquinoline using the signal amplification by reversible exchange hyperpolarization technique. </span><span class="cited-content_cbyCitation_journal-name">The Analyst</span><span> <strong>2020,</strong> <em>145 </em>
                                    (20)
                                     , 6478-6484. <a href="https://doi.org/10.1039/D0AN00967A" title="DOI URL">https://doi.org/10.1039/D0AN00967A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0AN00967A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0AN00967A%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Analyst%26atitle%3DAnalysis%252Bof%252B1-aminoisoquinoline%252Busing%252Bthe%252Bsignal%252Bamplification%252Bby%252Breversible%252Bexchange%252Bhyperpolarization%252Btechnique%26aulast%3DJeong%26aufirst%3DHye%2BJin%26date%3D2020%26date%3D2020%26volume%3D145%26issue%3D20%26spage%3D6478%26epage%3D6484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Li</span>, <span class="hlFld-ContribAuthor ">Zimu  Su</span>, <span class="hlFld-ContribAuthor ">Haijun  Hao</span>, <span class="hlFld-ContribAuthor ">Junpeng  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Photoinduced direct hydration of dipyridylacetylenes in acidic aqueous solution. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (55)
                                     , 7669-7672. <a href="https://doi.org/10.1039/D0CC01351J" title="DOI URL">https://doi.org/10.1039/D0CC01351J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC01351J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC01351J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPhotoinduced%252Bdirect%252Bhydration%252Bof%252Bdipyridylacetylenes%252Bin%252Bacidic%252Baqueous%252Bsolution%26aulast%3DLi%26aufirst%3DYa%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D55%26spage%3D7669%26epage%3D7672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Hang  Song</span>, <span class="hlFld-ContribAuthor ">Shiyi  Yu</span>, <span class="hlFld-ContribAuthor ">Kuo‐Hsiang  Huang</span>, <span class="hlFld-ContribAuthor ">Xinxing  Ma</span>, <span class="hlFld-ContribAuthor ">Yehui  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuang  Yu</span>, <span class="hlFld-ContribAuthor ">Jingzhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Liming  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2020,</strong> <em>24 </em>
                                    (3)
                                     , 2135-2144. <a href="https://doi.org/10.1111/jcmm.14772" title="DOI URL">https://doi.org/10.1111/jcmm.14772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.14772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.14772%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DProtein%252BKinase%252BD3%252Bpromotes%252Bthe%252Bcell%252Bproliferation%252Bby%252Bactivating%252Bthe%252BERK1%25252Fc%2525E2%252580%252590MYC%252Baxis%252Bin%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DYan%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D3%26spage%3D2135%26epage%3D2144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilige  Youssef</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Ricort</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2019,</strong> <em>17 </em>
                                    (10)
                                     , 1961-1974. <a href="https://doi.org/10.1158/1541-7786.MCR-19-0125" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-19-0125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-19-0125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-19-0125%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DDeciphering%252Bthe%252BRole%252Bof%252BProtein%252BKinase%252BD1%252B%252528PKD1%252529%252Bin%252BCellular%252BProliferation%26aulast%3DYoussef%26aufirst%3DIlige%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D10%26spage%3D1961%26epage%3D1974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju  Dash</span>, <span class="hlFld-ContribAuthor ">Md.  Arifuzzaman</span>, <span class="hlFld-ContribAuthor ">Sarmistha  Mitra</span>, <span class="hlFld-ContribAuthor ">Md.  Abdul Hannan</span>, <span class="hlFld-ContribAuthor ">Nurul  Absar</span>, <span class="hlFld-ContribAuthor ">S.M. Zahid  Hosen</span>. </span><span class="cited-content_cbyCitation_article-title">Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (10)
                                     , 1059-1074. <a href="https://doi.org/10.2174/1381612825666190527095510" title="DOI URL">https://doi.org/10.2174/1381612825666190527095510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190527095510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190527095510%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DUnveiling%252Bthe%252BStructural%252BInsights%252Binto%252Bthe%252BSelective%252BInhibition%252Bof%252BProtein%252BKinase%252BD1%26aulast%3DDash%26aufirst%3DRaju%26date%3D2019%26volume%3D25%26issue%3D10%26spage%3D1059%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Bilge</span>. </span><span class="cited-content_cbyCitation_article-title">A Dft Investigation of the Interaction of B- And Al-Doped C60 Fullerenes with Cyclopropylpipezarine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Chemistry</span><span> <strong>2018,</strong> <em>59 </em>
                                    (6)
                                     , 1271-1275. <a href="https://doi.org/10.1134/S0022476618060045" title="DOI URL">https://doi.org/10.1134/S0022476618060045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0022476618060045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0022476618060045%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Chemistry%26atitle%3DA%252BDft%252BInvestigation%252Bof%252Bthe%252BInteraction%252Bof%252BB-%252BAnd%252BAl-Doped%252BC60%252BFullerenes%252Bwith%252BCyclopropylpipezarine%26aulast%3DBilge%26aufirst%3DM.%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D6%26spage%3D1271%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ninel  Azoitei</span>, <span class="hlFld-ContribAuthor ">Mathias  Cobbaut</span>, <span class="hlFld-ContribAuthor ">Alexander  Becher</span>, <span class="hlFld-ContribAuthor ">Johan  Van Lint</span>, <span class="hlFld-ContribAuthor ">Thomas  Seufferlein</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase D2: a versatile player in cancer biology. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2018,</strong> <em>37 </em>
                                    (10)
                                     , 1263-1278. <a href="https://doi.org/10.1038/s41388-017-0052-8" title="DOI URL">https://doi.org/10.1038/s41388-017-0052-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-017-0052-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-017-0052-8%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DProtein%252Bkinase%252BD2%25253A%252Ba%252Bversatile%252Bplayer%252Bin%252Bcancer%252Bbiology%26aulast%3DAzoitei%26aufirst%3DNinel%26date%3D2018%26date%3D2017%26volume%3D37%26issue%3D10%26spage%3D1263%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini</span>, <span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Malkeet Singh  Bahia</span>, <span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Renu  Bahadur</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 47-56. <a href="https://doi.org/10.1007/s11030-017-9785-0" title="DOI URL">https://doi.org/10.1007/s11030-017-9785-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9785-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9785-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DComputational%252Bdesign%252Bof%252Bnew%252Bprotein%252Bkinase%252BD%252B1%252B%252528PKD1%252529%252Binhibitors%25253A%252Bhomology-based%252Bactive%252Bsite%252Bprediction%25252C%252Benergy-optimized%252Bpharmacophore%25252C%252Bdocking%252Band%252Bdatabase%252Bscreening%26aulast%3DNalini%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D47%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adhiraj  Roy</span>, <span class="hlFld-ContribAuthor ">Jing  Ye</span>, <span class="hlFld-ContribAuthor ">Fan  Deng</span>, <span class="hlFld-ContribAuthor ">Qiming Jane  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase D signaling in cancer: A friend or foe?. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2017,</strong> <em>1868 </em>
                                    (1)
                                     , 283-294. <a href="https://doi.org/10.1016/j.bbcan.2017.05.008" title="DOI URL">https://doi.org/10.1016/j.bbcan.2017.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2017.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2017.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DProtein%252Bkinase%252BD%252Bsignaling%252Bin%252Bcancer%25253A%252BA%252Bfriend%252Bor%252Bfoe%25253F%26aulast%3DRoy%26aufirst%3DAdhiraj%26date%3D2017%26volume%3D1868%26issue%3D1%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klaas  Verschueren</span>, <span class="hlFld-ContribAuthor ">Mathias  Cobbaut</span>, <span class="hlFld-ContribAuthor ">Joachim  Demaerel</span>, <span class="hlFld-ContribAuthor ">Lina  Saadah</span>, <span class="hlFld-ContribAuthor ">Arnout R. D.  Voet</span>, <span class="hlFld-ContribAuthor ">Johan  Van Lint</span>, <span class="hlFld-ContribAuthor ">Wim M.  De Borggraeve</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 640-646. <a href="https://doi.org/10.1039/C6MD00675B" title="DOI URL">https://doi.org/10.1039/C6MD00675B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00675B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00675B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252Bprotein%252Bkinase%252BD%252Binhibitor%25253A%252Binsights%252Bin%252Bthe%252Bbinding%252Bmode%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Banalogues%26aulast%3DVerschueren%26aufirst%3DKlaas%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D640%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuang  Xiong</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yanbo  Wang</span>, <span class="hlFld-ContribAuthor ">Shuang  Luo</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed C(sp
              2
              )–H aminoimidoylation of isocyano-containing arenes: synthesis of amino substituted N-heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (9)
                                     , 1768-1771. <a href="https://doi.org/10.1039/C7QO00368D" title="DOI URL">https://doi.org/10.1039/C7QO00368D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00368D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00368D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPalladium-catalyzed%252BC%252528sp%252B2%252B%252529%2525E2%252580%252593H%252Baminoimidoylation%252Bof%252Bisocyano-containing%252Barenes%25253A%252Bsynthesis%252Bof%252Bamino%252Bsubstituted%252BN-heterocycles%26aulast%3DXiong%26aufirst%3DZhuang%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D9%26spage%3D1768%26epage%3D1771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sibaji  Nandi</span>, <span class="hlFld-ContribAuthor ">Mullah Muhaiminul  Islam</span>, <span class="hlFld-ContribAuthor ">Mithu  Saha</span>, <span class="hlFld-ContribAuthor ">Sivaprasad  Mitra</span>, <span class="hlFld-ContribAuthor ">Snehadrinarayan  Khatua</span>, <span class="hlFld-ContribAuthor ">Amarta Kumar  Pal</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of functionalized [1,6]-naphthyridines by KF/basic alumina as a recyclable catalyst and a brief study of their photophysical properties. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (17)
                                     , 1461-1476. <a href="https://doi.org/10.1080/00397911.2016.1209778" title="DOI URL">https://doi.org/10.1080/00397911.2016.1209778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1209778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1209778%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bfunctionalized%252B%25255B1%25252C6%25255D-naphthyridines%252Bby%252BKF%25252Fbasic%252Balumina%252Bas%252Ba%252Brecyclable%252Bcatalyst%252Band%252Ba%252Bbrief%252Bstudy%252Bof%252Btheir%252Bphotophysical%252Bproperties%26aulast%3DNandi%26aufirst%3DSibaji%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D17%26spage%3D1461%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weston W.  Blakeslee</span>, <span class="hlFld-ContribAuthor ">Philip D.  Tatman</span>, <span class="hlFld-ContribAuthor ">Timothy A.  McKinsey</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic and Nongenomic Roles for Histone Deacetylases in Heart Failure. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 209-229. <a href="https://doi.org/10.1007/978-3-319-41457-7_9" title="DOI URL">https://doi.org/10.1007/978-3-319-41457-7_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-41457-7_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-41457-7_9%26sid%3Dliteratum%253Aachs%26atitle%3DEpigenetic%252Band%252BNongenomic%252BRoles%252Bfor%252BHistone%252BDeacetylases%252Bin%252BHeart%252BFailure%26aulast%3DBlakeslee%26aufirst%3DWeston%2BW.%26date%3D2016%26date%3D2016%26spage%3D209%26epage%3D229%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEpigenetics%252Bin%252BCardiac%252BDisease%26aulast%3DBacks%26aufirst%3DJohannes%26date%3D2016%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha  Durand</span>, <span class="hlFld-ContribAuthor ">Sahra  Borges</span>, <span class="hlFld-ContribAuthor ">Peter  Storz</span>. </span><span class="cited-content_cbyCitation_article-title">Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2015,</strong> <em>72 </em>
                                    (22)
                                     , 4369-4382. <a href="https://doi.org/10.1007/s00018-015-2011-2" title="DOI URL">https://doi.org/10.1007/s00018-015-2011-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-015-2011-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-015-2011-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DFunctional%252Band%252Btherapeutic%252Bsignificance%252Bof%252Bprotein%252Bkinase%252BD%252Benzymes%252Bin%252Binvasive%252Bbreast%252Bcancer%26aulast%3DDurand%26aufirst%3DNisha%26date%3D2015%26date%3D2015%26volume%3D72%26issue%3D22%26spage%3D4369%26epage%3D4382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas D.  Lemon</span>, <span class="hlFld-ContribAuthor ">Brooke C.  Harrison</span>, <span class="hlFld-ContribAuthor ">Todd R.  Horn</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Stratton</span>, <span class="hlFld-ContribAuthor ">Bradley S.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Michael F.  Wempe</span>, <span class="hlFld-ContribAuthor ">Timothy A.  McKinsey</span>. </span><span class="cited-content_cbyCitation_article-title">Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2015,</strong> <em>589 </em>
                                    (10)
                                     , 1080-1088. <a href="https://doi.org/10.1016/j.febslet.2015.03.017" title="DOI URL">https://doi.org/10.1016/j.febslet.2015.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.febslet.2015.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.febslet.2015.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DPromiscuous%252Bactions%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bthe%252Bprotein%252Bkinase%252BD-class%252BIIa%252BHDAC%252Baxis%252Bin%252Bstriated%252Bmuscle%26aulast%3DLemon%26aufirst%3DDouglas%2BD.%26date%3D2015%26date%3D2015%26volume%3D589%26issue%3D10%26spage%3D1080%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorenz H.  Lehmann</span>, <span class="hlFld-ContribAuthor ">Barbara C.  Worst</span>, <span class="hlFld-ContribAuthor ">David A.  Stanmore</span>, <span class="hlFld-ContribAuthor ">Johannes  Backs</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase signaling in cardioprotection. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2014,</strong> <em>71 </em>
                                    (9)
                                     , 1673-1690. <a href="https://doi.org/10.1007/s00018-013-1516-9" title="DOI URL">https://doi.org/10.1007/s00018-013-1516-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-013-1516-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-013-1516-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DHistone%252Bdeacetylase%252Bsignaling%252Bin%252Bcardioprotection%26aulast%3DLehmann%26aufirst%3DLorenz%2BH.%26date%3D2014%26date%3D2013%26volume%3D71%26issue%3D9%26spage%3D1673%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicky J.  Willis</span>, <span class="hlFld-ContribAuthor ">James M.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">An operationally simple, palladium catalysed dehydrogenative cross-coupling reaction of pyridine N-oxides and thiazoles “on water”. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (22)
                                     , 11059. <a href="https://doi.org/10.1039/c3ra44411b" title="DOI URL">https://doi.org/10.1039/c3ra44411b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra44411b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra44411b%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Boperationally%252Bsimple%25252C%252Bpalladium%252Bcatalysed%252Bdehydrogenative%252Bcross-coupling%252Breaction%252Bof%252Bpyridine%252BN-oxides%252Band%252Bthiazoles%252B%2525E2%252580%25259Con%252Bwater%2525E2%252580%25259D%26aulast%3DWillis%26aufirst%3DNicky%2BJ.%26date%3D2014%26volume%3D4%26issue%3D22%26spage%3D11059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">James  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Shuping  Xu</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Qiming Jane  Wang</span>, . </span><span class="cited-content_cbyCitation_article-title">New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (9)
                                     , e75601. <a href="https://doi.org/10.1371/journal.pone.0075601" title="DOI URL">https://doi.org/10.1371/journal.pone.0075601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0075601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0075601%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DNew%252BPyrazolopyrimidine%252BInhibitors%252Bof%252BProtein%252BKinase%252BD%252Bas%252BPotent%252BAnticancer%252BAgents%252Bfor%252BProstate%252BCancer%252BCells%26aulast%3DTandon%26aufirst%3DManuj%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3De75601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahra  Borges</span>, <span class="hlFld-ContribAuthor ">Peter  Storz</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase D isoforms: new targets for therapy in invasive breast cancers?. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2013,</strong> <em>13 </em>
                                    (8)
                                     , 895-898. <a href="https://doi.org/10.1586/14737140.2013.816460" title="DOI URL">https://doi.org/10.1586/14737140.2013.816460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14737140.2013.816460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14737140.2013.816460%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DProtein%252Bkinase%252BD%252Bisoforms%25253A%252Bnew%252Btargets%252Bfor%252Btherapy%252Bin%252Binvasive%252Bbreast%252Bcancers%25253F%26aulast%3DBorges%26aufirst%3DSahra%26date%3D2013%26date%3D2014%26volume%3D13%26issue%3D8%26spage%3D895%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert S.  Haworth</span>, <span class="hlFld-ContribAuthor ">Konstantina  Stathopoulou</span>, <span class="hlFld-ContribAuthor ">Alexandra J.  Candasamy</span>, <span class="hlFld-ContribAuthor ">Metin  Avkiran</span>. </span><span class="cited-content_cbyCitation_article-title">Neurohormonal Regulation of Cardiac Histone Deacetylase 5 Nuclear Localization by Phosphorylation-Dependent and Phosphorylation-Independent Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Circulation Research</span><span> <strong>2012,</strong> <em>110 </em>
                                    (12)
                                     , 1585-1595. <a href="https://doi.org/10.1161/CIRCRESAHA.111.263665" title="DOI URL">https://doi.org/10.1161/CIRCRESAHA.111.263665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCRESAHA.111.263665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCRESAHA.111.263665%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%2520Research%26atitle%3DNeurohormonal%252BRegulation%252Bof%252BCardiac%252BHistone%252BDeacetylase%252B5%252BNuclear%252BLocalization%252Bby%252BPhosphorylation-Dependent%252Band%252BPhosphorylation-Independent%252BMechanisms%26aulast%3DHaworth%26aufirst%3DRobert%2BS.%26date%3D2012%26volume%3D110%26issue%3D12%26spage%3D1585%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Shan  Zhao</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Zeng</span>, <span class="hlFld-ContribAuthor ">Hong-Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Hai  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative analysis of binding sites between human PKD1 and PKC1 based on homology modelling, molecular dynamics simulation and docking studies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2012,</strong> <em>38 </em>
                                    (4)
                                     , 309-314. <a href="https://doi.org/10.1080/08927022.2011.631010" title="DOI URL">https://doi.org/10.1080/08927022.2011.631010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2011.631010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2011.631010%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DA%252Bcomparative%252Banalysis%252Bof%252Bbinding%252Bsites%252Bbetween%252Bhuman%252BPKD1%252Band%252BPKC1%252Bbased%252Bon%252Bhomology%252Bmodelling%25252C%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bdocking%252Bstudies%26aulast%3DZhao%26aufirst%3DYong-Shan%26date%3D2012%26volume%3D38%26issue%3D4%26spage%3D309%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurice J.  van Eis</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Evenou</span>, <span class="hlFld-ContribAuthor ">Philipp  Floersheim</span>, <span class="hlFld-ContribAuthor ">Christoph  Gaul</span>, <span class="hlFld-ContribAuthor ">Sandra W.  Cowan-Jacob</span>, <span class="hlFld-ContribAuthor ">Lauren  Monovich</span>, <span class="hlFld-ContribAuthor ">Gabriele  Rummel</span>, <span class="hlFld-ContribAuthor ">Walter  Schuler</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Stark</span>, <span class="hlFld-ContribAuthor ">Andre  Strauss</span>, <span class="hlFld-ContribAuthor ">Anette von  Matt</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Juergen  Wagner</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>. </span><span class="cited-content_cbyCitation_article-title">2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (24)
                                     , 7367-7372. <a href="https://doi.org/10.1016/j.bmcl.2011.10.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2%25252C6-Naphthyridines%252Bas%252Bpotent%252Band%252Bselective%252Binhibitors%252Bof%252Bthe%252Bnovel%252Bprotein%252Bkinase%252BC%252Bisozymes%26aulast%3Dvan%2BEis%26aufirst%3DMaurice%2BJ.%26date%3D2011%26volume%3D21%26issue%3D24%26spage%3D7367%26epage%3D7372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>, <span class="hlFld-ContribAuthor ">Gabriela  Mustata Wilson</span>, <span class="hlFld-ContribAuthor ">David  Close</span>, <span class="hlFld-ContribAuthor ">Stephanie  Leimgruber</span>, <span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">Robyn B.  Reed</span>, <span class="hlFld-ContribAuthor ">Tong Ying  Shun</span>, <span class="hlFld-ContribAuthor ">Q. Jane  Wang</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">John S.  Lazo</span>, . </span><span class="cited-content_cbyCitation_article-title">Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2011,</strong> <em>6 </em>
                                    (10)
                                     , e25134. <a href="https://doi.org/10.1371/journal.pone.0025134" title="DOI URL">https://doi.org/10.1371/journal.pone.0025134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0025134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0025134%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DDiscovery%252Bof%252BDiverse%252BSmall%252BMolecule%252BChemotypes%252Bwith%252BCell-Based%252BPKD1%252BInhibitory%252BActivity%26aulast%3DSharlow%26aufirst%3DElizabeth%2BR.%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D10%26spage%3De25134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie  Bossuyt</span>, <span class="hlFld-ContribAuthor ">Chia-Wei  Chang</span>, <span class="hlFld-ContribAuthor ">Kathryn  Helmstadter</span>, <span class="hlFld-ContribAuthor ">Maya T.  Kunkel</span>, <span class="hlFld-ContribAuthor ">Alexandra C.  Newton</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jody L.  Martin</span>, <span class="hlFld-ContribAuthor ">Sven  Bossuyt</span>, <span class="hlFld-ContribAuthor ">Seth L.  Robia</span>, <span class="hlFld-ContribAuthor ">Donald M.  Bers</span>. </span><span class="cited-content_cbyCitation_article-title">Spatiotemporally Distinct Protein Kinase D Activation in Adult Cardiomyocytes in Response to Phenylephrine and Endothelin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2011,</strong> <em>286 </em>
                                    (38)
                                     , 33390-33400. <a href="https://doi.org/10.1074/jbc.M111.246447" title="DOI URL">https://doi.org/10.1074/jbc.M111.246447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M111.246447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M111.246447%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DSpatiotemporally%252BDistinct%252BProtein%252BKinase%252BD%252BActivation%252Bin%252BAdult%252BCardiomyocytes%252Bin%252BResponse%252Bto%252BPhenylephrine%252Band%252BEndothelin%26aulast%3DBossuyt%26aufirst%3DJulie%26date%3D2011%26volume%3D286%26issue%3D38%26spage%3D33390%26epage%3D33400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengqing  Ye</span>, <span class="hlFld-ContribAuthor ">Huanhuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">An expeditious approach to 1-aminoisoquinolines via an unexpected reaction of 2-alkynylbenzaldoxime, carbodiimide, with bromine. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (25)
                                     , 4628-4632. <a href="https://doi.org/10.1016/j.tet.2011.04.063" title="DOI URL">https://doi.org/10.1016/j.tet.2011.04.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.04.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Bexpeditious%252Bapproach%252Bto%252B1-aminoisoquinolines%252Bvia%252Ban%252Bunexpected%252Breaction%252Bof%252B2-alkynylbenzaldoxime%25252C%252Bcarbodiimide%25252C%252Bwith%252Bbromine%26aulast%3DYe%26aufirst%3DShengqing%26date%3D2011%26volume%3D67%26issue%3D25%26spage%3D4628%26epage%3D4632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kara M.  George</span>, <span class="hlFld-ContribAuthor ">Marie-Céline  Frantz</span>, <span class="hlFld-ContribAuthor ">Karla  Bravo-Altamirano</span>, <span class="hlFld-ContribAuthor ">Courtney R.  LaValle</span>, <span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">Stephanie  Leimgruber</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>, <span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Q. Jane  Wang</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of PKD Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2011,</strong> <em>3 </em>
                                    (2)
                                     , 186-228. <a href="https://doi.org/10.3390/pharmaceutics3020186" title="DOI URL">https://doi.org/10.3390/pharmaceutics3020186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics3020186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics3020186%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPKD%252BInhibitors%26aulast%3DGeorge%26aufirst%3DKara%2BM.%26date%3D2011%26date%3D2011%26volume%3D3%26issue%3D2%26spage%3D186%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel G.  Gamber</span>, <span class="hlFld-ContribAuthor ">Erik  Meredith</span>, <span class="hlFld-ContribAuthor ">Qingming  Zhu</span>, <span class="hlFld-ContribAuthor ">Wanlin  Yan</span>, <span class="hlFld-ContribAuthor ">Chang  Rao</span>, <span class="hlFld-ContribAuthor ">Michael  Capparelli</span>, <span class="hlFld-ContribAuthor ">Robin  Burgis</span>, <span class="hlFld-ContribAuthor ">Istvan  Enyedy</span>, <span class="hlFld-ContribAuthor ">Ji-Hu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>, <span class="hlFld-ContribAuthor ">Kimberley  Beattie</span>, <span class="hlFld-ContribAuthor ">Olga  Rozhitskaya</span>, <span class="hlFld-ContribAuthor ">Keith A.  Koch</span>, <span class="hlFld-ContribAuthor ">Nikos  Pagratis</span>, <span class="hlFld-ContribAuthor ">Vinayak  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Richard B.  Vega</span>, <span class="hlFld-ContribAuthor ">Timothy A.  McKinsey</span>, <span class="hlFld-ContribAuthor ">Lauren  Monovich</span>. </span><span class="cited-content_cbyCitation_article-title">3,5-Diarylazoles as novel and selective inhibitors of protein kinase D. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (5)
                                     , 1447-1451. <a href="https://doi.org/10.1016/j.bmcl.2011.01.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3%25252C5-Diarylazoles%252Bas%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252Bprotein%252Bkinase%252BD%26aulast%3DGamber%26aufirst%3DGabriel%2BG.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1447%26epage%3D1451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  McKinsey</span>. </span><span class="cited-content_cbyCitation_article-title">The Biology and Therapeutic Implications of HDACs in the Heart. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 57-78. <a href="https://doi.org/10.1007/978-3-642-21631-2_4" title="DOI URL">https://doi.org/10.1007/978-3-642-21631-2_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-21631-2_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-21631-2_4%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BBiology%252Band%252BTherapeutic%252BImplications%252Bof%252BHDACs%252Bin%252Bthe%252BHeart%26aulast%3DMcKinsey%26aufirst%3DTimothy%2BA.%26date%3D2011%26date%3D2011%26spage%3D57%26epage%3D78%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DHistone%252BDeacetylases%25253A%252Bthe%252BBiology%252Band%252BClinical%252BImplication%26aulast%3DYao%26aufirst%3DTso-Pang%26date%3D2011%26volume%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danqing  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient route to 1-aminoisoquinolines via AgOTf-catalyzed reaction of 2-alkynylbenzaldoxime with amine. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2011,</strong> <em>9 </em>
                                    (13)
                                     , 4763. <a href="https://doi.org/10.1039/c1ob05582h" title="DOI URL">https://doi.org/10.1039/c1ob05582h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ob05582h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ob05582h%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Befficient%252Broute%252Bto%252B1-aminoisoquinolines%252Bvia%252BAgOTf-catalyzed%252Breaction%252Bof%252B2-alkynylbenzaldoxime%252Bwith%252Bamine%26aulast%3DZheng%26aufirst%3DDanqing%26date%3D2011%26volume%3D9%26issue%3D13%26spage%3D4763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PKD inhibitor structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0024.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the 2,6-Naphthyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (MeO)<sub>2</sub>SO<sub>2</sub>, EtOH, H<sub>2</sub>O, 60 °C, 18 h; (ii) KCN, EtOH, H<sub>2</sub>O, 18 h; (iii) <i>t</i>-BuOH, conc H<sub>2</sub>SO<sub>4</sub>, 70 °C, 3 h; (iv) ethyl chloroformate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, then <i>t</i>-BuNH<sub>2</sub>; (v) <i>n</i>-BuLi, then MeI; (vi) <i>n</i>-BuLi, THF, −70 °C; (vii) DMF, reflux; (viii) AcOH, 100 °C; (ix) 25% NH<sub>3</sub>, EtOH; (x) POBr<sub>3</sub> or POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (xi) HNRR<sup>1</sup>, Et<sub>3</sub>N, EtOH, reflux; (xii) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (xiii) H<sub>2</sub>NR<sup>2</sup>, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (xiv) isobutyraldehyde, NaBH(OAc)<sub>3</sub>, Cl(CH<sub>2</sub>)<sub>2</sub>Cl.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0001.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alternative Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <i>n</i>-BuLi, <b>7b</b>, THF, −70 °C; (ii) AcOH, 100 °C; (iii) 25% NH<sub>3</sub>, EtOH; (iv) HCl, MeOH, dioxane; (v) Na, MeOH; (vi) POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (vii) BOC piperazine, Et<sub>3</sub>N, EtOH, reflux; (viii) cyclohexylamine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (ix) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0002.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Installation of Groups on the 1-Naphthyridine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaOMe, MeOH; (ii) cyclohexylamine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (iii) <i>t</i>-BuOK, <i>t</i>-BuOH, THF; (iv) POCl<sub>3</sub>, Me<sub>4</sub>NCl, 110 °C; (v) amine, Et<sub>3</sub>N, EtOH, reflux; (vi) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (vii) <i>N</i>-BOC-glycine, HBTU, Et<sub>3</sub>N; (viii) formic acid.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0003.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 1-Naphthyridines with Pendent Amides and Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) amine, Et<sub>3</sub>N, EtOH, reflux; (ii) amine, Pd(OAc)<sub>2</sub>, <i>t</i>-BuOK, BINAP, PhCH<sub>3</sub>, 85 °C; (iii) amine, Me<sub>3</sub>Al; (iv) LiOH, THF, water; (v) amine, PyBop, HOBt; (vi) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (vii) MsCl.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed key contacts for PKD inhibitor <b>13c</b> in PKD1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PKD inhibitors <b>13c</b> and <b>13y</b> block in vitro autophosphorylation of PKD1 (Ser916) and PKD2 (Ser867) in the absence or presence of an HDAC5 peptide. The concentrations at which PKD autophosphorylation is inhibited are consistent with the IC<sub>50</sub> values in the PKD biochemical assays: (a) (−) 0 μM, (∗) 0.01 μM, (∗∗) 0.1 μM, (∗∗∗) 1 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In neonatal rat ventricular myocytes (NRVMs), 1 μM <b>13c</b> blocks GFP-HDAC5 nuclear export in response to a variety of stimuli, including 10 μM phenylephrine (PE), endothelin-1 (ET-1), prostaglandin F2α (PGF2α), lysophosphatidic acid (LPA), or phorbol 12-myristate 13-acetate (PMA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In NRVMs, compound <b>13c</b> and <b>13y</b> block PE-stimulated PKD activity. In accordance with their relative and absolute potencies in the HDAC export assay, compounds <b>13c</b> (at 0.1 and 1 μM) and <b>13y</b> (at 1 μM) block phosphorylation of the PKD substrate HDAC (pSer498). At 1 μM, <b>13c</b> effectively blocks PKD autophosphorylation (pSer916) while <b>13y</b> produces partial reduction: (a) (−) 0 μM, (∗) 0.1 μM, (∗∗) 1 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0017.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. DSS rat plasma exposure following 50 mg/kg oral administration of <b>13c</b> and <b>13y</b> as a suspension in 0.5% methylcellulose and 0.5% Tween-80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0018.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>13c</b> and <b>13y</b> given 50 (mg/kg)/day po as a suspension in methylcellulose for 14 days in the DSS rat on (a) mean blood pressure and (b) cardiac hypertrophy (left ventricular mass/tibia length) on day 14. Neither compound attenuated the increase in mean blood pressure observed with high (8%) salt diet. Compound <b>13c</b>, but not <b>13y</b>, blunted high-salt-induced cardiac hypertrophy (LV/TL): (∗) <i>p</i> < 0.05 vs 0.05% NaCl plus vehicle; (†) <i>p</i> < 0.05 vs 8% NaCl plus vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0019.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Biomarker readout in the DSS rat in a surrogate cell type on day 14. In peripheral blood mononuclear cells (PBMCs), PMA-stimulated, (a) autophosphorylation of PKD at Ser916 is blunted by compound <b>13c</b> and (b) phosphorylation of the PKD substrate HDAC at Ser498 is blunted by both <b>13c</b> and <b>13y</b> relative to the vehicle control: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0020.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of compound <b>13c</b> given 5, 10, and 50 (mg/kg)/day po as a suspension in methylcellulose on day 14 of 14 days in the DSS rat on cardiac hypertrophy (left ventricular mass/tibia length). Only the 50 mg/kg po dose attenuates high-salt-diet-induced cardiac hypertrophy (LV/TL): (∗) <i>p</i> < 0.05 vs 0.05% NaCl plus vehicle; (†) <i>p</i> < 0.05 vs 8% NaCl plus vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0021.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Biomarker readout in the DSS rat in a surrogate cell type on day 14. In peripheral blood mononuclear cells (PBMCs), PMA-stimulated, (a) autophosphorylation of PKD at Ser916 is blunted by the highest dose of compound <b>13c</b> and (b) phosphorylation of the PKD substrate HDAC at Ser498 is reduced by all compound doses: (∗) <i>p</i> < 0.05 vs vehicle; (#) <i>p</i> < 0.05 vs vehicle plus PMA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0022.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effect of compound <b>13c</b> given 15 (mg/kg)/day sc in acidified captisol in the thoracic aortic banded (TAB) rat on (a) cardiac hypertrophy (left ventricular mass/tibia length) and (b) a marker of diastolic function isovolumic relaxation time (IVRT) on day 14. Neither parameter is affected by compound treatment: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/medium/jm-2010-00075z_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0023.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Biomarker readout in the TAB rat in a surrogate cell type on day 14. In PBMCs, PMA-stimulated, (a) autophosphorylation of PKD at Ser916 with compound <b>13c</b> treatment is not significantly different from vehicle control and (b) phosphorylation of the PKD substrate HDAC at Ser498 is normalized to baseline levels: (∗) <i>p</i> <0.05 vs vehicle; (#) <i>p</i> < 0.05 vs vehicle plus PMA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100075z/production/images/large/jm-2010-00075z_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100075z&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chatterjee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, B.</span><span> </span><span class="NLM_article-title">Systolic and diastolic heart failure: differences and similarities</span> <span class="citation_source-journal">J. Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.cardfail.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=17826648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A280%3ADC%252BD2srivFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=569&author=K.+Chatterjeeauthor=B.+Massie&title=Systolic+and+diastolic+heart+failure%3A+differences+and+similarities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Systolic and diastolic heart failure: differences and similarities</span></div><div class="casAuthors">Chatterjee Kanu; Massie Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiac failure</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">569-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Diastolic heart failure (DHF) and systolic heart failure (SHF) are 2 clinical subsets of the syndrome of chronic heart failure that are most commonly encountered in clinical practice.  METHODS AND RESULTS:  The clinically overt DHF and SHF appear to be 2 separate syndromes with distinctive morphologic and functional changes although signs, symptoms, and prognosis are very similar.  In DHF, the left ventricle is not dilated and the ejection fraction is preserved.  In contrast in SHF, it is dilated and the ejection fraction is reduced.  The neurohormonal abnormalities in DHF and SHF appear to be similar.  The stimuli and the signals that ultimately produce these 2 different phenotypes of chronic heart failure remain, presently, largely unknown.  CONCLUSIONS:  Although there has been considerable progress in the management of SHF, the management of DHF remains mostly empirical because of lack of knowledge of the molecular and biochemical mechanisms which produce myocardial structural and functional changes in this syndrome.  Further research and investigations are urgently required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbW9bU7wRYxkBuFdjgVNKSfW6udTcc2eb-e2N2rhDL5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srivFShsg%253D%253D&md5=b9441494a7af8ba487321134a17e8efd</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.cardfail.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardfail.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DMassie%26aufirst%3DB.%26atitle%3DSystolic%2520and%2520diastolic%2520heart%2520failure%253A%2520differences%2520and%2520similarities%26jtitle%3DJ.%2520Card.%2520Failure%26date%3D2007%26volume%3D13%26spage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koitabashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurabayashi, M.</span><span> </span><span class="NLM_article-title">Mechanisms that underlie diastolic heart failure and diastolic dysfunction</span> <span class="citation_source-journal">J Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=S142&issue=Suppl.+1&author=M.+Araiauthor=N.+Koitabashiauthor=A.+Watanabeauthor=K.+Niwanoauthor=H.+Matsuiauthor=Y.+Ohyamaauthor=M.+Kurabayashi&title=Mechanisms+that+underlie+diastolic+heart+failure+and+diastolic+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%26aulast%3DKoitabashi%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DNiwano%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DOhyama%26aufirst%3DY.%26aulast%3DKurabayashi%26aufirst%3DM.%26atitle%3DMechanisms%2520that%2520underlie%2520diastolic%2520heart%2520failure%2520and%2520diastolic%2520dysfunction%26jtitle%3DJ%2520Card.%2520Failure%26date%3D2008%26volume%3D14%26issue%3DSuppl.%25201%26spage%3DS142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> For WHO mortality data by country or region, see <a href="http://www.who.int/whosis/whostat2006_mortality.pdf" class="extLink">http://www.who.int/whosis/whostat2006_mortality.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+WHO+mortality+data+by+country+or+region%2C+see+http%3A%2F%2Fwww.who.int%2Fwhosis%2Fwhostat2006_mortality.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: cardiac plasticity</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1056%2FNEJMra072139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=18367740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFOnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=1370-1380&author=J.+A.+Hillauthor=E.+N.+Olson&title=Mechanisms+of+disease%3A+cardiac+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cardiac plasticity</span></div><div class="casAuthors">Hill, Joseph A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1370-1380</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include: (1) dynamics of myocardial growth; (2) changing ideas about cardiac hypertrophy; (3) the hypertrophic phenotype; (4) contrasting phenotypes of myocardial growth; (5) functional decompensation in pathol. cardiac hypertrophy; (6) myocardial atrophy; (7) signal transduction in cardiac growth; (8) cardiac plasticity in heart disease; (9) prospects for therapy; and (10) limitation and perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3rNhNyM1_7Vg90H21EOLACvtfcHk0lgDwCrQm5WAbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFOnsb8%253D&md5=758ba9dd5ef2172918ae146f018494e9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra072139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra072139%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DMechanisms%2520of%2520disease%253A%2520cardiac%2520plasticity%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D1370%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gosse, P.</span><span> </span><span class="NLM_article-title">Left ventricular hypertrophy as a predictor of cardiovascular risk</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S27</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=S27-S33&issue=Suppl.+1&author=P.+Gosse&title=Left+ventricular+hypertrophy+as+a+predictor+of+cardiovascular+risk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGosse%26aufirst%3DP.%26atitle%3DLeft%2520ventricular%2520hypertrophy%2520as%2520a%2520predictor%2520of%2520cardiovascular%2520risk%26jtitle%3DJ.%2520Hypertens.%26date%3D2005%26volume%3D23%26issue%3DSuppl.%25201%26spage%3DS27%26epage%3DS33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Devereux, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachtell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieminen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papademetriou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokkedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahloef, B.</span><span> </span><span class="NLM_article-title">Prognostic significance of left ventricular mass change during treatment of hypertension</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">2350</span><span class="NLM_x">–</span> <span class="NLM_lpage">2356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=2350-2356&author=R.+B.+Devereuxauthor=K.+Wachtellauthor=E.+Gerdtsauthor=K.+Bomanauthor=M.+S.+Nieminenauthor=V.+Papademetriouauthor=J.+Rokkedalauthor=K.+Harrisauthor=P.+Aurupauthor=B.+Dahloef&title=Prognostic+significance+of+left+ventricular+mass+change+during+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevereux%26aufirst%3DR.%2BB.%26aulast%3DWachtell%26aufirst%3DK.%26aulast%3DGerdts%26aufirst%3DE.%26aulast%3DBoman%26aufirst%3DK.%26aulast%3DNieminen%26aufirst%3DM.%2BS.%26aulast%3DPapademetriou%26aufirst%3DV.%26aulast%3DRokkedal%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DK.%26aulast%3DAurup%26aufirst%3DP.%26aulast%3DDahloef%26aufirst%3DB.%26atitle%3DPrognostic%2520significance%2520of%2520left%2520ventricular%2520mass%2520change%2520during%2520treatment%2520of%2520hypertension%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2004%26volume%3D292%26spage%3D2350%26epage%3D2356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Aurigemma, G. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zile, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaasch, W. H.</span><span> </span><span class="NLM_article-title">Contractile behavior of the left ventricle in diastolic heart failure with emphasis on regional systolic function</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=296-304&author=G.+P+Aurigemmaauthor=M.+R.+Zileauthor=W.+H.+Gaasch&title=Contractile+behavior+of+the+left+ventricle+in+diastolic+heart+failure+with+emphasis+on+regional+systolic+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAurigemma%26aufirst%3DG.%2BP%26aulast%3DZile%26aufirst%3DM.%2BR.%26aulast%3DGaasch%26aufirst%3DW.%2BH.%26atitle%3DContractile%2520behavior%2520of%2520the%2520left%2520ventricle%2520in%2520diastolic%2520heart%2520failure%2520with%2520emphasis%2520on%2520regional%2520systolic%2520function%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D296%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Frey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Cardiac hypertrophy: the good, the bad, and the ugly</span> <span class="citation_source-journal">Annu. Rev. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1146%2Fannurev.physiol.65.092101.142243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=12524460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Glt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=45-79&author=N.+Freyauthor=E.+N.+Olson&title=Cardiac+hypertrophy%3A+the+good%2C+the+bad%2C+and+the+ugly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac hypertrophy: The good, the bad, and the ugly</span></div><div class="casAuthors">Frey, N.; Olson, E. N.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-79</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Cardiac hypertrophy is the heart response to a variety of extrinsic and intrinsic stimuli that impose increased biomech. stress.  While hypertrophy can eventually normalize wall tension, it is assocd. with an unfavorable outcome and threatens affected patients with sudden death or progression to overt heart failure.  Accumulating evidence from studies in human patients and animal models suggests that in most instances hypertrophy is not a compensatory response to the change in mech. load, but rather is a maladaptive process.  Accordingly, modulation of myocardial growth without adversely affecting contractile function is increasingly recognized as a potentially auspicious approach in the prevention and treatment of heart failure.  In this review, we summarize recent insights into hypertrophic signaling and consider several novel antihypertrophic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzRYVovNsyZLVg90H21EOLACvtfcHk0lilg92JgcSLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Glt74%253D&md5=4b526e04a29f2a8707b2a2e85d86fdf1</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.physiol.65.092101.142243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.physiol.65.092101.142243%26sid%3Dliteratum%253Aachs%26aulast%3DFrey%26aufirst%3DN.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DCardiac%2520hypertrophy%253A%2520the%2520good%252C%2520the%2520bad%252C%2520and%2520the%2520ugly%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2003%26volume%3D65%26spage%3D45%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, D. A.</span><span> </span><span class="NLM_article-title">Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=617-635&author=T.+A.+McKinseyauthor=D.+A.+Kass&title=Small-molecule+therapies+for+cardiac+hypertrophy%3A+moving+beneath+the+cell+surface"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DSmall-molecule%2520therapies%2520for%2520cardiac%2520hypertrophy%253A%2520moving%2520beneath%2520the%2520cell%2520surface%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D617%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Potthoff, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">MEF2: a central regulator of diverse developmental programs</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">4131</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=4131-4140&author=M.+J.+Potthoffauthor=E.+N.+Olson&title=MEF2%3A+a+central+regulator+of+diverse+developmental+programs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotthoff%26aufirst%3DM.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DMEF2%253A%2520a%2520central%2520regulator%2520of%2520diverse%2520developmental%2520programs%26jtitle%3DDevelopment%26date%3D2007%26volume%3D134%26spage%3D4131%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rooij, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnally, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassel-Duby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=124-132&author=Y.+Kimauthor=D.+Phanauthor=E.+van+Rooijauthor=D.-Z.+Wangauthor=J.+McAnallyauthor=X.+Qiauthor=J.+A.+Richardsonauthor=J.+A.+Hillauthor=R.+Bassel-Dubyauthor=E.+N.+Olson&title=The+MEF2D+transcription+factor+mediates+stress-dependent+cardiac+remodeling+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPhan%26aufirst%3DD.%26aulast%3Dvan%2BRooij%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.-Z.%26aulast%3DMcAnally%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DBassel-Duby%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DThe%2520MEF2D%2520transcription%2520factor%2520mediates%2520stress-dependent%2520cardiac%2520remodeling%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D124%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8467</span><span class="NLM_x">–</span> <span class="NLM_lpage">8476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.19.8467-8476.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15367668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8467-8476&author=S.+Changauthor=T.+A.+McKinseyauthor=C.+L.+Zhangauthor=J.+A.+Richardsonauthor=J.+A.+Hillauthor=E.+N.+Olson&title=Histone+deacetylases+5+and+9+govern+responsiveness+of+the+heart+to+a+subset+of+stress+signals+and+play+redundant+roles+in+heart+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development</span></div><div class="casAuthors">Chang, Shurong; McKinsey, Timothy A.; Zhang, Chun Li; Richardson, James A.; Hill, Joseph A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8467-8476</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The adult heart responds to stress signals by hypertrophic growth, which is often accompanied by activation of a fetal cardiac gene program and eventual cardiac demise.  We showed previously that histone deacetylase 9 (HDAC9) acts as a suppressor of cardiac hypertrophy and that mice lacking HDAC9 are sensitized to cardiac stress signals.  Here we report that mice lacking HDAC5 display a similar cardiac phenotype and develop profoundly enlarged hearts in response to pressure overload resulting from aortic constriction or constitutive cardiac activation of calcineurin, a transducer of cardiac stress signals.  In contrast, mice lacking either HDAC5 or HDAC9 show a hypertrophic response to chronic β-adrenergic stimulation identical to that of wild-type littermates, suggesting that these HDACs modulate a specific subset of cardiac stress response pathways.  We also show that compd. mutant mice lacking both HDAC5 and HDAC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium.  These findings reveal central roles for HDACs 5 and 9 in the suppression of a subset of cardiac stress signals as well as redundant functions in the control of cardiac development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTFYzR2fShqLVg90H21EOLACvtfcHk0lilg92JgcSLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVakt7g%253D&md5=5f4115eb485d70a0e39ef5d4bf513e9a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8467-8476.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8467-8476.2004%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DZhang%26aufirst%3DC.%2BL.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DHistone%2520deacetylases%25205%2520and%25209%2520govern%2520responsiveness%2520of%2520the%2520heart%2520to%2520a%2520subset%2520of%2520stress%2520signals%2520and%2520play%2520redundant%2520roles%2520in%2520heart%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8467%26epage%3D8476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation</span> <span class="citation_source-journal">Novartis Found. Symp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">Heart Failure</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1002%2F0470029331.ch2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=17019803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2006&pages=3-19&issue=Heart+Failure&author=E.+N.+Olsonauthor=J.+Backsauthor=T.+A.+McKinsey&title=Control+of+cardiac+hypertrophy+and+heart+failure+by+histone+acetylation%2Fdeacetylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation</span></div><div class="casAuthors">Olson, Eric N.; Backs, Johannes; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Novartis Foundation Symposium</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">Heart Failure</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">NFSYF7</span>;
        ISSN:<span class="NLM_cas:issn">1528-2511</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The adult heart responds to acute and chronic stresses by a remodelling process that is accompanied by myocyte hypertrophy, impaired contractility, and pump failure, often culminating in sudden death.  Pathol. growth and remodelling of the adult heart is often assocd. with the reactivation of a fetal cardiac gene program that further weakens cardiac performance.  Recent studies have revealed key roles for histone deacetylases (HDACs) in the control of pathol. cardiac growth.  Class II HDACs assoc. with the MEF2 transcription factor, and other factors, to maintain normal cardiac size and function.  Stress signals lead to the phosphorylation of class II HDACs and their export from the nucleus to the cytoplasm, with consequent activation of genes involved in cardiac growth.  HDAC knockout mice are hypersensitive to stress signalling and develop massively enlarged hearts in response to various pathol. stress stimuli due to an inability to counteract pathol. signalling to MEF2.  Strategies for normalizing gene expression in the failing heart by regulating HDAC phosphorylation and function represent potentially powerful therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-O4mbpi8Em7Vg90H21EOLACvtfcHk0ljeVbc36UdIWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslGktLs%253D&md5=f729c73b12d5200d8955793c4649a9a5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2F0470029331.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0470029331.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DBacks%26aufirst%3DJ.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DControl%2520of%2520cardiac%2520hypertrophy%2520and%2520heart%2520failure%2520by%2520histone%2520acetylation%252Fdeacetylation%26jtitle%3DNovartis%2520Found.%2520Symp.%26date%3D2006%26volume%3D274%26issue%3DHeart%2520Failure%26spage%3D3%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Harrison, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">The CRM1 nuclear export receptor controls pathological cardiac gene expression</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">10636</span><span class="NLM_x">–</span> <span class="NLM_lpage">10649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.24.10636-10649.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15572669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10636-10649&author=B.+C.+Harrisonauthor=C.+R.+Robertsauthor=D.+B.+Hoodauthor=M.+Sweeneyauthor=J.+M.+Gouldauthor=E.+W.+Bushauthor=T.+A.+McKinsey&title=The+CRM1+nuclear+export+receptor+controls+pathological+cardiac+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The CRM1 nuclear export receptor controls pathological cardiac gene expression</span></div><div class="casAuthors">Harrison, Brooke C.; Roberts, Charles R.; Hood, David B.; Sweeney, Meghan; Gould, Jody M.; Bush, Erik W.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10636-10649</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Diverse pathol. insults trigger a cardiac remodeling process during which myocytes undergo hypertrophy, with consequent decline in cardiac function and eventual heart failure.  Multiple transcriptional regulators of pathol. cardiac hypertrophy are controlled at the level of subcellular distribution.  For example, prohypertrophic transcription factors belonging to the nuclear factor of activated T cells (NFAT) and GATA families are subject to CRM1-dependent nuclear export but are rapidly relocalized to the nucleus in response to cues for hypertrophic growth.  Here, we demonstrate that the antihypertrophic chromatin-modifying enzyme histone deacetylase 5 (HDAC5) is shuttled out of the cardiomyocyte nucleus via a CRM1-mediated pathway in response to diverse signals for hypertrophy.  CRM1 antagonists block the agonist-mediated nuclear export of HDAC 5 and repress pathol. gene expression and assocd. hypertrophy of cultured cardiomyocytes.  Conversely, CRM1 activity is dispensable for nonpathol. cardiac gene activation mediated by thyroid hormone and insulin-like growth factor 1, agonists that fail to trigger the nuclear export of HDAC5.  These results suggest a selective role for CRM1 in derepression of pathol. cardiac genes via its neutralizing effects on antihypertrophic factors such as HDAC5.  Pharmacol. approaches targeting CRM1-dependent nuclear export in heart muscle may have salutary effects on cardiac function by suppressing maladaptive changes in gene expression evoked by stress signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeYOqfQy_PrVg90H21EOLACvtfcHk0ljeVbc36UdIWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7fN&md5=9249c0679a51cb5046ecc3c99d9eae9b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10636-10649.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10636-10649.2004%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DB.%2BC.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DHood%26aufirst%3DD.%2BB.%26aulast%3DSweeney%26aufirst%3DM.%26aulast%3DGould%26aufirst%3DJ.%2BM.%26aulast%3DBush%26aufirst%3DE.%2BW.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DThe%2520CRM1%2520nuclear%2520export%2520receptor%2520controls%2520pathological%2520cardiac%2520gene%2520expression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10636%26epage%3D10649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fielitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassel-Duby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Requirement of protein kinase D1 for pathological cardiac remodeling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3059</span><span class="NLM_x">–</span> <span class="NLM_lpage">3063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3059-3063&author=J.+Fielitzauthor=M.-S.+Kimauthor=J.+M.+Sheltonauthor=X.+Qiauthor=J.+A.+Hillauthor=J.+A.+Richardsonauthor=R.+Bassel-Dubyauthor=E.+N.+Olson&title=Requirement+of+protein+kinase+D1+for+pathological+cardiac+remodeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFielitz%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.-S.%26aulast%3DShelton%26aufirst%3DJ.%2BM.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DJ.%2BA.%26aulast%3DBassel-Duby%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DRequirement%2520of%2520protein%2520kinase%2520D1%2520for%2520pathological%2520cardiac%2520remodeling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3059%26epage%3D3063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ha, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhun, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfizenmaier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.-G.</span><span> </span><span class="NLM_article-title">Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">14590</span><span class="NLM_x">–</span> <span class="NLM_lpage">14599</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=14590-14599&author=C.+H.+Haauthor=W.+Wangauthor=B.+S.+Jhunauthor=C.+Wongauthor=A.+Hausserauthor=K.+Pfizenmaierauthor=T.+A.+McKinseyauthor=E.+N.+Olsonauthor=Z.-G.+Jin&title=Protein+kinase+D-dependent+phosphorylation+and+nuclear+export+of+histone+deacetylase+5+mediates+vascular+endothelial+growth+factor-induced+gene+expression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJhun%26aufirst%3DB.%2BS.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHausser%26aufirst%3DA.%26aulast%3DPfizenmaier%26aufirst%3DK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DJin%26aufirst%3DZ.-G.%26atitle%3DProtein%2520kinase%2520D-dependent%2520phosphorylation%2520and%2520nuclear%2520export%2520of%2520histone%2520deacetylase%25205%2520mediates%2520vascular%2520endothelial%2520growth%2520factor-induced%2520gene%2520expression%2520and%2520angiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D14590%26epage%3D14599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Backs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backs, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezprozvannaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span> </span><span class="NLM_article-title">Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3437</span><span class="NLM_x">–</span> <span class="NLM_lpage">3445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.01611-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=18332106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFeqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3437-3445&author=J.+Backsauthor=T.+Backsauthor=S.+Bezprozvannayaauthor=T.+A.+McKinseyauthor=E.+N.+Olson&title=Histone+deacetylase+5+acquires+calcium%2Fcalmodulin-dependent+kinase+II+responsiveness+by+oligomerization+with+histone+deacetylase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4</span></div><div class="casAuthors">Backs, Johannes; Backs, Thea; Bezprozvannaya, Svetlana; McKinsey, Timothy A.; Olson, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3437-3445</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates histone deacetylase 4 (HDAC4), a class IIa HDAC, resulting in the cytosolic accumulation of HDAC4 and the derepression of the transcription factor myocyte enhancer factor 2.  Phosphorylation by CaMKII requires docking of the kinase to a specific domain of HDAC4 not present in other HDACs.  Paradoxically, however, CaMKII signaling can also promote the nuclear export of other class IIa HDACs, such as HDAC5.  Here, we show that HDAC4 and HDAC5 form homo- and hetero-oligomers via a conserved coiled-coil domain near their amino termini.  Whereas HDAC5 alone is unresponsive to CaMKII, it becomes responsive to CaMKII in the presence of HDAC4.  The acquisition of CaMKII responsiveness by HDAC5 is mediated by HDAC5's direct assocn. with HDAC4 and can occur by phosphorylation of HDAC4 or by transphosphorylation by CaMKII bound to HDAC4.  Thus, HDAC4 integrates upstream Ca2+-dependent signals via its assocn. with CaMKII and transmits these signals to HDAC5 by protein-protein interactions.  We conclude that HDAC4 represents a point of convergence for CaMKII signaling to downstream HDAC-regulated genes, and we suggest that modulation of the interaction of CaMKII and HDAC4 represents a means of regulating CaMKII-dependent gene programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_bAGWW1eqrVg90H21EOLACvtfcHk0ljeVbc36UdIWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFeqs7o%253D&md5=e8f7d2bade53387f54d47ee53ac25a11</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1128%2FMCB.01611-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01611-07%26sid%3Dliteratum%253Aachs%26aulast%3DBacks%26aufirst%3DJ.%26aulast%3DBacks%26aufirst%3DT.%26aulast%3DBezprozvannaya%26aufirst%3DS.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26atitle%3DHistone%2520deacetylase%25205%2520acquires%2520calcium%252Fcalmodulin-dependent%2520kinase%2520II%2520responsiveness%2520by%2520oligomerization%2520with%2520histone%2520deacetylase%25204%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D3437%26epage%3D3445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huynh, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2006&pages=141-148&author=Q.+K.+Huynhauthor=T.+A.+McKinsey&title=Protein+kinase+D+directly+phosphorylates+histone+deacetylase+5+via+a+random+sequential+kinetic+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DQ.%2BK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinase%2520D%2520directly%2520phosphorylates%2520histone%2520deacetylase%25205%2520via%2520a%2520random%2520sequential%2520kinetic%2520mechanism%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D450%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vega, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papst, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8374</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1128%2FMCB.24.19.8374-8385.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15367659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=8374-8385&author=R.+B.+Vegaauthor=B.+C.+Harrisonauthor=E.+Meadowsauthor=C.+R.+Robertsauthor=P.+J.+Papstauthor=E.+N.+Olsonauthor=T.+A.+McKinsey&title=Protein+kinases+C+and+D+mediate+agonist-dependent+cardiac+hypertrophy+through+nuclear+export+of+histone+deacetylase+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5</span></div><div class="casAuthors">Vega, Rick B.; Harrison, Brooke C.; Meadows, Eric; Roberts, Charles R.; Papst, Philip J.; Olson, Eric N.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8374-8385</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A variety of stress signals stimulate cardiac myocytes to undergo hypertrophy.  Persistent cardiac hypertrophy is assocd. with elevated risk for the development of heart failure.  Recently, we showed that class II histone deacetylases (HDACs) suppress cardiac hypertrophy and that stress signals neutralize this repressive function by triggering phosphorylation- and CRM1-dependent nuclear export of these chromatin-modifying enzymes.  However, the identities of cardiac HDAC kinases have remained unclear.  Here, we demonstrate that signaling by protein kinase C (PKC) is sufficient and, in some cases, necessary to drive nuclear export of class II HDAC5 in cardiomyocytes.  Inhibition of PKC prevents nucleocytoplasmic shuttling of HDAC5 in response to a subset of hypertrophic agonists.  Moreover, a nonphosphorylatable HDAC5 mutant is refractory to PKC signaling and blocks cardiomyocyte hypertrophy mediated by pharmacol. activators of PKC.  We also demonstrate that protein kinase D (PKD), a downstream effector of PKC, directly phosphorylates HDAC5 and stimulates its nuclear export.  These findings reveal a novel function for the PKC/PKD axis in coupling extracellular cues to chromatin modifications that control cellular growth, and they suggest potential utility for small-mol. inhibitors of this pathway in the treatment of pathol. cardiac gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVy-E3aJHSD7Vg90H21EOLACvtfcHk0li53niNohWe9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVaktrk%253D&md5=a7ac41a59512a2e64fbbb0b6e4261257</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.19.8374-8385.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.19.8374-8385.2004%26sid%3Dliteratum%253Aachs%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DHarrison%26aufirst%3DB.%2BC.%26aulast%3DMeadows%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DPapst%26aufirst%3DP.%2BJ.%26aulast%3DOlson%26aufirst%3DE.%2BN.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinases%2520C%2520and%2520D%2520mediate%2520agonist-dependent%2520cardiac%2520hypertrophy%2520through%2520nuclear%2520export%2520of%2520histone%2520deacetylase%25205%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D8374%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Monovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemon, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=631-637&author=L.+Monovichauthor=R.+B.+Vegaauthor=E.+Meredithauthor=K.+Mirandaauthor=C.+Raoauthor=M.+Capparelliauthor=D.+D.+Lemonauthor=D.+Phanauthor=K.+A.+Kochauthor=J.+A.+Chapoauthor=D.+B.+Hoodauthor=T.+A.+McKinsey&title=A+novel+kinase+inhibitor+establishes+a+predominant+role+for+protein+kinase+D+as+a+cardiac+class+IIa+histone+deacetylase+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DVega%26aufirst%3DR.%2BB.%26aulast%3DMeredith%26aufirst%3DE.%26aulast%3DMiranda%26aufirst%3DK.%26aulast%3DRao%26aufirst%3DC.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DLemon%26aufirst%3DD.%2BD.%26aulast%3DPhan%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DK.%2BA.%26aulast%3DChapo%26aufirst%3DJ.%2BA.%26aulast%3DHood%26aufirst%3DD.%2BB.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DA%2520novel%2520kinase%2520inhibitor%2520establishes%2520a%2520predominant%2520role%2520for%2520protein%2520kinase%2520D%2520as%2520a%2520cardiac%2520class%2520IIa%2520histone%2520deacetylase%2520kinase%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D631%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gschwendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieterich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, F.-J.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase c isoenzymes</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1996&pages=77&author=M.+Gschwendtauthor=S.+Dieterichauthor=J.+Renneckeauthor=W.+Kittsteinauthor=H.-J.+Muellerauthor=F.-J.+Johannes&title=Inhibition+of+protein+kinase+C+%CE%BC+by+various+inhibitors.+Differentiation+from+protein+kinase+c+isoenzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGschwendt%26aufirst%3DM.%26aulast%3DDieterich%26aufirst%3DS.%26aulast%3DRennecke%26aufirst%3DJ.%26aulast%3DKittstein%26aufirst%3DW.%26aulast%3DMueller%26aufirst%3DH.-J.%26aulast%3DJohannes%26aufirst%3DF.-J.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520C%2520%25CE%25BC%2520by%2520various%2520inhibitors.%2520Differentiation%2520from%2520protein%2520kinase%2520c%2520isoenzymes%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D392%26spage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Singh, R.; Li, H.; Zhao, H.; Payan, D. G.; Kolluri, R.; Tso, K.; Ramphal, J.; Gu, S.</span><span> </span><span class="NLM_article-title">Preparation of Cyclic Amine Substituted Pyrimidinediamines as PKC Inhibitors</span>. WO 2009012421,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+Singh&author=H.+Li&author=H.+Zhao&author=D.+G.+Payan&author=R.+Kolluri&author=K.+Tso&author=J.+Ramphal&author=S.+Gu&title=Preparation+of+Cyclic+Amine+Substituted+Pyrimidinediamines+as+PKC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520Cyclic%2520Amine%2520Substituted%2520Pyrimidinediamines%2520as%2520PKC%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">AP2 Inhibitor</span> WO 2008088006,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Yokoyama&title=AP2+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DAP2%2520Inhibitor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raynham, T. M.; Hammonds, T. R.; Charles, M. D.; Pave, G. A.; Foxton, C. H.; Blackaby, W. P.; Stevens, A. P.; Ekwuru, C. T.</span><span> </span><span class="NLM_article-title">Pyridine Benzamides and Pyrazine Benzamides as PKD Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>, WO 2008074997,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+M.+Raynham&author=T.+R.+Hammonds&author=M.+D.+Charles&author=G.+A.+Pave&author=C.+H.+Foxton&author=W.+P.+Blackaby&author=A.+P.+Stevens&author=C.+T.+Ekwuru&title=Pyridine+Benzamides+and+Pyrazine+Benzamides+as+PKD+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26atitle%3DPyridine%2520Benzamides%2520and%2520Pyrazine%2520Benzamides%2520as%2520PKD%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raynham, T. M.; Hammonds, T. R.; Gilliatt, J. H.; Charles, M. D.; Pave, G. A.; Foxton, C. H.; Carr, J. L.; Mistry, N. S.</span><span> </span><span class="NLM_article-title">Aminoethylamino-aryl (AEAA) Compounds as PKD Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of PKD-Mediated Diseases</span>. WO 2007125331,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+M.+Raynham&author=T.+R.+Hammonds&author=J.+H.+Gilliatt&author=M.+D.+Charles&author=G.+A.+Pave&author=C.+H.+Foxton&author=J.+L.+Carr&author=N.+S.+Mistry&title=Aminoethylamino-aryl+%28AEAA%29+Compounds+as+PKD+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+PKD-Mediated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26atitle%3DAminoethylamino-aryl%2520%2528AEAA%2529%2520Compounds%2520as%2520PKD%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520PKD-Mediated%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gschwendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, F.-J.</span><span> </span><span class="NLM_article-title">Differential effects of suramin on protein kinase C isoenzymes, a novel tool for discriminating protein kinase C activities</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=1998&pages=165-168&author=M.+Gschwendtauthor=W.+Kittsteinauthor=F.-J.+Johannes&title=Differential+effects+of+suramin+on+protein+kinase+C+isoenzymes%2C+a+novel+tool+for+discriminating+protein+kinase+C+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGschwendt%26aufirst%3DM.%26aulast%3DKittstein%26aufirst%3DW.%26aulast%3DJohannes%26aufirst%3DF.-J.%26atitle%3DDifferential%2520effects%2520of%2520suramin%2520on%2520protein%2520kinase%2520C%2520isoenzymes%252C%2520a%2520novel%2520tool%2520for%2520discriminating%2520protein%2520kinase%2520C%2520activities%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D421%26spage%3D165%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sharlow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaValle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimgruber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo-Altamirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. J.</span><span> </span><span class="NLM_article-title">Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33516</span><span class="NLM_x">–</span> <span class="NLM_lpage">33526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33516-33526&author=E.+R.+Sharlowauthor=K.+V.+Giridharauthor=C.+R.+LaValleauthor=J.+Chenauthor=S.+Leimgruberauthor=R.+Barrettauthor=K.+Bravo-Altamiranoauthor=P.+Wipfauthor=J.+S.+Lazoauthor=Q.+J.+Wang&title=Potent+and+selective+disruption+of+protein+kinase+D+functionality+by+a+benzoxoloazepinolone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharlow%26aufirst%3DE.%2BR.%26aulast%3DGiridhar%26aufirst%3DK.%2BV.%26aulast%3DLaValle%26aufirst%3DC.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLeimgruber%26aufirst%3DS.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DBravo-Altamirano%26aufirst%3DK.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DQ.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520disruption%2520of%2520protein%2520kinase%2520D%2520functionality%2520by%2520a%2520benzoxoloazepinolone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33516%26epage%3D33526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Slater, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stagliano, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzas, C. J.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase C by resveratrol</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1637</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2FS0925-4439%2802%2900214-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=12527408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1SmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1637&publication_year=2003&pages=59-69&author=S.+J.+Slaterauthor=J.+L.+Seizauthor=A.+C.+Cookauthor=B.+A.+Staglianoauthor=C.+J.+Buzas&title=Inhibition+of+protein+kinase+C+by+resveratrol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein kinase C by resveratrol</span></div><div class="casAuthors">Slater, Simon J.; Seiz, Jodie L.; Cook, Anthony C.; Stagliano, Brigid A.; Buzas, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1637</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Resveratrol (RV), a polyphenolic phytoalexin present in dietary sources such as red wine, may protect against atherosclerosis and cardiovascular disease by enhancing the integrity of vascular endothelium.  Such beneficial effects of RV may arise from modulation of protein kinase C (PKC)-mediated signaling.  This was investigated by detg. the effects of RV on in vitro activities of recombinant PKC isoenzymes (PKCα, PKCβ1, and PKCε) obtained in Sf9 insect cell expression system.  The Ca2+-dependent activities of membrane-assocd. PKCα induced by phorbol ester or diacylglycerol were potently inhibited by RV (IC50 ∼2 μM each compd.).  The inhibitory effect of RV was also obsd. for conventional PKCβI, whereas the activities of novel PKCε and atypical PKCζ were not affected.  The inhibition of PKCα activity was competitive with respect to phorbol ester concn., but noncompetitive with respect to Ca2+ and phosphatidylserine concns., suggesting that RV may compete for phorbol ester binding to the C1 domains.  Supporting this, it was found that RV bound to a fusion peptide contg. the C1A and C1B domains of PKCα.  Similar to the effects of diacylglycerol and phorbol ester, the interaction of RV with the C1 domains induced the assocn. of PKCα with membrane lipid vesicles, although this did not result in activation.  The inhibitory effect of RV on PKC activity and on the assocd. signaling networks may underlie the mechanism(s) by which this agent exerts its beneficial effects on endothelial and cardiovascular functions.  The effects of RV on these signaling networks may differ according to the cellular localization and the regulating PKC isoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoocPDllWO2bbVg90H21EOLACvtfcHk0lgKXQ7ijhNxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1SmsA%253D%253D&md5=372a5e1f9dd63a099a434153277123df</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2802%2900214-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252802%252900214-4%26sid%3Dliteratum%253Aachs%26aulast%3DSlater%26aufirst%3DS.%2BJ.%26aulast%3DSeiz%26aufirst%3DJ.%2BL.%26aulast%3DCook%26aufirst%3DA.%2BC.%26aulast%3DStagliano%26aufirst%3DB.%2BA.%26aulast%3DBuzas%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520C%2520by%2520resveratrol%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2003%26volume%3D1637%26spage%3D59%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Haworth, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase D by resveratrol</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1647</span><span class="NLM_x">–</span> <span class="NLM_lpage">1651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1647-1651&author=R.+S.+Haworthauthor=M.+Avkiran&title=Inhibition+of+protein+kinase+D+by+resveratrol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaworth%26aufirst%3DR.%2BS.%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520D%2520by%2520resveratrol%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1647%26epage%3D1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Storz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toker, A.</span><span> </span><span class="NLM_article-title">Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=870-879&author=P.+Storzauthor=H.+Dopplerauthor=A.+Toker&title=Activation+loop+phosphorylation+controls+protein+kinase+D-dependent+activation+of+nuclear+factor+kappaB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DActivation%2520loop%2520phosphorylation%2520controls%2520protein%2520kinase%2520D-dependent%2520activation%2520of%2520nuclear%2520factor%2520kappaB%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D870%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rozengurt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, T.</span><span> </span><span class="NLM_article-title">Protein kinase D signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13205</span><span class="NLM_x">–</span> <span class="NLM_lpage">13208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13205-13208&author=E.+Rozengurtauthor=O.+Reyauthor=T.+Waldron&title=Protein+kinase+D+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozengurt%26aufirst%3DE.%26aulast%3DRey%26aufirst%3DO.%26aulast%3DWaldron%26aufirst%3DT.%26atitle%3DProtein%2520kinase%2520D%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13205%26epage%3D13208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1093%2Fbioinformatics%2Fbtp650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=19942586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=198-204&author=D.+Huangauthor=T.+Zhouauthor=K.+Lafleurauthor=C.+Nevadoauthor=A.+Caflisch&title=Kinase+selectivity+potential+for+inhibitors+targeting+the+ATP+binding+site%3A+a+network+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span></div><div class="casAuthors">Huang, Danzhi; Zhou, Ting; Lafleur, Karine; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Small-mol. inhibitors targeting the ATP binding pocket of the catalytic domain of protein kinases have potential to become drugs devoid of (major) side effects, particularly if they bind selectively.  Here, the sequences of the 518 human kinases are first mapped onto the structural alignment of 116 kinases of known three-dimensional structure.  The multiple structure alignment is then used to encode the known strategies for developing selective inhibitors into a fingerprint.  Finally, a network anal. is used to partition the kinases into clusters according to similarity of their fingerprints, i.e., physico-chem. characteristics of the residues responsible for selective binding.  For each kinase the network anal. reveals the likelihood to find selective inhibitors targeting the ATP binding site.  Systematic guidelines are proposed to develop selective inhibitors.  Importantly, the network anal. suggests that the tyrosine kinase EphB4 has high selectivity potential, which is consistent with the selectivity profile of two novel EphB4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVQsrpqB_ILVg90H21EOLACvtfcHk0lgKXQ7ijhNxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D&md5=b6c63ccd4654219a56752f9cfc1356a3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp650%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DKinase%2520selectivity%2520potential%2520for%2520inhibitors%2520targeting%2520the%2520ATP%2520binding%2520site%253A%2520a%2520network%2520analysis%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D198%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wang, Q. J.</span><span> </span><span class="NLM_article-title">PKD at the crossroads of DAG and PKC signaling</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=317-323&author=Q.+J.+Wang&title=PKD+at+the+crossroads+of+DAG+and+PKC+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BJ.%26atitle%3DPKD%2520at%2520the%2520crossroads%2520of%2520DAG%2520and%2520PKC%2520signaling%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D317%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Huynh, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">Protein kinase D directly phoshporylates histone deacetylase 5 via a random sequential kinetic mechansim</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2006&pages=141-148&author=Q.+K.+Huynhauthor=T.+A.+McKinsey&title=Protein+kinase+D+directly+phoshporylates+histone+deacetylase+5+via+a+random+sequential+kinetic+mechansim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DQ.%2BK.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DProtein%2520kinase%2520D%2520directly%2520phoshporylates%2520histone%2520deacetylase%25205%2520via%2520a%2520random%2520sequential%2520kinetic%2520mechansim%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D450%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Izumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanmatsuse, K.</span><span> </span><span class="NLM_article-title">Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the α 1-adrenergic antagonist bunazosin in Dahl salt-sensitive rats</span> <span class="citation_source-journal">Hypertens. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1291%2Fhypres.19.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=8891742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADyaK28XmsVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=147-150&author=Y.+Izumiauthor=M.+Matsuokaauthor=A.+Kuboauthor=T.+Nakayamaauthor=N.+Fukudaauthor=Y.+Watanabeauthor=M.+Somaauthor=K.+Kanmatsuse&title=Prevention+of+cardiac+hypertrophy+by+a+sub-antihypertensive+dose+of+the+%CE%B1+1-adrenergic+antagonist+bunazosin+in+Dahl+salt-sensitive+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the α1-adrenergic antagonist bunazosin in Dahl salt-sensitive rats</span></div><div class="casAuthors">Izumi, Yoichi; Matsuoka, Masako; Kubo, Atsusi; Nakayama, Tomohiro; Fukuda, Noboru; Watanabe, Yoshiyasu; Soma, Masayoshi; Kanmatsuse, Katsuo</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-150</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Hypertension</span>)
        </div><div class="casAbstract">To assess the protective effect of an α1-blocker on the development of cardiac hypertrophy, the selective α1-receptor antagonist bunazosin (2 mg/kg/d, by oral gavage and in drinking water) was given to male Dahl salt-sensitive rats fed a 4% NaCl diet for 7 wk.  Control animals received water only by the same method.  Treatment with bunazosin was started when the animals were 7 wk of age.  Blood pressure, pulse rates, and body wt. were measured every week during the expt.  Urine was collected for 24 h on the final day of the expt.  All animals were killed by decapitation, blood was collected, and the heart was removed.  In both the treated and control groups, time-dependent increases in blood pressure and body wt. were obsd., and there were no significant differences between the groups in blood pressure or body wt. during the expt.  Pulse rate remained unchanged in both groups throughout the expt.  The left ventricular wt./body wt. ratio and the left ventricular tissue DNA content were significantly lower in the rats receiving bunazosin than in the control rats.  Plasma renin activity, plasma aldosterone, and plasma atrial natriuretic peptide did not differ significantly between the two groups.  No significant differences in glomerular filtration rate, urine vol., sodium excretion, urinary metanephrine excretion, and urinary normetanephrine excretion were noted between the two groups.  The results indicate that a sub-antihypertensive dose of bunazosin can inhibit the development of cardiac hypertrophy without suppression of the pressure load, suggesting an important role of α1-adrenergic receptors in the pathogenesis of cardiac hypertrophy following the development of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEGyLYtavRLbVg90H21EOLACvtfcHk0ljmh_Bw2W3vow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVaisLk%253D&md5=d21ef76dacf40b5c49ba42e983694a24</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1291%2Fhypres.19.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1291%252Fhypres.19.147%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DSoma%26aufirst%3DM.%26aulast%3DKanmatsuse%26aufirst%3DK.%26atitle%3DPrevention%2520of%2520cardiac%2520hypertrophy%2520by%2520a%2520sub-antihypertensive%2520dose%2520of%2520the%2520%25CE%25B1%25201-adrenergic%2520antagonist%2520bunazosin%2520in%2520Dahl%2520salt-sensitive%2520rats%26jtitle%3DHypertens.%2520Res.%26date%3D1996%26volume%3D19%26spage%3D147%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, Y.</span><span> </span><span class="NLM_article-title">β-Blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.amjhyper.2004.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15607617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100075z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyqsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1112-1119&author=M.+Kobayashiauthor=N.+Machidaauthor=M.+Mitsuishiauthor=Y.+Yamane&title=%CE%B2-Blocker+improves+survival%2C+left+ventricular+function%2C+and+myocardial+remodeling+in+hypertensive+rats+with+diastolic+heart+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">β-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure</span></div><div class="casAuthors">Kobayashi, Masayuki; Machida, Noboru; Mitsuishi, Megumi; Yamane, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">1112-1119</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Chronic β-blocker therapy improves survival and left ventricular (LV) systolic function in patients with congestive heart failure.  However, its efficacy in diastolic heart failure (DHF) with preserved normal LV systolic function remains uncertain.  Methods: Dahl salt-sensitive hypertensive rats fed a high-salt diet from 7 wk of age were randomized to groups that were either not treated (DHF; n = 20) or treated with metoprolol (MP) from 7 wk of age (DHF+7wkMP; n = 22) or from 17 wk of age (DHF+17wkMP; n = 8).  Both LV function and remodeling were evaluated by serial echocardiog., followed by hemodynamic and pathol. studies.  Results: Hypertension and pressure-overload LV hypertrophy were established by 17 wk of age in DHF rats.  At about 20 wk of age DHF rats experienced overt heart failure, which was accompanied not by a decrease in LV fractional shortening but by diastolic filling abnormalities.  The LV concentric hypertrophy was strikingly attenuated in DHF+7wkMP rats but not in DHF+17wkMP rats.  However, LV myocardial fibrosis and the further progression of diastolic dysfunction were prevented in both MP-treated groups.  Survival at 21 wk of age was significantly improved in DHF+7wkMP (86%) and DHF+17wkMP (75%) rats compared with DHF rats (25%).  Conclusions: In this study, MP prevented not only the development of LV hypertrophy but also the progression of diastolic dysfunction, and improved survival in rats with DHF.  The preventive effect of MP on myocardial fibrosis is suggested as one of the mechanisms contributing to halt the progression of diastolic dysfunction, a finding that may lead to clin. benefits in regard to DHF caused by hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcHDw2HXKN7Vg90H21EOLACvtfcHk0ljmh_Bw2W3vow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyqsrjK&md5=2d9f6b6d3cc6e481ceabda26c8672038</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2004.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2004.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMachida%26aufirst%3DN.%26aulast%3DMitsuishi%26aufirst%3DM.%26aulast%3DYamane%26aufirst%3DY.%26atitle%3D%25CE%25B2-Blocker%2520improves%2520survival%252C%2520left%2520ventricular%2520function%252C%2520and%2520myocardial%2520remodeling%2520in%2520hypertensive%2520rats%2520with%2520diastolic%2520heart%2520failure%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2004%26volume%3D17%26spage%3D1112%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hardt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadoshima, J.</span><span> </span><span class="NLM_article-title">Negative regulators of cardiac hypertrophy</span> <span class="citation_source-journal">Cardiovas. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm100075z&amp;key=10.1016%2Fj.cardiores.2004.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm100075z&amp;key=15276475" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=500-509&author=S.+E.+Hardtauthor=J.+Sadoshima&title=Negative+regulators+of+cardiac+hypertrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DHardt%26aufirst%3DS.%2BE.%26aulast%3DSadoshima%26aufirst%3DJ.%26atitle%3DNegative%2520regulators%2520of%2520cardiac%2520hypertrophy%26jtitle%3DCardiovas.%2520Res.%26date%3D2004%26spage%3D500%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Meredith, E. L.; Beattie, K.; Burgis, R.; Capparelli, M.; Chapo, J.; DiPietro, L.; Gamber, G.; Enyedy, I.; Hood, D. B.; Hosagrahara, V.; Jewell, C.; Koch, K. A.; Lee, W.; Lemon, D. D.; McKinsey, T. A.; Miranda, K.; Pagratis, N.; Phan, D.; Plato, C.; Rao, C.; Rozhitskaya, O.; Soldermann, N.; Springer, C.; Van Eis, M.; Vega, R. B.; Yan, W.; Zhu, Q.; Monovich, L.</span><span> </span><span class="NLM_article-title">Identification of potent and selective amidobipyridyl inhibitors of protein kinase D</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm100076w</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm100076w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Meredith%2C+E.+L.%3B+Beattie%2C+K.%3B+Burgis%2C+R.%3B+Capparelli%2C+M.%3B+Chapo%2C+J.%3B+DiPietro%2C+L.%3B+Gamber%2C+G.%3B+Enyedy%2C+I.%3B+Hood%2C+D.+B.%3B+Hosagrahara%2C+V.%3B+Jewell%2C+C.%3B+Koch%2C+K.+A.%3B+Lee%2C+W.%3B+Lemon%2C+D.+D.%3B+McKinsey%2C+T.+A.%3B+Miranda%2C+K.%3B+Pagratis%2C+N.%3B+Phan%2C+D.%3B+Plato%2C+C.%3B+Rao%2C+C.%3B+Rozhitskaya%2C+O.%3B+Soldermann%2C+N.%3B+Springer%2C+C.%3B+Van+Eis%2C+M.%3B+Vega%2C+R.+B.%3B+Yan%2C+W.%3B+Zhu%2C+Q.%3B+Monovich%2C+L.+Identification+of+potent+and+selective+amidobipyridyl+inhibitors+of+protein+kinase+D.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm100076w."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100076w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100076w%26sid%3Dliteratum%253Aachs%26aulast%3DMeredith%26aufirst%3DE.%2BL.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520amidobipyridyl%2520inhibitors%2520of%2520protein%2520kinase%2520D%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm100076w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrino, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, D. A.</span><span> </span><span class="NLM_article-title">Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-<i>a</i>]isoquinoline platelet activating factor receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3098</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00073a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3098-3102&author=W.+J.+Houlihanauthor=S.+H.+Cheonauthor=V.+A.+Parrinoauthor=D.+A.+Handleyauthor=D.+A.+Larson&title=Structural+modification+of+5-aryl-2%2C3-dihydroimidazo%5B2%2C1-a%5Disoquinoline+platelet+activating+factor+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00073a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00073a008%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCheon%26aufirst%3DS.%2BH.%26aulast%3DParrino%26aufirst%3DV.%2BA.%26aulast%3DHandley%26aufirst%3DD.%2BA.%26aulast%3DLarson%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520modification%2520of%25205-aryl-2%252C3-dihydroimidazo%255B2%252C1-a%255Disoquinoline%2520platelet%2520activating%2520factor%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3098%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a href="/doi/suppl/10.1021/jm100075z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66862"></div></div></div></div></div><hr /></hr><p class="last">Figures S1 and S2 showing the PK iv and po curves for <b>13c</b> and <b>13y</b>; Table T1 listing percent activity remaining for kinases. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100075z/suppl_file/jm100075z_si_001.pdf">jm100075z_si_001.pdf (157.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100075z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100075z%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100075z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679999131e0dd187","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
